8-K
Alexandria Real Estate Equities, Inc. (ARE)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 26, 2013
ALEXANDRIA REAL ESTATE EQUITIES, INC.
(Exact name of registrant as specified in its charter)
| Maryland | 1-12993 | 95-4502084 |
|---|---|---|
| (State or other jurisdiction of<br> incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 385 East Colorado Boulevard, Suite 299 | **** | |
| --- | --- | |
| Pasadena, California | 91101 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (626) 578-0777
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))
Item 1.01. Entry into a Material Definitive Agreement.
On July 26, 2013, Alexandria Real Estate Equities, Inc. and Alexandria Real Estate Equities, L.P. (collectively, the “Company”) entered into a Second Amended and Restated Term Loan Agreement with Citibank, N.A., as administrative agent, Citigroup Global Markets Inc., RBC Capital Markets and RBS Securities Inc., as joint lead arrangers and joint book running managers, and certain financial institutions party thereto as lenders (the “Amended Term Loan Agreement”). The Amended Term Loan Agreement amends and restates that certain Amended and Restated Term Loan Agreement, dated June 30, 2011, as amended on April 30, 2012, among the Company, Citibank N.A. and certain financial institutions party thereto as lenders (the “Prior Term Loan Agreement”) to, among other things, decrease the applicable interest rate margins in respect of the loan thereunder (the “Loan”) and extend the maturity date of the loan originally provided under the Prior Term Loan Agreement from June 30, 2015, to July 31, 2015, subject to the Company’s sole option to extend the maturity date up to two times for an additional term of six months each time upon the satisfaction of certain conditions.
Under the Amended Term Loan Agreement, the Loan will bear interest at a “Eurodollar Rate” or a “Base Rate” specified in the Amended Term Loan Agreement, plus, in either case, a margin specified in the Amended Term Loan Agreement. The margin at closing was 1.20% and was applied to the Eurodollar Rate.
The “Eurodollar Rate” is the rate per annum equal to the British Bankers Association (or any other person which takes over the administration of that rate) LIBOR Rate, or if such rate is not available at the time of determination, the rate per annum determined by the administrative agent to be the rate at which deposits in US dollars for delivery on the date of determination in same day funds in the approximate amount of the borrowing would be offered by Citibank’s London Branch to major banks in the London interbank Eurodollar market at their request. The “Base Rate” means for any day a fluctuating rate per annum equal to the highest of (a) the federal funds rate plus 1/2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by Citibank as its “base rate,” and (c) the Eurodollar Rate plus 1.00%.
Under the Amended Term Loan Agreement, the financial covenants under the Prior Term Loan Agreement were not amended and are identical to the financial covenants required under the Company’s existing unsecured credit facility. The Company must not, as of the last day of any fiscal quarter, permit its:
· leverage ratio to exceed 60.0%, except for four calculation dates immediately following any acquisition in which the assets acquired exceed 5% of the Company’s total assets (a “Material Acquisition”), in which case its leverage ratio is not to exceed 65.0%
· unsecured leverage ratio to exceed 60.0%, except for four calculation dates immediately following any Material Acquisition, in which case its unsecured leverage ratio is not to exceed 65.0%
· unsecured interest coverage ratio to be less than 1.75 to 1.00
· secured debt ratio to exceed 40.0%, except for four calculation dates immediately following any Material Acquisition, in which case its secured debt ratio is not to exceed 45.0%
· fixed charge coverage ratio to be less than 1.50:1.00
· minimum book value to be less than the sum of $2.0 billion and 50% of the net proceeds of equity offerings after January 28, 2011
The Company may, upon notice to the administrative agent, at any time or from time to time voluntarily prepay the Loan in whole or in part without premium or penalty; provided that any prepayment shall be in a principal amount of at least $500,000 or, if less, the entire principal amount thereof then outstanding.
The foregoing summary of the Amended Term Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended Term Loan Agreement, a copy of which will be filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2013.
Item 2.02. Results of Operations and Financial Condition.
On July 29, 2013, the Company issued a press release entitled “Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2013 Financial and Operating Results” which sets forth the Company’s results of operations and financial condition for the second quarter ended June 30, 2013. The press release referred to certain supplemental information that is available on the Company’s website at www.are.com. Copies of the press release and supplemental information are attached hereto as Exhibits 99.1 and 99.2, respectively.
2
The information contained in this Item 2.02, including the exhibits referenced herein, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information included in Item 1.01 is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press Release dated July 29, 2013.
99.2 Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the Second Quarter Ended June 30, 2013.
Forward-looking Statements
This current report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates,” or “anticipates,” or the negative of these words or similar words, and include (without limitation) statements regarding the anticipated maturity date of the Amended Term Loan Agreement. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement. A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company’s filings with the Securities and Exchange Commission, including the Company’s most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q. The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | ||
|---|---|---|
| July 30, 2013 | By: | /s/ Joel S. Marcus |
| Joel S. Marcus | ||
| Chairman/Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| By: | /s/ Dean A. Shigenaga | |
| Dean A. Shigenaga | ||
| Chief Financial Officer | ||
| (Principal Financial Officer) |
4
EXHIBIT INDEX
| Exhibit **** Number | Exhibit Title |
|---|---|
| 99.1 | Press Release dated July 29, 2013. |
| 99.2 | Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the Second Quarter Ended June 30, 2013. |
5
Exhibit 99.1

| Contact: | Joel S. Marcus |
|---|---|
| Chairman, Chief Executive Officer, & Founder | |
| Alexandria Real Estate Equities, Inc. | |
| **** | (626) 578-9693 |
Alexandria Real Estate Equities, Inc.
Reports
Second Quarter Ended June 30, 2013
Financial and Operating Results
FFO Per Share – Diluted, as Adjusted, of $1.07 for 2Q13
AFFO Per Share – Diluted of $1.00 for 2Q13
EPS Per Share – Diluted of $0.38 for 2Q13
Total Revenues of $154.2 Million for 2Q13
NOI of $107.9 Million for 2Q13
Continued Solid Life Science Space Demand in Key Cluster Submarkets
PASADENA, CA. – July 29, 2013 – Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the second quarter ended June 30, 2013.
Second quarter ended June 30, 2013, highlights
Results
· Funds from operations (“FFO”) attributable to Alexandria Real Estate Equities, Inc.’s (“Alexandria’s”) common stockholders – diluted, as adjusted:
· $71.6 million, or $1.07 per share, for 2Q13 compared to $65.8 million, or $1.07 per share, for 2Q12
· $141.6 million, or $2.18 per share, for YTD 2Q13 compared to $132.0 million, or $2.14 per share, for YTD 2Q12
· Adjusted funds from operations (“AFFO”) attributable to Alexandria’s common stockholders – diluted:
· $66.8 million, or $1.00 per share, for 2Q13 compared to $64.0 million, or $1.04 per share, for 2Q12
· $134.7 million, or $2.07 per share, for YTD 2Q13 compared to $126.4 million, or $2.05 per share, for YTD 2Q12
· Net income attributable to Alexandria’s common stockholders – diluted:
· $25.5 million, or $0.38 per share, for 2Q13 compared to $17.6 million, or $0.29 per share, for 2Q12
· $47.9 million, or $0.74 per share, for YTD 2Q13 compared to $36.0 million, or $0.58 per share, for YTD 2Q12
Core operating metrics
· Total revenues from continuing operations:
· $154.2 million for 2Q13, up 5.9%, compared to $145.6 million for 2Q12
· $304.6 million YTD 2Q13, up 8.3%, compared to $281.3 million for YTD 2Q12
· Net operating income (“NOI”) from continuing operations:
· $107.9 million for 2Q13, up 4.3%, compared to $103.5 million for 2Q12
· $213.1 million for YTD 2Q13, up 7.2%, compared to $198.7 million for YTD 2Q12
· Same property NOI performance:
· 7.2% and 3.2% increases on a cash and GAAP basis, respectively, for 2Q13 compared to 2Q12
· 8.3% and 2.0% increases on a cash and GAAP basis, respectively, for YTD 2Q13 compared to YTD 2Q12
· Leasing activity solid during the three months ended June 30, 2013:
· Executed 66 leases for 768,000 rentable square feet (“RSF”), including 270,000 RSF of development and redevelopment space
· Rental rate increase of 6.7% and 12.7% on a cash and GAAP basis, respectively, on renewed/re-leased space
· Key life science space leasing:
· Investment-grade entity leased 121,632 RSF at 430 East 29th Street development in the Greater NYC market
· Illumina, Inc. leased 97,702 RSF at 499 Illinois Street development in the San Francisco Bay Area market
· Sarepta Therapeutics, Inc. leased 46,376 RSF at 215 First Street in the Greater Boston market
· Eli Lilly and Company leased 27,950 RSF at 620 Professional Drive in the Suburban Washington, D.C. market
· Nominal remaining expiring leases in 2013 of 410,254 RSF, or 3% of total operating RSF
· Occupancy for North American Properties, as of June 30, 2013:
· 94.6% for operating properties and 92.9% for operating and redevelopment properties, up 40 bps and 110 bps, respectively, since March 31, 2013
· Operating margins remained steady at 70% for 2Q13 and YTD 2Q13
· Investment-grade client tenants represented 46% of total annualized base rent (“ABR”)
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Second Quarter Ended June 30, 2013
Financial and Operating Results
Core operating metrics (continued)
· Investment-grade client tenants represented 72% of ABR from our top 10 client tenants
· Contractual annual rent escalations in 95% of our leases
Balance sheet
· Completed in 2Q13 secondary offering of 7.6 million shares of common stock at a price of $73.50 per share. The net proceeds of $535.5 million were used to repay outstanding balances under our unsecured senior line of credit.
· Completed in 2Q13 $500 million 3.90% 10-year unsecured senior notes payable offering. Net proceeds of $495.3 million were used to reduce outstanding variable rate bank debt, including a $150 million partial repayment of our $750 million 2016 Unsecured Senior Bank Term Loan and to increase our available cash balance. In connection with the partial repayment of our 2016 Unsecured Senior Bank Term Loan, we recognized a loss on the early extinguishment of debt related to the write-off of unamortized loan fees totaling $0.6 million, or $0.01 per share.
· Liquidity of $1.8 billion, including $1.5 billion available under our unsecured senior line of credit and $302.2 million in cash and cash equivalents as of June 30, 2013.
· Closed in 2Q13 secured construction loan, with aggregate commitments of $36 million at a rate of LIBOR + 1.40%, for 100% pre-leased development project at 269 East Grand Avenue in the San Francisco Bay Area market.
· Net debt to EBITDA of 6.6x for the twelve months ended June 30, 2013.
· Fixed charge coverage ratio of 2.7x for the twelve months ended June 30, 2013.
· Unhedged variable rate debt totaling 11% of total consolidated debt as of June 30, 2013.
· Completed in 2Q13 $22.5 million of real estate property sales, at a gain of $1.0 million, as follows:
· $4.4 million of non-strategic income producing assets at a gain of $0.2 million
· $18.1 million of non-income-producing land at a gain of $0.8 million
Subsequent events
Ariad Pharmaceuticals, Inc. expansion
On July 3, 2013, Ariad Pharmaceuticals, Inc. executed an LOI to lease an additional 139,374 RSF for a 15 year term at our 75/125 Binney Street development in the Cambridge submarket of Greater Boston. An amendment to their lease is under negotiation to increase their lease to 383,497 RSF, or 99% of the total RSF of the project.
Sale of land parcel at 1600 Owens Street
On July 8, 2013, we executed a purchase and sale agreement to dispose of our land parcel at 1600 Owens Street in the Mission Bay submarket of the San Francisco Bay Area for an aggregate sales price of $55.2 million, inclusive of certain parking spaces. Ownership of the parcel was strategically important to the buyer and we will earn a fee to manage the construction of the building. This sale is expected to close in December 2013.
Acquisition of 10121/10151 Barnes Canyon Road
On July 5, 2013, we acquired 10121/10151 Barnes Canyon Road, an approximate 116,000 RSF office property located in the Sorrento Mesa submarket of San Diego, for a total purchase price of $13.1 million. The acquisition will be funded in two installments: i) $5.4 million to be funded in August, 2013 (which will earn a 7% return until the next payment is made), and ii) $7.7 million to be funded no later than October 2014. The property is currently 100% occupied with leases that expire in 2014 and 2015. We intend to convert the existing office space into laboratory space through redevelopment when the space becomes available. Initial stabilized yields will be provided in the future upon commencement of the redevelopment.
Unsecured senior bank loan financings
On July 26, 2013, we amended our $600 million 2016 Unsecured Senior Bank Term Loan to reduce our interest rate on outstanding borrowings. We did not extend the maturity of this loan as we expect to repay the loan over the next one to three years. In addition, we expect to complete amendments to our $1.5 billion unsecured senior line of credit and our $600 million 2017 Unsecured Senior Bank Term Loan in the third quarter of 2013 to reduce our interest rate on outstanding borrowings, extend the maturity dates and amend certain financial covenants. The commitments available for each facility will not change.
| Maturity Date (including extensions) | Applicable Rate | Facility Fee | |||||
|---|---|---|---|---|---|---|---|
| Facility | Status | Prior/<br> Current | Extended/<br> Proposed | Prior/<br> Current | Extended/<br> Proposed | Prior/<br> Current | Extended/<br> Proposed |
| $600 million 2016 Unsecured Senior Bank Term Loan | Complete | June 2016 | July 2016 | L +1.75% | L +1.20% | N/A | N/A |
| $600 million 2017 Unsecured Senior Bank Term Loan | In Progress | January 2017 | January 2019 | L +1.50% | L +1.20% | N/A | N/A |
| $1.5 billion unsecured senior line of credit | In Progress | April 2017 | January 2019 | L +1.20% | L +1.10% | 0.25% | 0.20% |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 2 | ||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Guidance
Based on our current view of existing market conditions and certain current assumptions, we have updated guidance for earnings per share attributable to Alexandria’s common stockholders – diluted and FFO per share attributable to Alexandria’s common stockholders – diluted for the year ended December 31, 2013, as set forth in the table below. The table below provides a reconciliation of FFO per share, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure, as well as other key assumptions included in our guidance for the year ended December 31, 2013. To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.
| Guidance for the Year Ended December 31, 2013 | Reported on July 29, 2013 | Reported on May 13, 2013 |
|---|---|---|
| Earnings per share attributable to Alexandria’s common stockholders – diluted | $1.53 to $1.63 | $1.50 to $1.60 |
| Depreciation and amortization | $2.76 to $2.86 | $2.80 to $2.90 |
| (Gain) loss on sale of real estate | $(0.01) | $0.01 |
| Other | $(0.01) | $(0.01) |
| FFO per share attributable to Alexandria’s common stockholders – diluted | $4.32 to $4.42 | $4.35 to $4.45 |
| Add back: actual 2Q13 per share loss on early extinguishment of debt (1) | $0.01 | N/A |
| Add back: projected 3Q13 per share loss on early extinguishment of debt (1) | $0.02 | N/A |
| FFO per share attributable to Alexandria’s common stockholders - diluted, as adjusted | $4.35 to $4.45 | $4.35 to $4.45 |
| Key projection assumptions: | ||
| Same property NOI growth – cash basis | 5% to 7% | 5% to 7% |
| Same property NOI growth – GAAP basis | 1% to 3% | 1% to 3% |
| Rental rate steps on lease renewals and re-leasing of space – cash basis | 3% to 5% | 1% to 3% |
| Rental rate steps on lease renewals and re-leasing of space – GAAP basis | 11% to 13% | 7% to 12% |
| Occupancy percentage for all operating properties at December 31, 2013 | 94.3% to 94.7% | 94.3% to 94.7% |
| Straight-line rents | $24 to $26 million | $24 to $26 million |
| Amortization of above and below market leases | $3 to $4 million | $3 to $4 million |
| General and administrative expenses | $48 to $51 million | $48 to $51 million |
| Capitalization of interest | $51 to $57 million | $51 to $57 million |
| Interest expense, net | $71 to $81 million | $71 to $81 million |
| Net debt to adjusted EBITDA for the annualized three months ended December 31, 2013 | 6.5x | 6.5x |
| Fixed charge coverage ratio for the annualized three months ended December 31, 2013 | 3.0x | 3.0x |
| Non-income-producing land as a percentage of gross real estate by December 31, 2013 | 15% to 17% | 15% to 17% |
(1) Represents loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.01 per share as a result of the $150 million partial repayment of our 2016 Unsecured Senior Bank Term Loan during the three months ended June 30, 2013, and the estimated loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.02 per share as a result of amendments of our 2016 Unsecured Senior Bank Term Loan, 2017 Unsecured Senior Bank Term Loan, and $1.5 billion unsecured senior line of credit which we expect to complete in the third quarter of 2013.
We expect that our principal liquidity needs for the year ended December 31, 2013, will be satisfied by the following multiple sources of capital as shown in the table below. There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.
| Reported on<br> July 29, 2013 | Reported on<br> May 13, 2013 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sources and Uses of Capital for the Year Ended December 31, 2013 (in millions) | Completed | Projected | Total | Total | |||||
| Sources of capital: | |||||||||
| Net cash provided by operating activities less dividends | $ | 66 | $ | 64 - 84 | $ | 130 - 150 | $ | 130 - 150 | |
| Non-income-producing land sales | 18 | 131 - 171 | (1) | 149 - 189 | 149 - 189 | ||||
| Income producing asset sales | 129 | 0 - 5 | 129 - 134 | 125 - 138 | |||||
| Secured construction loan borrowings | 26 | 19 - 39 | 45 - 65 | 45 - 55 | |||||
| Unsecured senior notes payable | 500 | – | 500 | 350 - 450 | |||||
| Common stock offering | 536 | – | 536 | 415 - 490 | |||||
| Available cash and borrowings on unsecured senior line of credit (2) | – | 324 - 369 | 324 - 369 | – | |||||
| Total sources of capital | $ | 1,275 | $ | 538 - 668 | $ | 1,813 - 1,943 | $ | 1,214 - 1,472 | |
| Uses of capital: | |||||||||
| Development, redevelopment, and construction | $ | 253 | $ | 346 - 376 | $ | 599 - 629 | $ | 617 - 667 | |
| Seller financing of asset sales | 39 | – | 39 | 39 | |||||
| Acquisitions: | |||||||||
| Completed/in process acquisitions | 13 | 64 | 77 | – | |||||
| Additional acquisitions | - | 123 - 223 | 123 - 223 | 200 - 300 | |||||
| Secured notes payable repayments | 32 | 5 | 37 | 37 | |||||
| Unsecured senior bank term loan repayment | 150 | – | 150 | 125 - 175 | |||||
| Excess cash retained from issuance of unsecured senior notes payable/pay down of unsecured senior line of credit | 788 | – | 788 | 196 - 254 | |||||
| Total uses of capital | $ | 1,275 | $ | 538 - 668 | $ | 1,813 - 1,943 | $ | 1,214 - 1,472 |
(1) See Balance Sheet section of our Supplemental Package for additional information.
(2) We had $302.2 million in cash and cash equivalents as of June 30, 2013.
The key assumptions behind the sources and uses of capital in the table are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals. Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking statements” section under Part I, the “Risk Factors” section under Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2012. We expect to update our forecast of sources and uses of capital on a quarterly basis.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 3 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Earnings Call Information
We will host a conference call on Tuesday, July 30, 2013, at 3:00 p.m. Eastern Time (“ET”)/12:00 p.m. noon Pacific Time (“PT”) that is open to the general public to discuss our financial and operating results for the three months ended June 30, 2013. To participate in this conference call, dial (888) 724-9493 or (913) 312-1456 and confirmation code 7393551, shortly before 3:00 p.m. ET/12:00 p.m. noon PT. The audio web cast can be accessed at: www.are.com, in the “For Investors” section. A replay of the call will be available for a limited time from 6:00 p.m. ET/3:00 p.m. PT on Tuesday, July 30, 2013. The replay number is (888) 203-1112 or (719) 457-0820 and the confirmation code is 7393551.
Additionally, a copy of this Earnings Press Release and Supplemental Information for the second quarter ended June 30, 2013, is available in the “For Investors” section of our website at www.are.com or by following this link: http://www.are.com/fs/2013q2.pdf.
About the Company
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade REIT, is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and a longstanding and expansive network in the life science community. We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.
***********
This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2013 earnings per share attributable to Alexandria’s common stockholders – diluted, 2013 FFO per share attributable to Alexandria’s common stockholders – diluted, NOI and our projected sources and uses of capital for the year ended December 31, 2013. These forward-looking statements are based on our current expectations, beliefs, projections, future plans, strategies, anticipated events, trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 4 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)
| Three Months Ended | Six Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | ||||||||||
| Revenues: | ||||||||||||||||
| Rental | $ | 114,743 | $ | 111,776 | $ | 112,048 | $ | 106,216 | $ | 104,329 | $ | 226,519 | $ | 205,530 | ||
| Tenant recoveries | 35,923 | 35,611 | 35,721 | 34,006 | 31,881 | 71,534 | 63,763 | |||||||||
| Other income | 3,569 | 2,993 | 3,785 | 2,628 | 9,383 | 6,562 | 12,011 | |||||||||
| Total revenues | 154,235 | 150,380 | 151,554 | 142,850 | 145,593 | 304,615 | 281,304 | |||||||||
| Expenses: | ||||||||||||||||
| Rental operations | 46,323 | 45,224 | 46,176 | 44,203 | 42,102 | 91,547 | 82,555 | |||||||||
| General and administrative | 12,472 | 11,648 | 12,635 | 12,470 | 12,298 | 24,120 | 22,655 | |||||||||
| Interest | 15,978 | 18,020 | 17,941 | 17,092 | 17,922 | 33,998 | 34,148 | |||||||||
| Depreciation and amortization | 46,580 | 46,065 | 47,515 | 46,584 | 50,741 | 92,645 | 92,527 | |||||||||
| Impairment of land parcel | – | – | 2,050 | – | – | – | – | |||||||||
| Loss on early extinguishment of debt | 560 | – | – | – | 1,602 | 560 | 2,225 | |||||||||
| Total expenses | 121,913 | 120,957 | 126,317 | 120,349 | 124,665 | 242,870 | 234,110 | |||||||||
| Income from continuing operations | 32,322 | 29,423 | 25,237 | 22,501 | 20,928 | 61,745 | 47,194 | |||||||||
| Income (loss) from discontinued operations: | ||||||||||||||||
| Income from discontinued operations before impairment of real estate | 243 | 814 | 5,171 | 5,603 | 4,713 | 1,057 | 9,358 | |||||||||
| Impairment of real estate | – | – | (1,601 | ) | (9,799 | ) | – | – | – | |||||||
| Income (loss) from discontinued operations, net | 243 | 814 | 3,570 | (4,196 | ) | 4,713 | 1,057 | 9,358 | ||||||||
| Gain on sale of land parcel | 772 | – | – | – | – | 772 | 1,864 | |||||||||
| Net income | 33,337 | 30,237 | 28,807 | 18,305 | 25,641 | 63,574 | 58,416 | |||||||||
| Net income attributable to noncontrolling interests | 980 | 982 | 1,012 | 828 | 851 | 1,962 | 1,562 | |||||||||
| Dividends on preferred stock | 6,471 | 6,471 | 6,471 | 6,471 | 6,903 | 12,942 | 14,386 | |||||||||
| Preferred stock redemption charge | – | – | – | – | – | – | 5,978 | |||||||||
| Net income attributable to unvested restricted stock awards | 403 | 342 | 324 | 360 | 271 | 745 | 506 | |||||||||
| Net income attributable to Alexandria’s common stockholders | $ | 25,483 | $ | 22,442 | $ | 21,000 | $ | 10,646 | $ | 17,616 | $ | 47,925 | $ | 35,984 | ||
| Earnings per share attributable to Alexandria’s common stockholders – basic and diluted: | ||||||||||||||||
| Continuing operations | $ | 0.38 | $ | 0.35 | $ | 0.27 | $ | 0.24 | $ | 0.21 | $ | 0.72 | $ | 0.43 | ||
| Discontinued operations, net | – | 0.01 | 0.06 | (0.07 | ) | 0.08 | 0.02 | 0.15 | ||||||||
| Earnings per share – basic and diluted | $ | 0.38 | $ | 0.36 | $ | 0.33 | $ | 0.17 | $ | 0.29 | $ | 0.74 | $ | 0.58 | ||
| Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria’s common stockholders: | ||||||||||||||||
| – Basic | 66,973 | 63,161 | 63,092 | 62,364 | 61,663 | 65,078 | 61,586 | |||||||||
| – Diluted | 66,973 | 63,161 | 63,092 | 62,364 | 61,664 | 65,078 | 61,586 | |||||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 5 | |||||||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Consolidated Balance Sheets
(In thousands)
(Unaudited)
| June 30, | March 31, | December 31, | September 30, | June 30, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 2013 | 2012 | 2012 | 2012 | |||||||||||
| Assets | |||||||||||||||
| Investments in real estate, net | $ | 6,453,379 | $ | 6,375,182 | $ | 6,424,578 | $ | 6,300,027 | $ | 6,208,354 | |||||
| Cash and cash equivalents | 302,205 | 87,001 | 140,971 | 94,904 | 80,937 | ||||||||||
| Restricted cash | 30,914 | 30,008 | 39,947 | 44,863 | 41,897 | ||||||||||
| Tenant receivables | 7,577 | 9,261 | 8,449 | 10,124 | 6,143 | ||||||||||
| Deferred rent | 177,507 | 170,100 | 170,396 | 160,914 | 155,295 | ||||||||||
| Deferred leasing and financing costs, net | 164,362 | 159,872 | 160,048 | 152,021 | 151,355 | ||||||||||
| Investments | 122,605 | 123,543 | 115,048 | 107,808 | 104,454 | ||||||||||
| Other assets | 120,740 | 135,952 | 90,679 | 94,356 | 93,304 | ||||||||||
| Total assets | $ | 7,379,289 | $ | 7,090,919 | $ | 7,150,116 | $ | 6,965,017 | $ | 6,841,739 | |||||
| Liabilities, Noncontrolling Interests, and Equity | |||||||||||||||
| Secured notes payable | $ | 711,029 | $ | 730,714 | $ | 716,144 | $ | 719,350 | $ | 719,977 | |||||
| Unsecured senior notes payable | 1,048,395 | 549,816 | 549,805 | 549,794 | 549,783 | ||||||||||
| Unsecured senior line of credit | – | 554,000 | 566,000 | 413,000 | 379,000 | ||||||||||
| Unsecured senior bank term loans | 1,200,000 | 1,350,000 | 1,350,000 | 1,350,000 | 1,350,000 | ||||||||||
| Accounts payable, accrued expenses, and tenant security deposits | 368,249 | 367,153 | 423,708 | 376,785 | 348,037 | ||||||||||
| Dividends payable | 52,141 | 43,955 | 41,401 | 39,468 | 38,357 | ||||||||||
| Total liabilities | 3,379,814 | 3,595,638 | 3,647,058 | 3,448,397 | 3,385,154 | ||||||||||
| Commitments and contingencies | |||||||||||||||
| Redeemable noncontrolling interests | 14,505 | 14,534 | 14,564 | 15,610 | 15,817 | ||||||||||
| Alexandria Real Estate Equities, Inc.’s stockholders’ equity: | |||||||||||||||
| Series D Cumulative Convertible Preferred Stock | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | ||||||||||
| Series E Cumulative Redeemable Preferred Stock | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | ||||||||||
| Common stock | 710 | 633 | 632 | 632 | 622 | ||||||||||
| Additional paid-in capital | 3,596,477 | 3,075,860 | 3,086,052 | 3,094,987 | 3,053,269 | ||||||||||
| Accumulated other comprehensive loss | (39,565 | ) | (22,890 | ) | (24,833 | ) | (19,729 | ) | (37,370 | ) | |||||
| Alexandria’s stockholders’ equity | 3,937,622 | 3,433,603 | 3,441,851 | 3,455,890 | 3,396,521 | ||||||||||
| Noncontrolling interests | 47,348 | 47,144 | 46,643 | 45,120 | 44,247 | ||||||||||
| Total equity | 3,984,970 | 3,480,747 | 3,488,494 | 3,501,010 | 3,440,768 | ||||||||||
| Total liabilities, noncontrolling interests, and equity | $ | 7,379,289 | $ | 7,090,919 | $ | 7,150,116 | $ | 6,965,017 | $ | 6,841,739 | |||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 6 | ||||||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Funds From Operations and Adjusted Funds From Operations
(In thousands, except per share amounts)
(Unaudited)
The following table presents a reconciliation of net income attributable to Alexandria’s common stockholders – basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria’s common stockholders – diluted, FFO attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria’s common stockholders – diluted, for the periods below:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | |||||||||||||||
| Net income attributable to Alexandria’s common stockholders – basic | $ | 25,483 | **** | $ | 22,442 | **** | $ | 21,000 | **** | $ | 10,646 | **** | $ | 17,616 | **** | $ | 47,925 | **** | $ | 35,984 | **** |
| Depreciation and amortization | 46,580 | 46,995 | 48,072 | 48,173 | 52,355 | 93,575 | 95,760 | ||||||||||||||
| Loss (gain) on sale of real estate | (219 | ) | 340 | – | (1,562 | ) | (2 | ) | 121 | (2 | ) | ||||||||||
| Impairment of real estate | – | – | 1,601 | 9,799 | – | – | – | ||||||||||||||
| Gain on sale of land parcel | (772 | ) | – | – | – | – | (772 | ) | (1,864 | ) | |||||||||||
| Amount attributable to noncontrolling interests/unvested restricted stock awards: | |||||||||||||||||||||
| Net income | 1,383 | 1,324 | 1,336 | 1,188 | 1,122 | 2,707 | 2,068 | ||||||||||||||
| FFO | (1,437 | ) | (1,064 | ) | (1,109 | ) | (1,148 | ) | (1,133 | ) | (2,501 | ) | (2,305 | ) | |||||||
| FFO attributable to Alexandria’s common stockholders – basic | 71,018 | 70,037 | 70,900 | 67,096 | 69,958 | 141,055 | 129,641 | ||||||||||||||
| Assumed conversion of 8.00% Unsecured Senior Convertible Notes | 5 | 5 | 5 | 5 | 6 | 10 | 11 | ||||||||||||||
| FFO attributable to Alexandria’s common stockholders – diluted | 71,023 | **** | 70,042 | **** | 70,905 | **** | 67,101 | **** | 69,964 | **** | 141,065 | **** | 129,652 | **** | |||||||
| Realized gain on equity investment primarily related to one non-tenant life science entity | – | – | – | – | (5,811 | ) | – | (5,811 | ) | ||||||||||||
| Impairment of land parcel | – | – | 2,050 | – | – | – | – | ||||||||||||||
| Loss on early extinguishment of debt | 560 | – | – | – | 1,602 | 560 | 2,225 | ||||||||||||||
| Preferred stock redemption charge | – | – | – | – | – | – | 5,978 | ||||||||||||||
| Allocation to unvested restricted stock awards | (12 | ) | – | (19 | ) | – | 35 | (12 | ) | (20 | ) | ||||||||||
| FFO attributable to Alexandria’s common stockholders – diluted, as adjusted | 71,571 | **** | 70,042 | **** | 72,936 | **** | 67,101 | **** | 65,790 | **** | 141,613 | **** | 132,024 | **** | |||||||
| Non-revenue-enhancing capital expenditures: | |||||||||||||||||||||
| Maintenance building improvements | (337 | ) | (596 | ) | (329 | ) | (935 | ) | (594 | ) | (933 | ) | (804 | ) | |||||||
| Tenant improvements and leasing commissions | (2,990 | ) | (882 | ) | (3,170 | ) | (1,844 | ) | (2,148 | ) | (3,872 | ) | (4,167 | ) | |||||||
| Straight-line rent revenue | (8,239 | ) | (6,198 | ) | (9,240 | ) | (5,225 | ) | (5,195 | ) | (14,437 | ) | (13,991 | ) | |||||||
| Straight-line rent expense on ground leases | 539 | 538 | 471 | 201 | 1,207 | 1,077 | 2,613 | ||||||||||||||
| Capitalized income from development projects | 9 | 22 | 45 | 50 | 72 | 31 | 550 | ||||||||||||||
| Amortization of acquired above and below market leases | (830 | ) | (830 | ) | (844 | ) | (778 | ) | (778 | ) | (1,660 | ) | (1,578 | ) | |||||||
| Amortization of loan fees | 2,427 | 2,386 | 2,505 | 2,470 | 2,214 | 4,813 | 4,857 | ||||||||||||||
| Amortization of debt premiums/discounts | 115 | 115 | 110 | 112 | 110 | 230 | 289 | ||||||||||||||
| Stock compensation | 4,463 | 3,349 | 3,748 | 3,845 | 3,274 | 7,812 | 6,567 | ||||||||||||||
| Allocation to unvested restricted stock awards | 50 | 19 | 63 | 19 | 15 | 69 | 48 | ||||||||||||||
| AFFO attributable to Alexandria’s common stockholders – diluted | $ | 66,778 | **** | $ | 67,965 | **** | $ | 66,295 | **** | $ | 65,016 | **** | $ | 63,967 | **** | $ | 134,743 | **** | $ | 126,408 | **** |
The following table presents a reconciliation of net income per share attributable to Alexandria’s common stockholders – basic, to FFO per share attributable to Alexandria’s common stockholders – diluted, FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – diluted, for the periods below. For the computation of the weighted average shares used to compute the per share information, refer to the “Definitions and Other Information” section in our supplemental information:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | |||||||||||||||
| Net income per share attributable to Alexandria’s common stockholders – basic | $ | 0.38 | **** | $ | 0.36 | **** | $ | 0.33 | **** | $ | 0.17 | **** | $ | 0.29 | **** | $ | 0.74 | **** | $ | 0.58 | **** |
| Depreciation and amortization | 0.69 | 0.74 | 0.76 | 0.78 | 0.84 | 1.43 | 1.56 | ||||||||||||||
| Loss (gain) on sale of real estate | – | 0.01 | – | (0.03 | ) | – | 0.01 | – | |||||||||||||
| Impairment of real estate | – | – | 0.03 | 0.16 | – | – | – | ||||||||||||||
| Gain on sale of land parcel | (0.01 | ) | – | – | – | – | (0.01 | ) | (0.03 | ) | |||||||||||
| Amount attributable to noncontrolling interests/unvested restricted stock awards: | |||||||||||||||||||||
| Net income | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | ||||||||||||||
| FFO | (0.02 | ) | (0.02 | ) | (0.02 | ) | (0.02 | ) | (0.02 | ) | (0.04 | ) | (0.04 | ) | |||||||
| FFO per share attributable to Alexandria’s common stockholders – basic | 1.06 | 1.11 | 1.12 | 1.08 | 1.13 | 2.17 | 2.11 | ||||||||||||||
| Assumed conversion of 8.00% Unsecured Senior Convertible Notes | – | – | – | – | – | – | – | ||||||||||||||
| FFO per share attributable to Alexandria’s common stockholders – diluted | 1.06 | **** | 1.11 | **** | 1.12 | **** | 1.08 | **** | 1.13 | **** | 2.17 | **** | 2.11 | **** | |||||||
| Realized gain on equity investment primarily related to one non-tenant life science entity | – | – | – | – | (0.09 | ) | – | (0.09 | ) | ||||||||||||
| Impairment of land parcel | – | – | 0.04 | – | – | – | – | ||||||||||||||
| Loss on early extinguishment of debt | 0.01 | – | – | – | 0.03 | 0.01 | 0.03 | ||||||||||||||
| Preferred stock redemption charge | – | – | – | – | – | – | 0.10 | ||||||||||||||
| Allocation to unvested restricted stock awards | – | – | – | – | – | – | – | ||||||||||||||
| FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted | 1.07 | **** | 1.11 | **** | 1.16 | **** | 1.08 | **** | 1.07 | **** | 2.18 | **** | 2.14 | **** | |||||||
| Non-revenue-enhancing capital expenditures: | |||||||||||||||||||||
| Maintenance building improvements | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | |||||||
| Tenant improvements and leasing commissions | (0.04 | ) | (0.01 | ) | (0.05 | ) | (0.03 | ) | (0.03 | ) | (0.06 | ) | (0.07 | ) | |||||||
| Straight-line rent revenue | (0.12 | ) | (0.10 | ) | (0.15 | ) | (0.08 | ) | (0.08 | ) | (0.22 | ) | (0.23 | ) | |||||||
| Straight-line rent expense on ground leases | 0.01 | 0.01 | 0.01 | – | 0.02 | 0.02 | 0.04 | ||||||||||||||
| Amortization of acquired above and below market leases | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.03 | ) | (0.03 | ) | |||||||
| Amortization of loan fees | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.07 | 0.09 | ||||||||||||||
| Stock compensation | 0.07 | 0.05 | 0.06 | 0.06 | 0.05 | 0.12 | 0.11 | ||||||||||||||
| Allocation to unvested restricted stock awards | – | – | – | – | – | – | – | ||||||||||||||
| Other | – | – | – | – | – | – | 0.01 | ||||||||||||||
| AFFO per share attributable to Alexandria’s common stockholders – diluted | $ | 1.00 | **** | $ | 1.08 | **** | $ | 1.05 | **** | $ | 1.04 | **** | $ | 1.04 | **** | $ | 2.07 | **** | $ | 2.05 | **** |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 7 | ||||||||||||||||||||
| --- | --- |
Exhibit 99.2

ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Table of Contents
| **** | Page |
|---|---|
| EARNINGS PRESS RELEASE | |
| Second Quarter Ended June 30, 2013, Financial and Operating Results | 1 |
| Guidance | 3 |
| Earnings Call Information | 4 |
| Consolidated Statements of Income | 5 |
| Consolidated Balance Sheets | 6 |
| Funds From Operations and Adjusted Funds From Operations | 7 |
| SUPPLEMENTAL INFORMATION | |
| Company Profile | 9 |
| Company and Investor Information | 10 |
| Financial and Asset Base Highlights | 11 |
| Core Operating Metrics | |
| Core Operating Metrics | 13 |
| Summary of Same Property Comparisons | 14 |
| Same Property Performance Historical Results | 15 |
| Summary of Leasing Activity | 16 |
| Summary of Lease Expirations | 17 |
| Summary of Properties and Occupancy | 18 |
| Top 20 Client Tenants and Client Tenant Mix | 19 |
| Property Listing | 20 |
| Value-Added Opportunities and External Growth | |
| Summary of Investments in Real Estate | 24 |
| Summary of Capital Expenditures | 25 |
| All Active Development Projects in North America | 26 |
| All Active Redevelopment Projects in North America | 28 |
| Future Value-Added Projects in North America | 31 |
| Summary of Real Estate Investment in Asia | 43 |
| Balance Sheet | |
| Credit Metrics | 45 |
| Summary of Debt | 46 |
| Assets Held for Sale and Summary of Real Estate Sales | 48 |
| Definitions and Other Information | |
| Definitions and Other Information | 50 |
This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can identify the forward-looking statements by their use of forward-looking words, such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates,” or “anticipates,” or the negative of those words or similar words. These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission (“SEC”). Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of July 29, 2013, the date this document was first made available on our website, and we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q. Note that certain figures are rounded throughout this document, which may impact footing and/or crossfooting of totals and subtotals.
This document is not an offer to sell or solicitation to buy securities of Alexandria Real Estate Equities, Inc. Any offers to sell or solicitations to buy securities of Alexandria Real Estate Equities, Inc. shall be made only by means of a prospectus approved for that purpose. Unless otherwise indicated, the “Company,” “Alexandria,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and its consolidated subsidiaries.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | i |
|---|
EARNINGS PRESS RELEASE
SECOND QUARTER ENDED
JUNE 30, 2013
FINANCIAL
AND
OPERATING RESULTS

| Contact: | Joel S. Marcus |
|---|---|
| **** | Chairman, Chief Executive Officer, & Founder |
| **** | Alexandria Real Estate Equities, Inc. |
| **** | (626) 578-9693 |
Alexandria Real Estate Equities, Inc.
Reports
Second Quarter Ended June 30, 2013
Financial and Operating Results
FFO Per Share – Diluted, as Adjusted, of $1.07 for 2Q13
AFFO Per Share – Diluted of $1.00 for 2Q13
EPS Per Share – Diluted of $0.38 for 2Q13
Total Revenues of $154.2 Million for 2Q13
NOI of $107.9 Million for 2Q13
Continued Solid Life Science Space Demand in Key Cluster Submarkets
PASADENA, CA. – July 29, 2013 – Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the second quarter ended June 30, 2013.
Second quarter ended June 30, 2013, highlights
Results
· Funds from operations (“FFO”) attributable to Alexandria Real Estate Equities, Inc.’s (“Alexandria’s”) common stockholders – diluted, as adjusted:
· $71.6 million, or $1.07 per share, for 2Q13 compared to $65.8 million, or $1.07 per share, for 2Q12
· $141.6 million, or $2.18 per share, for YTD 2Q13 compared to $132.0 million, or $2.14 per share, for YTD 2Q12
· Adjusted funds from operations (“AFFO”) attributable to Alexandria’s common stockholders – diluted:
· $66.8 million, or $1.00 per share, for 2Q13 compared to $64.0 million, or $1.04 per share, for 2Q12
· $134.7 million, or $2.07 per share, for YTD 2Q13 compared to $126.4 million, or $2.05 per share, for YTD 2Q12
· Net income attributable to Alexandria’s common stockholders – diluted:
· $25.5 million, or $0.38 per share, for 2Q13 compared to $17.6 million, or $0.29 per share, for 2Q12
· $47.9 million, or $0.74 per share, for YTD 2Q13 compared to $36.0 million, or $0.58 per share, for YTD 2Q12
Core operating metrics
· Total revenues from continuing operations:
· $154.2 million for 2Q13, up 5.9%, compared to $145.6 million for 2Q12
· $304.6 million YTD 2Q13, up 8.3%, compared to $281.3 million for YTD 2Q12
· Net operating income (“NOI”) from continuing operations:
· $107.9 million for 2Q13, up 4.3%, compared to $103.5 million for 2Q12
· $213.1 million for YTD 2Q13, up 7.2%, compared to $198.7 million for YTD 2Q12
· Same property NOI performance:
· 7.2% and 3.2% increases on a cash and GAAP basis, respectively, for 2Q13 compared to 2Q12
· 8.3% and 2.0% increases on a cash and GAAP basis, respectively, for YTD 2Q13 compared to YTD 2Q12
· Leasing activity solid during the three months ended June 30, 2013:
· Executed 66 leases for 768,000 rentable square feet (“RSF”), including 270,000 RSF of development and redevelopment space
· Rental rate increase of 6.7% and 12.7% on a cash and GAAP basis, respectively, on renewed/re-leased space
· Key life science space leasing:
· Investment-grade entity leased 121,632 RSF at 430 East 29th Street development in the Greater NYC market
· Illumina, Inc. leased 97,702 RSF at 499 Illinois Street development in the San Francisco Bay Area market
· Sarepta Therapeutics, Inc. leased 46,376 RSF at 215 First Street in the Greater Boston market
· Eli Lilly and Company leased 27,950 RSF at 620 Professional Drive in the Suburban Washington, D.C. market
· Nominal remaining expiring leases in 2013 of 410,254 RSF, or 3% of total operating RSF
· Occupancy for North American Properties, as of June 30, 2013:
· 94.6% for operating properties and 92.9% for operating and redevelopment properties, up 40 bps and 110 bps, respectively, since March 31, 2013
· Operating margins remained steady at 70% for 2Q13 and YTD 2Q13
· Investment-grade client tenants represented 46% of total annualized base rent (“ABR”)
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 1 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Second Quarter Ended June 30, 2013
Financial and Operating Results
Core operating metrics (continued)
· Investment-grade client tenants represented 72% of ABR from our top 10 client tenants
· Contractual annual rent escalations in 95% of our leases
Balance sheet
· Completed in 2Q13 secondary offering of 7.6 million shares of common stock at a price of $73.50 per share. The net proceeds of $535.5 million were used to repay outstanding balances under our unsecured senior line of credit.
· Completed in 2Q13 $500 million 3.90% 10-year unsecured senior notes payable offering. Net proceeds of $495.3 million were used to reduce outstanding variable rate bank debt, including a $150 million partial repayment of our $750 million 2016 Unsecured Senior Bank Term Loan and to increase our available cash balance. In connection with the partial repayment of our 2016 Unsecured Senior Bank Term Loan, we recognized a loss on the early extinguishment of debt related to the write-off of unamortized loan fees totaling $0.6 million, or $0.01 per share.
· Liquidity of $1.8 billion, including $1.5 billion available under our unsecured senior line of credit and $302.2 million in cash and cash equivalents as of June 30, 2013.
· Closed in 2Q13 secured construction loan, with aggregate commitments of $36 million at a rate of LIBOR + 1.40%, for 100% pre-leased development project at 269 East Grand Avenue in the San Francisco Bay Area market.
· Net debt to EBITDA of 6.6x for the twelve months ended June 30, 2013.
· Fixed charge coverage ratio of 2.7x for the twelve months ended June 30, 2013.
· Unhedged variable rate debt totaling 11% of total consolidated debt as of June 30, 2013.
· Completed in 2Q13 $22.5 million of real estate property sales, at a gain of $1.0 million, as follows:
· $4.4 million of non-strategic income producing assets at a gain of $0.2 million
· $18.1 million of non-income-producing land at a gain of $0.8 million
Subsequent events
Ariad Pharmaceuticals, Inc. expansion
On July 3, 2013, Ariad Pharmaceuticals, Inc. executed an LOI to lease an additional 139,374 RSF for a 15 year term at our 75/125 Binney Street development in the Cambridge submarket of Greater Boston. An amendment to their lease is under negotiation to increase their lease to 383,497 RSF, or 99% of the total RSF of the project.
Sale of land parcel at 1600 Owens Street
On July 8, 2013, we executed a purchase and sale agreement to dispose of our land parcel at 1600 Owens Street in the Mission Bay submarket of the San Francisco Bay Area for an aggregate sales price of $55.2 million, inclusive of certain parking spaces. Ownership of the parcel was strategically important to the buyer and we will earn a fee to manage the construction of the building. This sale is expected to close in December 2013.
Acquisition of 10121/10151 Barnes Canyon Road
On July 5, 2013, we acquired 10121/10151 Barnes Canyon Road, an approximate 116,000 RSF office property located in the Sorrento Mesa submarket of San Diego, for a total purchase price of $13.1 million. The acquisition will be funded in two installments: i) $5.4 million to be funded in August, 2013 (which will earn a 7% return until the next payment is made), and ii) $7.7 million to be funded no later than October 2014. The property is currently 100% occupied with leases that expire in 2014 and 2015. We intend to convert the existing office space into laboratory space through redevelopment when the space becomes available. Initial stabilized yields will be provided in the future upon commencement of the redevelopment.
Unsecured senior bank loan financings
On July 26, 2013, we amended our $600 million 2016 Unsecured Senior Bank Term Loan to reduce our interest rate on outstanding borrowings. We did not extend the maturity of this loan as we expect to repay the loan over the next one to three years. In addition, we expect to complete amendments to our $1.5 billion unsecured senior line of credit and our $600 million 2017 Unsecured Senior Bank Term Loan in the third quarter of 2013 to reduce our interest rate on outstanding borrowings, extend the maturity dates and amend certain financial covenants. The commitments available for each facility will not change.
| **** | **** | Maturity Date (including extensions) | Applicable Rate | Facility Fee | |||
|---|---|---|---|---|---|---|---|
| Facility | Status | Prior/ Current | Extended/ Proposed | Prior/ Current | Extended/ Proposed | Prior/ Current | Extended/ Proposed |
| $600 million 2016 Unsecured Senior Bank Term Loan | Complete | June 2016 | July 2016 | L +1.75% | L +1.20% | N/A | N/A |
| $600 million 2017 Unsecured Senior Bank Term Loan | In Progress | January 2017 | January 2019 | L +1.50% | L +1.20% | N/A | N/A |
| $1.5 billion unsecured senior line of credit | In Progress | April 2017 | January 2019 | L +1.20% | L +1.10% | 0.25% | 0.20% |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 2 | ||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Guidance
Based on our current view of existing market conditions and certain current assumptions, we have updated guidance for earnings per share attributable to Alexandria’s common stockholders – diluted and FFO per share attributable to Alexandria’s common stockholders – diluted for the year ended December 31, 2013, as set forth in the table below. The table below provides a reconciliation of FFO per share, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure, as well as other key assumptions included in our guidance for the year ended December 31, 2013. To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.
| Guidance for the Year Ended December 31, 2013 | Reported on July 29, 2013 | Reported on May 13, 2013 |
|---|---|---|
| Earnings per share attributable to Alexandria’s common stockholders – diluted | $1.53 to $1.63 | $1.50 to $1.60 |
| Depreciation and amortization | $2.76 to $2.86 | $2.80 to $2.90 |
| (Gain) loss on sale of real estate | $(0.01) | $0.01 |
| Other | $(0.01) | $(0.01) |
| FFO per share attributable to Alexandria’s common stockholders – diluted | $4.32 to $4.42 | $4.35 to $4.45 |
| Add back: actual 2Q13 per share loss on early extinguishment of debt (1) | $0.01 | N/A |
| Add back: projected 3Q13 per share loss on early extinguishment of debt (1) | $0.02 | N/A |
| FFO per share attributable to Alexandria’s common stockholders - diluted, as adjusted | $4.35 to $4.45 | $4.35 to $4.45 |
| Key projection assumptions: | ||
| Same property NOI growth – cash basis | 5% to 7% | 5% to 7% |
| Same property NOI growth – GAAP basis | 1% to 3% | 1% to 3% |
| Rental rate steps on lease renewals and re-leasing of space – cash basis | 3% to 5% | 1% to 3% |
| Rental rate steps on lease renewals and re-leasing of space – GAAP basis | 11% to 13% | 7% to 12% |
| Occupancy percentage for all operating properties at December 31, 2013 | 94.3% to 94.7% | 94.3% to 94.7% |
| Straight-line rents | $24 to $26 million | $24 to $26 million |
| Amortization of above and below market leases | $3 to $4 million | $3 to $4 million |
| General and administrative expenses | $48 to $51 million | $48 to $51 million |
| Capitalization of interest | $51 to $57 million | $51 to $57 million |
| Interest expense, net | $71 to $81 million | $71 to $81 million |
| Net debt to adjusted EBITDA for the annualized three months ended December 31, 2013 | 6.5x | 6.5x |
| Fixed charge coverage ratio for the annualized three months ended December 31, 2013 | 3.0x | 3.0x |
| Non-income-producing land as a percentage of gross real estate by December 31, 2013 | 15% to 17% | 15% to 17% |
(1) Represents loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.01 per share as a result of the $150 million partial repayment of our 2016 Unsecured Senior Bank Term Loan during the three months ended June 30, 2013, and the estimated loss on early extinguishment of debt related to the write-off of unamortized loan fees of $0.02 per share as a result of amendments of our 2016 Unsecured Senior Bank Term Loan, 2017 Unsecured Senior Bank Term Loan, and $1.5 billion unsecured senior line of credit which we expect to complete in the third quarter of 2013.
We expect that our principal liquidity needs for the year ended December 31, 2013, will be satisfied by the following multiple sources of capital as shown in the table below. There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.
| Reported on<br> July 29, 2013 | Reported on<br> May 13, 2013 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sources and Uses of Capital for the Year Ended December 31, 2013 (in millions) | Completed | Projected | Total | Total | |||||
| Sources of capital: | |||||||||
| Net cash provided by operating activities less dividends | $ | 66 | $ | 64 - 84 | $ | 130 - 150 | $ | 130 - 150 | |
| Non-income-producing land sales | 18 | 131 - 171 | (1) | 149 - 189 | 149 - 189 | ||||
| Income producing asset sales | 129 | 0 - 5 | 129 - 134 | 125 - 138 | |||||
| Secured construction loan borrowings | 26 | 19 - 39 | 45 - 65 | 45 - 55 | |||||
| Unsecured senior notes payable | 500 | – | 500 | 350 - 450 | |||||
| Common stock offering | 536 | – | 536 | 415 - 490 | |||||
| Available cash and borrowings on unsecured senior line of credit (2) | – | 324 - 369 | 324 - 369 | – | |||||
| Total sources of capital | $ | 1,275 | $ | 538 - 668 | $ | 1,813 - 1,943 | $ | 1,214 - 1,472 | |
| Uses of capital: | |||||||||
| Development, redevelopment, and construction | $ | 253 | $ | 346 - 376 | $ | 599 - 629 | $ | 617 - 667 | |
| Seller financing of asset sales | 39 | – | 39 | 39 | |||||
| Acquisitions: | |||||||||
| Completed/in process acquisitions | 13 | 64 | 77 | – | |||||
| Additional acquisitions | - | 123 - 223 | 123 - 223 | 200 - 300 | |||||
| Secured notes payable repayments | 32 | 5 | 37 | 37 | |||||
| Unsecured senior bank term loan repayment | 150 | – | 150 | 125 - 175 | |||||
| Excess cash retained from issuance of unsecured senior notes payable/pay down of unsecured senior line of credit | 788 | – | 788 | 196 - 254 | |||||
| Total uses of capital | $ | 1,275 | $ | 538 - 668 | $ | 1,813 - 1,943 | $ | 1,214 - 1,472 |
(1) See Balance Sheet section of our Supplemental Package for additional information.
(2) We had $302.2 million in cash and cash equivalents as of June 30, 2013.
The key assumptions behind the sources and uses of capital in the table on the prior page are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals. Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking statements” section under Part I, the “Risk Factors” section under Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2012. We expect to update our forecast of sources and uses of capital on a quarterly basis.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 3 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Earnings Call Information
We will host a conference call on Tuesday, July 30, 2013, at 3:00 p.m. Eastern Time (“ET”)/12:00 p.m. noon Pacific Time (“PT”) that is open to the general public to discuss our financial and operating results for the three months ended June 30, 2013. To participate in this conference call, dial (888) 724-9493 or (913) 312-1456 and confirmation code 7393551, shortly before 3:00 p.m. ET/12:00 p.m. noon PT. The audio web cast can be accessed at: www.are.com, in the “For Investors” section. A replay of the call will be available for a limited time from 6:00 p.m. ET/3:00 p.m. PT on Tuesday, July 30, 2013. The replay number is (888) 203-1112 or (719) 457-0820 and the confirmation code is 7393551.
Additionally, a copy of this Earnings Press Release and Supplemental Information for the second quarter ended June 30, 2013, is available in the “For Investors” section of our website at www.are.com or by following this link: http://www.are.com/fs/2013q2.pdf.
About the Company
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade REIT, is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and a longstanding and expansive network in the life science community. We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.
***********
This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2013 earnings per share attributable to Alexandria’s common stockholders – diluted, 2013 FFO per share attributable to Alexandria’s common stockholders – diluted, NOI and our projected sources and uses of capital for the year ended December 31, 2013. These forward-looking statements are based on our current expectations, beliefs, projections, future plans, strategies, anticipated events, trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 4 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)
| Three Months Ended | Six Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | ||||||||||
| Revenues: | ||||||||||||||||
| Rental | $ | 114,743 | $ | 111,776 | $ | 112,048 | $ | 106,216 | $ | 104,329 | $ | 226,519 | $ | 205,530 | ||
| Tenant recoveries | 35,923 | 35,611 | 35,721 | 34,006 | 31,881 | 71,534 | 63,763 | |||||||||
| Other income | 3,569 | 2,993 | 3,785 | 2,628 | 9,383 | 6,562 | 12,011 | |||||||||
| Total revenues | 154,235 | 150,380 | 151,554 | 142,850 | 145,593 | 304,615 | 281,304 | |||||||||
| Expenses: | ||||||||||||||||
| Rental operations | 46,323 | 45,224 | 46,176 | 44,203 | 42,102 | 91,547 | 82,555 | |||||||||
| General and administrative | 12,472 | 11,648 | 12,635 | 12,470 | 12,298 | 24,120 | 22,655 | |||||||||
| Interest | 15,978 | 18,020 | 17,941 | 17,092 | 17,922 | 33,998 | 34,148 | |||||||||
| Depreciation and amortization | 46,580 | 46,065 | 47,515 | 46,584 | 50,741 | 92,645 | 92,527 | |||||||||
| Impairment of land parcel | – | – | 2,050 | – | – | – | – | |||||||||
| Loss on early extinguishment of debt | 560 | – | – | – | 1,602 | 560 | 2,225 | |||||||||
| Total expenses | 121,913 | 120,957 | 126,317 | 120,349 | 124,665 | 242,870 | 234,110 | |||||||||
| Income from continuing operations | 32,322 | 29,423 | 25,237 | 22,501 | 20,928 | 61,745 | 47,194 | |||||||||
| Income (loss) from discontinued operations: | ||||||||||||||||
| Income from discontinued operations before impairment of real estate | 243 | 814 | 5,171 | 5,603 | 4,713 | 1,057 | 9,358 | |||||||||
| Impairment of real estate | – | – | (1,601 | ) | (9,799 | ) | – | – | – | |||||||
| Income (loss) from discontinued operations, net | 243 | 814 | 3,570 | (4,196 | ) | 4,713 | 1,057 | 9,358 | ||||||||
| Gain on sale of land parcel | 772 | – | – | – | – | 772 | 1,864 | |||||||||
| Net income | 33,337 | 30,237 | 28,807 | 18,305 | 25,641 | 63,574 | 58,416 | |||||||||
| Net income attributable to noncontrolling interests | 980 | 982 | 1,012 | 828 | 851 | 1,962 | 1,562 | |||||||||
| Dividends on preferred stock | 6,471 | 6,471 | 6,471 | 6,471 | 6,903 | 12,942 | 14,386 | |||||||||
| Preferred stock redemption charge | – | – | – | – | – | – | 5,978 | |||||||||
| Net income attributable to unvested restricted stock awards | 403 | 342 | 324 | 360 | 271 | 745 | 506 | |||||||||
| Net income attributable to Alexandria’s common stockholders | $ | 25,483 | $ | 22,442 | $ | 21,000 | $ | 10,646 | $ | 17,616 | $ | 47,925 | $ | 35,984 | ||
| Earnings per share attributable to Alexandria’s common stockholders – basic and diluted: | ||||||||||||||||
| Continuing operations | $ | 0.38 | $ | 0.35 | $ | 0.27 | $ | 0.24 | $ | 0.21 | $ | 0.72 | $ | 0.43 | ||
| Discontinued operations, net | – | 0.01 | 0.06 | (0.07 | ) | 0.08 | 0.02 | 0.15 | ||||||||
| Earnings per share – basic and diluted | $ | 0.38 | $ | 0.36 | $ | 0.33 | $ | 0.17 | $ | 0.29 | $ | 0.74 | $ | 0.58 | ||
| Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria’s common stockholders: | ||||||||||||||||
| – Basic | 66,973 | 63,161 | 63,092 | 62,364 | 61,663 | 65,078 | 61,586 | |||||||||
| – Diluted | 66,973 | 63,161 | 63,092 | 62,364 | 61,664 | 65,078 | 61,586 | |||||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 5 | |||||||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Consolidated Balance Sheets
(In thousands)
(Unaudited)
| June 30, | March 31, | December 31, | September 30, | June 30, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 2013 | 2012 | 2012 | 2012 | |||||||||||
| Assets | |||||||||||||||
| Investments in real estate, net | $ | 6,453,379 | $ | 6,375,182 | $ | 6,424,578 | $ | 6,300,027 | $ | 6,208,354 | |||||
| Cash and cash equivalents | 302,205 | 87,001 | 140,971 | 94,904 | 80,937 | ||||||||||
| Restricted cash | 30,914 | 30,008 | 39,947 | 44,863 | 41,897 | ||||||||||
| Tenant receivables | 7,577 | 9,261 | 8,449 | 10,124 | 6,143 | ||||||||||
| Deferred rent | 177,507 | 170,100 | 170,396 | 160,914 | 155,295 | ||||||||||
| Deferred leasing and financing costs, net | 164,362 | 159,872 | 160,048 | 152,021 | 151,355 | ||||||||||
| Investments | 122,605 | 123,543 | 115,048 | 107,808 | 104,454 | ||||||||||
| Other assets | 120,740 | 135,952 | 90,679 | 94,356 | 93,304 | ||||||||||
| Total assets | $ | 7,379,289 | $ | 7,090,919 | $ | 7,150,116 | $ | 6,965,017 | $ | 6,841,739 | |||||
| Liabilities, Noncontrolling Interests, and Equity | |||||||||||||||
| Secured notes payable | $ | 711,029 | $ | 730,714 | $ | 716,144 | $ | 719,350 | $ | 719,977 | |||||
| Unsecured senior notes payable | 1,048,395 | 549,816 | 549,805 | 549,794 | 549,783 | ||||||||||
| Unsecured senior line of credit | – | 554,000 | 566,000 | 413,000 | 379,000 | ||||||||||
| Unsecured senior bank term loans | 1,200,000 | 1,350,000 | 1,350,000 | 1,350,000 | 1,350,000 | ||||||||||
| Accounts payable, accrued expenses, and tenant security deposits | 368,249 | 367,153 | 423,708 | 376,785 | 348,037 | ||||||||||
| Dividends payable | 52,141 | 43,955 | 41,401 | 39,468 | 38,357 | ||||||||||
| Total liabilities | 3,379,814 | 3,595,638 | 3,647,058 | 3,448,397 | 3,385,154 | ||||||||||
| Commitments and contingencies | |||||||||||||||
| Redeemable noncontrolling interests | 14,505 | 14,534 | 14,564 | 15,610 | 15,817 | ||||||||||
| Alexandria Real Estate Equities, Inc.’s stockholders’ equity: | |||||||||||||||
| Series D Cumulative Convertible Preferred Stock | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | ||||||||||
| Series E Cumulative Redeemable Preferred Stock | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | ||||||||||
| Common stock | 710 | 633 | 632 | 632 | 622 | ||||||||||
| Additional paid-in capital | 3,596,477 | 3,075,860 | 3,086,052 | 3,094,987 | 3,053,269 | ||||||||||
| Accumulated other comprehensive loss | (39,565 | ) | (22,890 | ) | (24,833 | ) | (19,729 | ) | (37,370 | ) | |||||
| Alexandria’s stockholders’ equity | 3,937,622 | 3,433,603 | 3,441,851 | 3,455,890 | 3,396,521 | ||||||||||
| Noncontrolling interests | 47,348 | 47,144 | 46,643 | 45,120 | 44,247 | ||||||||||
| Total equity | 3,984,970 | 3,480,747 | 3,488,494 | 3,501,010 | 3,440,768 | ||||||||||
| Total liabilities, noncontrolling interests, and equity | $ | 7,379,289 | $ | 7,090,919 | $ | 7,150,116 | $ | 6,965,017 | $ | 6,841,739 | |||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 6 | ||||||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Funds From Operations and Adjusted Funds From Operations
(In thousands, except per share amounts)
(Unaudited)
The following table presents a reconciliation of net income attributable to Alexandria’s common stockholders – basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria’s common stockholders – diluted, FFO attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria’s common stockholders – diluted, for the periods below:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | |||||||||||||||
| Net income attributable to Alexandria’s common stockholders – basic | $ | 25,483 | **** | $ | 22,442 | **** | $ | 21,000 | **** | $ | 10,646 | **** | $ | 17,616 | **** | $ | 47,925 | **** | $ | 35,984 | **** |
| Depreciation and amortization | 46,580 | 46,995 | 48,072 | 48,173 | 52,355 | 93,575 | 95,760 | ||||||||||||||
| Loss (gain) on sale of real estate | (219 | ) | 340 | – | (1,562 | ) | (2 | ) | 121 | (2 | ) | ||||||||||
| Impairment of real estate | – | – | 1,601 | 9,799 | – | – | – | ||||||||||||||
| Gain on sale of land parcel | (772 | ) | – | – | – | – | (772 | ) | (1,864 | ) | |||||||||||
| Amount attributable to noncontrolling interests/unvested restricted stock awards: | |||||||||||||||||||||
| Net income | 1,383 | 1,324 | 1,336 | 1,188 | 1,122 | 2,707 | 2,068 | ||||||||||||||
| FFO | (1,437 | ) | (1,064 | ) | (1,109 | ) | (1,148 | ) | (1,133 | ) | (2,501 | ) | (2,305 | ) | |||||||
| FFO attributable to Alexandria’s common stockholders – basic | 71,018 | 70,037 | 70,900 | 67,096 | 69,958 | 141,055 | 129,641 | ||||||||||||||
| Assumed conversion of 8.00% Unsecured Senior Convertible Notes | 5 | 5 | 5 | 5 | 6 | 10 | 11 | ||||||||||||||
| FFO attributable to Alexandria’s common stockholders – diluted | 71,023 | **** | 70,042 | **** | 70,905 | **** | 67,101 | **** | 69,964 | **** | 141,065 | **** | 129,652 | **** | |||||||
| Realized gain on equity investment primarily related to one non-tenant life science entity | – | – | – | – | (5,811 | ) | – | (5,811 | ) | ||||||||||||
| Impairment of land parcel | – | – | 2,050 | – | – | – | – | ||||||||||||||
| Loss on early extinguishment of debt | 560 | – | – | – | 1,602 | 560 | 2,225 | ||||||||||||||
| Preferred stock redemption charge | – | – | – | – | – | – | 5,978 | ||||||||||||||
| Allocation to unvested restricted stock awards | (12 | ) | – | (19 | ) | – | 35 | (12 | ) | (20 | ) | ||||||||||
| FFO attributable to Alexandria’s common stockholders – diluted, as adjusted | 71,571 | **** | 70,042 | **** | 72,936 | **** | 67,101 | **** | 65,790 | **** | 141,613 | **** | 132,024 | **** | |||||||
| Non-revenue-enhancing capital expenditures: | |||||||||||||||||||||
| Maintenance building improvements | (337 | ) | (596 | ) | (329 | ) | (935 | ) | (594 | ) | (933 | ) | (804 | ) | |||||||
| Tenant improvements and leasing commissions | (2,990 | ) | (882 | ) | (3,170 | ) | (1,844 | ) | (2,148 | ) | (3,872 | ) | (4,167 | ) | |||||||
| Straight-line rent revenue | (8,239 | ) | (6,198 | ) | (9,240 | ) | (5,225 | ) | (5,195 | ) | (14,437 | ) | (13,991 | ) | |||||||
| Straight-line rent expense on ground leases | 539 | 538 | 471 | 201 | 1,207 | 1,077 | 2,613 | ||||||||||||||
| Capitalized income from development projects | 9 | 22 | 45 | 50 | 72 | 31 | 550 | ||||||||||||||
| Amortization of acquired above and below market leases | (830 | ) | (830 | ) | (844 | ) | (778 | ) | (778 | ) | (1,660 | ) | (1,578 | ) | |||||||
| Amortization of loan fees | 2,427 | 2,386 | 2,505 | 2,470 | 2,214 | 4,813 | 4,857 | ||||||||||||||
| Amortization of debt premiums/discounts | 115 | 115 | 110 | 112 | 110 | 230 | 289 | ||||||||||||||
| Stock compensation | 4,463 | 3,349 | 3,748 | 3,845 | 3,274 | 7,812 | 6,567 | ||||||||||||||
| Allocation to unvested restricted stock awards | 50 | 19 | 63 | 19 | 15 | 69 | 48 | ||||||||||||||
| AFFO attributable to Alexandria’s common stockholders – diluted | $ | 66,778 | **** | $ | 67,965 | **** | $ | 66,295 | **** | $ | 65,016 | **** | $ | 63,967 | **** | $ | 134,743 | **** | $ | 126,408 | **** |
The following table presents a reconciliation of net income per share attributable to Alexandria’s common stockholders - basic, to FFO per share attributable to Alexandria’s common stockholders – diluted, FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – diluted, for the periods below. For the computation of the weighted average shares used to compute the per share information, refer to the “Definitions and Other Information” section in our supplemental information:
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | |||||||||||||||
| Net income per share attributable to Alexandria’s common stockholders – basic | $ | 0.38 | **** | $ | 0.36 | **** | $ | 0.33 | **** | $ | 0.17 | **** | $ | 0.29 | **** | $ | 0.74 | **** | $ | 0.58 | **** |
| Depreciation and amortization | 0.69 | 0.74 | 0.76 | 0.78 | 0.84 | 1.43 | 1.56 | ||||||||||||||
| Loss (gain) on sale of real estate | – | 0.01 | – | (0.03 | ) | – | 0.01 | – | |||||||||||||
| Impairment of real estate | – | – | 0.03 | 0.16 | – | – | – | ||||||||||||||
| Gain on sale of land parcel | (0.01 | ) | – | – | – | – | (0.01 | ) | (0.03 | ) | |||||||||||
| Amount attributable to noncontrolling interests/unvested restricted stock awards: | |||||||||||||||||||||
| Net income | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | ||||||||||||||
| FFO | (0.02 | ) | (0.02 | ) | (0.02 | ) | (0.02 | ) | (0.02 | ) | (0.04 | ) | (0.04 | ) | |||||||
| FFO per share attributable to Alexandria’s common stockholders – basic | 1.06 | 1.11 | 1.12 | 1.08 | 1.13 | 2.17 | 2.11 | ||||||||||||||
| Assumed conversion of 8.00% Unsecured Senior Convertible Notes | – | – | – | – | – | – | – | ||||||||||||||
| FFO per share attributable to Alexandria’s common stockholders – diluted | 1.06 | **** | 1.11 | **** | 1.12 | **** | 1.08 | **** | 1.13 | **** | 2.17 | **** | 2.11 | **** | |||||||
| Realized gain on equity investment primarily related to one non-tenant life science entity | – | – | – | – | (0.09 | ) | – | (0.09 | ) | ||||||||||||
| Impairment of land parcel | – | – | 0.04 | – | – | – | – | ||||||||||||||
| Loss on early extinguishment of debt | 0.01 | – | – | – | 0.03 | 0.01 | 0.03 | ||||||||||||||
| Preferred stock redemption charge | – | – | – | – | – | – | 0.10 | ||||||||||||||
| Allocation to unvested restricted stock awards | – | – | – | – | – | – | – | ||||||||||||||
| FFO per share attributable to Alexandria’s common stockholders – diluted, as adjusted | 1.07 | **** | 1.11 | **** | 1.16 | **** | 1.08 | **** | 1.07 | **** | 2.18 | **** | 2.14 | **** | |||||||
| Non-revenue-enhancing capital expenditures: | |||||||||||||||||||||
| Maintenance building improvements | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | |||||||
| Tenant improvements and leasing commissions | (0.04 | ) | (0.01 | ) | (0.05 | ) | (0.03 | ) | (0.03 | ) | (0.06 | ) | (0.07 | ) | |||||||
| Straight-line rent revenue | (0.12 | ) | (0.10 | ) | (0.15 | ) | (0.08 | ) | (0.08 | ) | (0.22 | ) | (0.23 | ) | |||||||
| Straight-line rent expense on ground leases | 0.01 | 0.01 | 0.01 | – | 0.02 | 0.02 | 0.04 | ||||||||||||||
| Amortization of acquired above and below market leases | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.01 | ) | (0.03 | ) | (0.03 | ) | |||||||
| Amortization of loan fees | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.07 | 0.09 | ||||||||||||||
| Stock compensation | 0.07 | 0.05 | 0.06 | 0.06 | 0.05 | 0.12 | 0.11 | ||||||||||||||
| Allocation to unvested restricted stock awards | – | – | – | – | – | – | – | ||||||||||||||
| Other | – | – | – | – | – | – | 0.01 | ||||||||||||||
| AFFO per share attributable to Alexandria’s common stockholders – diluted | $ | 1.00 | **** | $ | 1.08 | **** | $ | 1.05 | **** | $ | 1.04 | **** | $ | 1.04 | **** | $ | 2.07 | **** | $ | 2.05 | **** |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 7 | ||||||||||||||||||||
| --- | --- |
SUPPLEMENTAL
INFORMATION
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Company Profile
The Company
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade real estate investment trust (“REIT”), is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community. We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.
Unique Niche Strategy
Alexandria’s primary business objective is to maximize stockholder value by providing its stockholders with the greatest possible total return and long-term asset value based on a multifaceted platform of internal and external growth. The key elements to our strategy include our consistent focus on high-quality assets and operations in the top life science cluster locations with our properties located adjacent to life science entities, driving growth and technological advances within each cluster. These adjacency locations are characterized by high barriers to entry for new landlords, high barriers to exit for client tenants, and limited supply of available space. They represent highly desirable locations for tenancy by life science entities because of the close proximity to concentrations of specialized skills, knowledge, institutions, and related businesses. Alexandria’s strategy also includes drawing upon our deep and broad life science and real estate relationships in order to attract new and leading life science client tenants and value-added real estate. Alexandria was founded in 1994 by Jerry M. Sudarsky and Joel S. Marcus. Alexandria executed its initial public offering in 1997 and received its investment-grade ratings in 2011.
Management
Alexandria’s executive and senior management team is highly experienced in the REIT industry (uniquely with life science and real estate development, construction, operations, ownership, and expertise) and is the most accomplished team focused on providing high-quality, environmentally sustainable real estate, technical infrastructure, and unique expertise to the broad and diverse life science industry. Our deep and talented team has decades of life science industry experience. Our management team also includes highly experienced regional market directors averaging over 21 years of real estate experience, including approximately 11 years with Alexandria. We believe that our expertise, experience, reputation, and key life science relationships provide Alexandria significant competitive advantages in attracting new business opportunities.
Client Tenant Base
The quality, diversity, breadth, and depth of our significant relationships with our life science client tenants provide Alexandria with solid and stable cash flows. Investment-grade client tenants represented 46% of Alexandria’s total annualized base rent as of June 30, 2013. Additionally, investment-grade client tenants represented 72% of Alexandria’s top 10 client tenants by annualized base rent as of June 30, 2013. As of June 30, 2013, our multinational pharmaceutical client tenants represented approximately 26.1% of our annualized base rent, led by Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., and Roche; revenue producing life science product and service, medical device, and industrial biotech companies represented approximately 22.1%, led by Illumina, Inc., Laboratory Corporation of America Holdings, Monsanto Company, and Quest Diagnostics Incorporated; non-profit, renowned medical and research institutions, and government agencies represented approximately 17.6% and included Fred Hutchinson Cancer Research Center, Massachusetts Institute of Technology, The Regents of the University of California, Sanford-Burnham Medical Research Institute, The Scripps Research Institute, the United States Government, and University of Washington; public biotechnology companies represented approximately 17.1% and included Amgen Inc., Biogen Idec Inc., Celgene Corporation, Gilead Sciences, Inc., and Onyx Pharmaceuticals, Inc.; private biotechnology companies represented approximately 13.0% and included high-quality, leading-edge companies with blue-chip venture and institutional investors, including Constellation Pharmaceuticals, Inc., FibroGen, Inc., and FORMA Therapeutics, Inc.; and the remaining approximately 4.1% consisted of traditional office client tenants. Alexandria’s strong life science underwriting skills, long-term life science industry relationships, and sophisticated management with both real estate and life science operating expertise positively distinguish Alexandria from all other publicly traded real estate investment trusts and real estate companies.
Executive/Senior Management
| Joel S. Marcus | Chairman, Chief Executive Officer, & Founder | Thomas J. Andrews | EVP – Regional Market Director-Greater Boston |
|---|---|---|---|
| Dean A. Shigenaga | Chief Financial Officer, EVP, & Treasurer | Daniel J. Ryan | EVP – Regional Market Director-San Diego & Strategic Operations |
| Stephen A. Richardson | Chief Operating Officer & Regional Market Director-San Francisco Bay Area | John J. Cox | SVP – Regional Market Director-Seattle |
| Peter M. Moglia | Chief Investment Officer | John H. Cunningham | SVP – Regional Market Director-NY & Strategic Operations |
| Jennifer J. Banks | SVP, General Counsel, & Corporate Secretary | Larry J. Diamond | SVP – Regional Market Director-Mid Atlantic |
| Marc E. Binda | SVP – Finance | Vincent R. Ciruzzi | SVP – Construction & Development |
| Andres R. Gavinet | Chief Accounting Officer | ||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 9 | ||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Company Information
| Corporate Headquarters | Trading Symbols | Information Requests | |
|---|---|---|---|
| 385 East Colorado Boulevard, Suite 299 | New York Stock Exchange | Phone: | (626) 396-4828 |
| Pasadena, California 91101 | Common stock: ARE | E-mail: | corporateinformation@are.com |
| Series E preferred stock: ARE–E | Web: | www.are.com |
Summary Data
| Cluster Markets | Total Properties | Total Rentable<br> Square Feet |
|---|---|---|
| Greater Boston, San Francisco Bay Area, San Diego, Greater NYC, Suburban Washington, D.C., Seattle, Research Triangle Park, Canada, India, and China | 173 | 17.0 million |
Common Stock Data
| 2Q13 | 1Q13 | 4Q12 | 3Q12 | 2Q12 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| High/low trading price | $ | 78.43/61.20 | $ | 73.51/69.77 | $ | 74.59/64.09 | $ | 77.10/70.97 | $ | 76.50/67.40 |
| Closing stock price, average for period | $ | 70.68 | $ | 71.98 | $ | 69.88 | $ | 73.65 | $ | 71.67 |
| Closing stock price, at the end of the quarter | $ | 65.72 | $ | 70.98 | $ | 69.32 | $ | 73.52 | $ | 72.72 |
| Dividend per share – quarter/annualized | $ | 0.65/2.60 | $ | 0.60/2.40 | $ | 0.56/2.24 | $ | 0.53/2.12 | $ | 0.51/2.04 |
| Closing dividend yield – annualized | 4.0% | 3.4% | 3.2% | 2.9% | 2.8% | |||||
| Common shares outstanding, at the end of the quarter (in thousands) | 70,997 | 63,317 | 63,245 | 63,161 | 62,250 | |||||
| Closing market value of outstanding common shares (in thousands) | $ | 4,665,948 | $ | 4,494,262 | $ | 4,384,119 | $ | 4,643,610 | $ | 4,526,818 |
| Total market capitalization (in thousands) | $ | 8,005,581 | $ | 8,066,072 | $ | 7,953,348 | $ | 8,064,386 | $ | 7,912,286 |
Investor Information
Equity Research Coverage
Alexandria is currently covered by the following research analysts. This list may not be complete and is subject to change as firms initiate or discontinue coverage of our company. Please note that any opinions, estimates, or forecasts regarding our historical or predicted performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of Alexandria or its management. Alexandria does not by its reference below or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations. Interested persons may obtain copies of analysts’ reports on their own as we do not distribute these reports. Several of these firms may from time-to-time own our stock and/or hold other long or short positions in our stock, and may provide compensated services to us.
| Argus Research Group, Inc. | **** | Evercore Partners | **** | RBC Capital Markets | **** |
|---|---|---|---|---|---|
| William Eddleman, Jr. | (212) 425-7500 | Sheila McGrath | (212) 497-0882 | Michael Carroll | (440) 715-2649 |
| Nathan Crossett | (212) 497-0870 | Rich Moore | (440) 715-2646 | ||
| Bank of America Merrill Lynch | **** | Green Street Advisors, Inc. | Robert W. Baird & Company | ||
| James Feldman | (646) 855-5808 | Jeff Theiler | (949) 640-8780 | David Rodgers | (216) 737-7341 |
| Jeffrey Spector | (646) 855-1363 | John Hornbeak | (949) 640-8780 | Mathew R. Spencer | (414) 298-5053 |
| Stephen Sihelnik | (646) 855-1829 | ||||
| Barclays Capital Inc. | International Strategy & Investment Group Inc. | Standard & Poor’s | **** | ||
| Ross L. Smotrich | (212) 526-2306 | George Auerbach | (212) 446-9459 | Roy Shepard | (212) 438-1947 |
| Michael R. Lewis | (212) 526-3098 | Steve Sakwa | (212) 446-9462 | ||
| Gwen Clark | (212) 446-5611 | ||||
| Citigroup Global Markets Inc. | JMP Securities – JMP Group, Inc. | UBS Financial Services Inc. | |||
| Michael Bilerman | (212) 816-1383 | William C. Marks | (415) 835-8944 | Ross Nussbaum | (212) 713-2484 |
| Quentin Velleley | (212) 816-6981 | Whitney Stevenson | (415) 835-8948 | Gabriel Hilmoe | (212) 713-3876 |
| Emmanuel Korchman | (212) 816-1382 | Weina Hou | (212) 713-4057 | ||
| Cowen and Company, LLC | J.P. Morgan Securities LLC | ||||
| James Sullivan | (646) 562-1380 | Anthony Paolone | (212) 622-6682 | ||
| Tom Catherwood | (646) 562-1382 | Joseph Dazio | (212) 622-6416 |
Rating Agencies
| Moody’s Investors Service | **** | Rating | Standard & Poor’s | **** | Rating |
|---|---|---|---|---|---|
| Philip Kibel | (212) 553-4569 | Baa2 | George Skoufis | (212) 438-2608 | BBB- |
| Maria Maslovsky | (212) 553-4831 | Stable Outlook | Jaime Gitler | (212) 438-5049 | Stable Outlook |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 10 | ||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Financial and Asset Base Highlights
(Dollars in thousands, except per share amounts)
(Unaudited)
| Three Months Ended (unless stated otherwise) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Credit Metrics | 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | ||||||||
| Unencumbered NOI as a percentage of total NOI | 70% | 68% | 71% | 72% | 72% | ||||||||
| Percentage outstanding on unsecured senior line of credit at end of period | 0% | 37% | 38% | 28% | 25% | ||||||||
| Net debt to gross assets at end of period | 33% | 39% | 38% | 38% | 38% | ||||||||
| Net debt to Adjusted EBITDA – quarter annualized | 6.6x | 7.8x | 7.3x | 7.6x | 7.1x | ||||||||
| Net debt to Adjusted EBITDA – trailing 12 months | 6.6x | 7.7x | 7.6x | 7.5x | 7.5x | ||||||||
| Fixed charge coverage ratio – quarter annualized | 2.8x | 2.7x | 2.8x | 2.5x | 2.6x | ||||||||
| Fixed charge coverage ratio – trailing 12 months | 2.7x | 2.7x | 2.6x | 2.6x | 2.7x | ||||||||
| Interest coverage ratio – quarter annualized | 3.4x | 3.3x | 3.4x | 3.1x | 3.2x | ||||||||
| Dividend payout ratio (common stock) | 65% | 55% | 49% | 50% | 49% | ||||||||
| Selected Balance Sheet Information – at end of period | **** | **** | **** | **** | **** | **** | **** | **** | |||||
| Gross investments in real estate | $ | 7,331,578 | $ | 7,225,073 | $ | 7,299,613 | $ | 7,154,359 | $ | 7,030,723 | |||
| Total assets | $ | 7,379.289 | $ | 7,090,919 | $ | 7,150,116 | $ | 6,965,017 | $ | 6,841,739 | |||
| Total unsecured debt | $ | 2,248,395 | $ | 2,453,816 | $ | 2,465,805 | $ | 2,312,794 | $ | 2,278,783 | |||
| Total debt | $ | 2,959,424 | $ | 3,184,530 | $ | 3,181,949 | $ | 3,032,114 | $ | 2,998,760 | |||
| Net debt | $ | 2,626,305 | $ | 3,067,521 | $ | 3,001,031 | $ | 2,892,377 | $ | 2,875,926 | |||
| Total liabilities | $ | 3,379,814 | $ | 3,595,638 | $ | 3,647,058 | $ | 3,448,397 | $ | 3,385,154 | |||
| Common shares outstanding (in thousands) | 70,997 | 63,317 | 63,245 | 63,161 | 62,250 | ||||||||
| Total market capitalization | $ | 8,005,581 | $ | 8,066,072 | $ | 7,953,348 | $ | 8,064,386 | $ | 7,912,286 | |||
| Operating Data | |||||||||||||
| Total revenues | $ | 154,235 | $ | 150,380 | $ | 151,554 | $ | 142,850 | $ | 145,593 | |||
| Rental operations | $ | 46,323 | $ | 45,224 | $ | 46,176 | $ | 44,203 | $ | 42,102 | |||
| Operating margins | 70% | 70% | 70% | 69% | 71% | ||||||||
| General and administrative expense as a percentage of total revenues | 8.1% | 7.7% | 8.3% | 8.7% | 8.4% | ||||||||
| Capitalized interest | $ | 15,690 | $ | 14,021 | $ | 14,897 | $ | 16,763 | $ | 15,825 | |||
| Weighted average interest rate used for capitalization during period | 4.13% | 3.97% | 4.10% | 4.35% | 4.41% | ||||||||
| Adjusted EBITDA – quarter annualized | $ | 399,708 | $ | 395,764 | $ | 408,876 | $ | 382,608 | $ | 403,168 | |||
| Adjusted EBITDA – trailing 12 months | $ | 396,739 | $ | 397,606 | $ | 393,124 | $ | 385,393 | $ | 384,033 | |||
| Adjusted EBITDA margins – quarter annualized | 65% | 66% | 67% | 67% | 69% | ||||||||
| Net Income, FFO, and AFFO | |||||||||||||
| Net income attributable to Alexandria’s common stockholders – diluted | $ | 25,483 | $ | 22,442 | $ | 21,000 | $ | 10,646 | (1) | $ | 17,616 | ||
| FFO attributable to Alexandria’s common stockholders – diluted | $ | 71,023 | $ | 70,042 | $ | 70,905 | $ | 67,101 | $ | 69,964 | |||
| FFO attributable to Alexandria’s common stockholders – diluted, as adjusted | $ | 71,571 | $ | 70,042 | $ | 72,936 | $ | 67,101 | $ | 65,790 | |||
| AFFO attributable to Alexandria’s common stockholders – diluted | $ | 66,778 | $ | 67,965 | $ | 66,295 | $ | 65,016 | $ | 63,967 | |||
| Per Share Data | **** | **** | **** | **** | **** | **** | **** | **** | |||||
| Earnings per share – diluted | $ | 0.38 | $ | 0.36 | $ | 0.33 | $ | 0.17 | (1) | $ | 0.29 | ||
| FFO per share – diluted | $ | 1.06 | $ | 1.11 | $ | 1.12 | $ | 1.08 | $ | 1.13 | |||
| FFO per share – diluted, as adjusted | $ | 1.07 | $ | 1.11 | $ | 1.16 | $ | 1.08 | $ | 1.07 | |||
| AFFO per share – diluted | $ | 1.00 | $ | 1.08 | $ | 1.05 | $ | 1.04 | $ | 1.04 | |||
| Asset Base Statistics – at end of period | **** | **** | **** | **** | **** | **** | **** | **** | |||||
| Number of properties at end of period | 173 | 174 | 179 | 178 | 183 | ||||||||
| Rentable square feet at end of period | 17,035,097 | 17,075,268 | 17,521,772 | 17,101,966 | 17,385,572 | ||||||||
| Occupancy of operating properties at end of period | 93.3% | 93.0% | 93.4% | 93.0% | 92.9% | ||||||||
| Occupancy of operating and redevelopment properties at end of period | 91.2% | 90.1% | 89.8% | 88.3% | 86.9% | ||||||||
| Leasing Activity and Same Property Performance | |||||||||||||
| Leasing activity – rentable square feet | 767,935 | 702,901 | 677,781 | 732,094 | 959,295 | ||||||||
| Leasing activity – change in average new rental rates over expiring rates – cash basis | 6.7% | 5.9% | (2.9% | ) | (2.9% | ) | (0.8% | ) | |||||
| Leasing activity – change in average new rental rates over expiring rates – GAAP basis | 12.7% | 12.7% | 2.6% | 7.6% | 5.8% | ||||||||
| Same property – change in NOI over comparable quarter from prior year – cash basis | 7.2% | 8.8% | 6.3% | 4.3% | 1.6% | ||||||||
| Same property – change in NOI over comparable quarter from prior year – GAAP basis | 3.2% | 0.4% | 0.7% | (0.9% | ) | (0.2% | ) |
(1) Net income attributable to Alexandria’s common stockholders – diluted excluding $9.8 million, or $0.16 per share, impairment of real estate, was $20.4 million, or $0.33 per share.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 11 |
|---|
CORE OPERATING METRICS
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Core Operating Metrics
(Unaudited)
Quarterly percentage change in same property NOI

Percentage change in rental rates on renewed/re-leased space

Occupancy percentage

Solid leasing capabilities – rentable square feet leased (in thousands)

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 13 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Same Property Comparisons
(Dollars in thousands)
(Unaudited)
| **** | Three Months Ended | Six Months Ended |
|---|---|---|
| Same property data | June 30, 2013 | June 30, 2013 |
| Percentage change in net operating income – cash basis | 7.2% | 8.3% |
| Percentage change in net operating income – GAAP basis | 3.2% | 2.0% |
| Number of properties | 137 | 135 |
| Rentable square feet | 11,182,003 | 11,032,453 |
| Occupancy – current period | 93.4% | 93.1% |
| Occupancy – same period prior year | 92.5% | 92.5% |
The following table presents a comparison of the components of same property and non-same property NOI for the three months and six months ended June 30, 2013, compared to the three months and six months ended June 30, 2012, and a reconciliation of NOI to income from continuing operations, the most directly comparable GAAP financial measure:
| **** | Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues: | 2013 | 2012 | % Change | 2013 | 2012 | **** | % Change | |||||||||
| Rental – same properties | $ | 96,605 | $ | 92,794 | 4.1 | % | $ | 190,681 | $ | 185,022 | 3.1 | % | ||||
| Rental – non-same properties | 18,138 | 11,535 | 57.2 | 35,838 | 20,508 | 74.8 | ||||||||||
| Total rental – GAAP basis | 114,743 | 104,329 | 10.0 | 226,519 | 205,530 | 10.2 | ||||||||||
| Tenant recoveries – same properties | 29,830 | 29,282 | 1.9 | 60,087 | 58,034 | 3.5 | ||||||||||
| Tenant recoveries – non-same properties | 6,093 | 2,599 | 134.4 | 11,447 | 5,729 | 99.8 | ||||||||||
| Total tenant recoveries | 35,923 | 31,881 | 12.7 | 71,534 | 63,763 | 12.2 | ||||||||||
| Other income – same properties | 203 | 24 | 745.8 | 323 | 82 | 293.9 | ||||||||||
| Other income – non-same properties | 3,366 | 9,359 | (64.0 | ) | 6,239 | 11,929 | (47.7 | ) | ||||||||
| Total other income | 3,569 | 9,383 | (62.0 | ) | 6,562 | 12,011 | (45.4 | ) | ||||||||
| Total revenues – same properties | 126,638 | 122,100 | 3.7 | 251,091 | 243,138 | 3.3 | ||||||||||
| Total revenues – non-same properties | 27,597 | 23,493 | 17.5 | 53,524 | 38,166 | 40.2 | ||||||||||
| Total revenues | 154,235 | 145,593 | 5.9 | 304,615 | 281,304 | 8.3 | ||||||||||
| Expenses: | ||||||||||||||||
| Rental operations – same properties | 39,143 | 37,291 | 5.0 | 78,234 | 73,672 | 6.2 | ||||||||||
| Rental operations – non-same properties | 7,180 | 4,811 | 49.2 | 13,313 | 8,883 | 49.9 | ||||||||||
| Total rental operations | 46,323 | 42,102 | 10.0 | 91,547 | 82,555 | 10.9 | ||||||||||
| Net operating income: | ||||||||||||||||
| NOI – same properties | 87,495 | 84,809 | 3.2 | 172,857 | 169,466 | 2.0 | ||||||||||
| NOI – non-same properties | 20,417 | 18,682 | 9.3 | 40,211 | 29,283 | 37.3 | ||||||||||
| Total NOI – GAAP basis | 107,912 | 103,491 | 4.3 | 213,068 | 198,749 | 7.2 | ||||||||||
| Other expenses: | ||||||||||||||||
| General and administrative | 12,472 | 12,298 | 1.4 | 24,120 | 22,655 | 6.5 | ||||||||||
| Interest | 15,978 | 17,922 | (10.8 | ) | 33,998 | 34,148 | (0.4 | ) | ||||||||
| Depreciation and amortization | 46,580 | 50,741 | (8.2 | ) | 92,645 | 92,527 | 0.1 | |||||||||
| Loss on early extinguishment of debt | 560 | 1,602 | (65.0 | ) | 560 | 2,225 | (74.8 | ) | ||||||||
| Total other expenses | 75,590 | 82,563 | (8.4 | ) | 151,323 | 151,555 | (0.2 | ) | ||||||||
| Income from continuing operations | $ | 32,322 | $ | 20,928 | 54.4 | % | $ | 61,745 | $ | 47,194 | 30.8 | % | ||||
| NOI – same properties – GAAP basis | $ | 87,495 | **** | $ | 84,809 | **** | 3.2 | % | $ | 172,857 | **** | $ | 169,466 | **** | 2.0 | % |
| Less: straight-line rent adjustments | (1,807 | ) | (4,897 | ) | (63.1 | ) | (2,306 | ) | (11,952 | ) | (80.7 | ) | ||||
| NOI – same properties – cash basis | $ | 85,688 | **** | $ | 79,912 | **** | 7.2 | % | $ | 170,551 | **** | $ | 157,514 | **** | 8.3 | % |
The following table reconciles same properties to total properties for the six months ended June 30, 2013:
| Development – active | Properties | Development – deliveries since January 1, 2012 | Properties | Properties | |||
|---|---|---|---|---|---|---|---|
| 225 Binney Street | 1 | 259 East Grand Avenue | 1 | Development – active | 6 | ||
| 499 Illinois Street | 1 | 400/450 East Jamie Court | 2 | Redevelopment – active | 7 | ||
| 269 East Grand Avenue | 1 | Canada | 1 | (1) | Development – deliveries | 6 | |
| 430 East 29th Street | 1 | 4755 Nexus Center Drive | 1 | Redevelopment – deliveries | 9 | ||
| 75/125 Binney Street | 1 | 5200 Illumina Way | 1 | (1) | |||
| 360 Longwood Avenue (JV) | 1 | 6 | Development/Redevelopment – Asia | 7 | (2) | ||
| 6 | Redevelopment – deliveries since January 1, 2012 | ||||||
| Redevelopment – active | 10300 Campus Point Drive | 1 | Acquisitions in North America since January 1, 2012 | ||||
| 9800 Medical Center Drive | 3 | 20 Walkup Drive | 1 | 6 Davis Drive | 1 | ||
| 1616 Eastlake Avenue | 1 | 11119 North Torrey Pines Road | 1 | ||||
| 285 Bear Hill Road | 1 | 3530/3550 John Hopkins Court | 2 | Properties held for sale | 2 | ||
| 343 Oyster Point Boulevard | 1 | 620 Professional Drive | 1 | Total properties excluded from same | 38 | ||
| 4757 Nexus Center Drive | 1 | 6275 Nancy Ridge Drive | 1 | properties | |||
| 7 | 1551 Eastlake Avenue | 1 | |||||
| 400 Technology Square | 1 | Same properties | 135 | ||||
| 9 | Total consolidated and unconsolidated properties as of June 30, 2013 | 173 | |||||
| (1) | These properties each represent multiple buildings, a portion of which are included in our same property results. As a result, 26,426 RSF and 127,373 RSF for Canada and 5200 Illumina Way, respectively, have been excluded from our same property results. | ||||||
| --- | --- | ||||||
| (2) | Property count in Asia includes one development delivery, one property acquired since January 1, 2012, and five active development and redevelopment properties. | ||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 14 | ||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Same Property Performance Historical Results
(Unaudited)
The charts below provide two alternative calculations of same property performance in comparison to our historical same property performance. Our reported same property performance has been based upon a pool of operating assets and completed developed and redeveloped assets to the extent that those assets were operating for the entirety of the comparable same property period presented. The alternative calculations presented below include 1) same property performance for the operating portfolio excluding assets that were recently developed or redeveloped and 2) the same property performance for the operating portfolio including those assets that were either under active redevelopment or previously completed redevelopments. From 2008 through 2012, our same property performance was generally consistent in each of the three calculations. For the six months ended June 30, 2013, same property performance including redevelopment properties, as shown in the table, would have been meaningfully higher than our traditional method of reporting same property performance. Same property performance including redevelopment properties will, from time to time, have significant growth in net operating income as a result of the completion of the conversion of non-laboratory space (with lower net operating income) to laboratory space (with higher net operating income) through redevelopment. We believe our traditional method of reporting same property performance is a more useful presentation since it excludes the potential significant increases in performance as a result of completion of significant redevelopment projects.
Percentage change in same property NOI over preceding period - cash basis

Percentage change in same property NOI over preceding period - GAAP basis

| (1) | Recently delivered developments and redevelopments are included in the same property data in the periods after their completion only if the property was operating during the entire same property periods. For example, projects completed in 2010 are included in 2012 vs. 2011 same property performance. Additionally, projects completed in 2011 are excluded from the 2012 vs. 2011 same property performance but included in the six months ended June 30, 2013, vs. six months ended June 30, 2012, same property performance. |
|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 15 |
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Leasing Activity
(Unaudited)
| Three Months Ended | Six Months Ended | Year Ended | |
|---|---|---|---|
| June 30, 2013 | June 30, 2013 | December 31, 2012 | |
| Leasing activity: | Cash | Cash | Cash |
| Renewed/re-leased space | |||
| Rental rate changes | 6.7% | 6.5% | (2.0%) |
| New rates | 33.22 | 32.65 | 29.86 |
| Expiring rates | 31.12 | 30.66 | 30.47 |
| Rentable square footage | 331,043 | 486,924 | 1,475,403 |
| Number of leases | 33 | 50 | 102 |
| TI’s/lease commissions per square foot | 9.03 | 7.95 | 6.22 |
| Average lease terms | 4.8 years | 4.1 years | 4.7 years |
| Developed/redeveloped/previously vacant space leased | |||
| New rates | 46.73 | 49.04 | 30.66 |
| Rentable square footage | 436,892 | 983,912 | 1,805,693 |
| Number of leases | 33 | 58 | 85 |
| TI’s/lease commissions per square foot | 31.40 | 18.12 | 11.02 |
| Average lease terms | 11.2 years | 10.7 years | 9.0 years |
| Leasing activity summary: | |||
| Totals (1) | |||
| New rates | 40.91 | 43.62 | 30.30 |
| Rentable square footage | 767,935 | 1,470,836 | 3,281,096 |
| Number of leases | 66 | 108 | 187 |
| TI’s/lease commissions per square foot | 21.76 | 14.75 | 8.87 |
| Average lease terms | 8.4 years | 8.6 years | 7.1 years |
| Lease expirations | |||
| Expiring rates | 31.15 | 31.44 | 30.03 |
| Rentable square footage | 440,712 | 747,722 | 2,350,348 |
| Number of leases | 50 | 81 | 162 |
All values are in US Dollars.
(1) Excludes 10 month-to-month leases for 37,011 RSF at June 30, 2013.
During the three months ended June 30, 2013, we granted tenant concessions/free rent averaging approximately 1.8 months with respect to the 767,935 RSF leased. During the six months ended June 30, 2013, we granted tenant concessions/free rent averaging approximately 1.8 months with respect to the 1,470,836 RSF leased.
| Lease Structure | June 30, 2013 |
|---|---|
| Percentage of triple net leases | 94% |
| Percentage of leases containing annual rent escalations | 95% |
| Percentage of leases providing for the recapture of capital expenditures | 92% |
The following chart presents our total RSF leased (in thousands) by development/redevelopment/previously vacant space and renewed/re-leased space:

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 16 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Lease Expirations
(Unaudited)
| Year of Lease Expiration | Number of Leases Expiring | RSF of Expiring Leases | Percentage of<br> Aggregate Total RSF | Annualized Base Rent of<br> Expiring Leases (per RSF) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 43 | (1) | 410,254 | (1) | 3.0 | % | $31.83 | ||||||
| 2014 | 102 | 1,176,749 | 8.6 | % | $28.93 | ||||||||
| 2015 | 77 | 1,411,738 | 10.3 | % | $32.45 | ||||||||
| 2016 | 66 | 1,413,108 | 10.3 | % | $30.38 | ||||||||
| 2017 | 64 | 1,585,740 | 11.5 | % | $30.67 | ||||||||
| 2018 | 36 | 1,296,499 | 9.4 | % | $39.48 | ||||||||
| 2019 | 24 | 690,566 | 5.0 | % | $32.83 | ||||||||
| 2020 | 17 | 789,909 | 5.8 | % | $39.93 | ||||||||
| 2021 | 20 | 828,009 | 6.0 | % | $37.02 | ||||||||
| 2022 | 16 | 567,703 | 4.1 | % | $29.32 | ||||||||
| Thereafter | 29 | 2,318,276 | 16.9 | % | $39.73 | ||||||||
| Annualized | |||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2013 RSF of Expiring Leases | Base Rent of | ||||||||||||
| Negotiating/ | Targeted for | Remaining | Expiring Leases | ||||||||||
| Market | Leased | Anticipating | Redevelopment | Expiring Leases | Total | (per RSF) | |||||||
| Greater Boston | 47,160 | 21,396 | – | 33,620 | 102,176 | $ | 38.04 | ||||||
| San Francisco Bay Area | 12,313 | 16,818 | – | 36,003 | 65,134 | 22.13 | |||||||
| San Diego | – | – | – | 34,013 | 34,013 | 29.51 | |||||||
| Greater NYC | – | – | – | – | – | – | |||||||
| Suburban Washington, D.C. | – | 114,568 | (2) | – | 54,352 | 168,920 | 34.53 | ||||||
| Seattle | – | 1,350 | – | 9,574 | 10,924 | 27.46 | |||||||
| Research Triangle Park | – | 16,587 | – | 1,603 | 18,190 | 25.24 | |||||||
| Canada | – | – | – | – | – | – | |||||||
| Non-cluster markets | – | 3,508 | – | 1,000 | 4,508 | 12.35 | |||||||
| Asia | – | 4,069 | – | 2,320 | 6,389 | 12.00 | (3) | ||||||
| Total | 59,473 | 178,296 | – | 172,485 | 410,254 | (1) | $ | 31.83 | |||||
| Percentage of expiring leases | 15 | % | 43 | % | – | % | 42 | % | 100 | % | |||
| Annualized | |||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2014 RSF of Expiring Leases | Base Rent of | ||||||||||||
| Negotiating/ | Targeted for | Remaining | Expiring Leases | ||||||||||
| Market | Leased | Anticipating | Redevelopment | Expiring Leases | Total | (per RSF) | |||||||
| Greater Boston | – | 87,516 | – | 237,327 | 324,843 | $ | 38.03 | ||||||
| San Francisco Bay Area | 19,291 | 31,760 | – | 280,164 | 331,215 | 27.08 | |||||||
| San Diego | – | – | – | 52,153 | 52,153 | 23.25 | |||||||
| Greater NYC | – | 48,281 | – | 42,487 | 90,768 | 38.65 | |||||||
| Suburban Washington, D.C. | – | 8,319 | 85,297 | (4) | 74,017 | 167,633 | 19.18 | ||||||
| Seattle | – | 13,401 | – | 9,571 | 22,972 | 43.57 | |||||||
| Research Triangle Park | – | 10,527 | – | 45,812 | 56,339 | 22.91 | |||||||
| Canada | – | – | – | 81,870 | 81,870 | 21.51 | |||||||
| Non-cluster markets | – | – | – | 22,407 | 22,407 | 18.35 | |||||||
| Asia | – | 15,760 | – | 10,789 | 26,549 | 11.89 | (3) | ||||||
| Total | 19,291 | 215,564 | 85,297 | 856,597 | 1,176,749 | $ | 28.93 | ||||||
| Percentage of expiring leases | 2 | % | 18 | % | 7 | % | 73 | % | 100 | % | |||
| (1) | Excludes 10 month-to-month leases for approximately 37,011 RSF. | ||||||||||||
| --- | --- | ||||||||||||
| (2) | Includes approximately 55,000 RSF at 5 Research Court. We expect the tenant to extend their lease beyond their 2013 lease expiration date. This property consists of non-laboratory space and upon rollover will likely undergo conversion into laboratory space through redevelopment subsequent to the final lease expiration. | ||||||||||||
| (3) | Expirations relate to two properties with an average investment of $101 per RSF. | ||||||||||||
| (4) | Represents projects containing approximately 60,000 RSF and 25,000 RSF at 930 Clopper Road and 1500 East Gude Drive, respectively, which we expect to convert from non-laboratory space to laboratory space through redevelopment. | ||||||||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 17 | ||||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Properties and Occupancy
(Unaudited)
Summary of properties
| Rentable Square Feet | Number of | Annualized Base Rent | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market | Operating | Development | Redevelopment | Total | % Total | Properties | (dollars in thousands) | ||||
| Greater Boston | 3,093,019 | 691,487 | 26,270 | 3,810,776 | 22 | % | 36 | $ | 119,616 | 27 | % |
| San Francisco Bay Area | 2,504,258 | 330,030 | 36,473 | 2,870,761 | 17 | 26 | 95,849 | 22 | |||
| San Diego | 2,575,382 | – | 68,423 | 2,643,805 | 16 | 33 | 84,267 | 20 | |||
| Greater NYC | 494,656 | 419,806 | – | 914,462 | 5 | 6 | 32,048 | 7 | |||
| Suburban Washington, D.C. | 2,088,291 | – | 67,055 | 2,155,346 | 13 | 29 | 43,627 | 10 | |||
| Seattle | 720,496 | – | 26,020 | 746,516 | 4 | 10 | 29,170 | 7 | |||
| Research Triangle Park | 941,807 | – | – | 941,807 | 6 | 14 | 18,764 | 4 | |||
| Canada | 1,103,507 | – | – | 1,103,507 | 7 | 5 | 9,397 | 2 | |||
| Non-cluster markets | 61,002 | – | – | 61,002 | – | 2 | 609 | – | |||
| North America | 13,582,418 | 1,441,323 | 224,241 | 15,247,982 | 90 | **** | 161 | 433,347 | 99 | **** | |
| Asia | 617,602 | 618,976 | 85,728 | 1,322,306 | 8 | 9 | 4,736 | 1 | |||
| Continuing operations | 14,200,020 | 2,060,299 | 309,969 | 16,570,288 | 98 | 170 | $ | 438,083 | 100 | % | |
| Discontinued operations | 51,273 | – | – | 51,273 | – | 2 | – | ||||
| Consolidated | 14,251,293 | 2,060,299 | 309,969 | 16,621,561 | 98 | 172 | $ | 438,083 | |||
| Greater Boston - unconsolidated | – | 413,536 | – | 413,536 | 2 | 1 | |||||
| Total consolidated and unconsolidated | 14,251,293 | 2,473,835 | 309,969 | 17,035,097 | 100 | % | 173 |
Summary of occupancy percentages
| Operating Properties | Operating and Redevelopment Properties | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market | June 30, 2013 | March 31, 2013 | June 30, 2012 | June 30, 2013 | March 31, 2013 | June 30, 2012 | ||||||
| Greater Boston | 95.5 | % | 95.8 | % | 93.1 | % | 94.7 | % | 93.5 | % | 84.1 | % |
| San Francisco Bay Area | 97.3 | 95.8 | 97.0 | 95.9 | 93.8 | 94.7 | ||||||
| San Diego | 94.2 | 93.4 | 95.5 | 91.7 | 91.0 | 85.5 | ||||||
| Greater NYC | 98.4 | 98.4 | 94.2 | 98.4 | 98.4 | 94.2 | ||||||
| Suburban Washington, D.C. | 92.3 | 90.8 | 90.1 | 89.4 | 88.0 | 86.3 | ||||||
| Seattle | 93.1 | (1) | 96.7 | 96.1 | 89.9 | 88.2 | 90.8 | |||||
| Research Triangle Park | 91.4 | (2) | 93.6 | 95.5 | 91.4 | 93.6 | 95.5 | |||||
| Canada | 96.8 | 94.7 | 92.7 | 96.8 | 94.7 | 92.7 | ||||||
| Non-cluster markets | 54.0 | 54.0 | 51.4 | 54.0 | 54.0 | 51.4 | ||||||
| North America | 94.6 | **** | 94.2 | **** | 93.9 | **** | 92.9 | **** | 91.8 | **** | 88.4 | **** |
| Asia | 68.1 | 67.1 | 67.4 | 59.8 | 57.7 | 55.0 | ||||||
| Continuing operations | 93.3 | % | 93.0 | % | 92.9 | % | 91.2 | % | 90.1 | % | 86.9 | % |
| (1) | Decrease primarily attributable to the delivery of 39,661 vacant RSF at our redevelopment project at 1551 Eastlake Avenue in the Lake Union submarket. Excluding this delivery, the occupancy percentage of operating properties was 98.5%. | |||||||||||
| --- | --- | |||||||||||
| (2) | We anticipate an increase in occupancy during the fourth quarter of 2013. | |||||||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 18 | |||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Top 20 Client Tenants and Client Tenant Mix
(Dollars in thousands)
(Unaudited)
Top 20 client tenants
| Remaining | Aggregate | Percentage of<br> Aggregate | Percentage of<br> Aggregate | Investment-Grade<br> Client Tenants | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Client Tenant | Number<br> of Leases | Lease Term<br> in Years (1) | Rentable<br> Square Feet | Total Square<br> Feet | Annualized<br> Base Rent | Annualized<br> Base Rent | Fitch<br> Rating | Moody’s<br> Rating | S&P<br> Rating | Education/<br> Research | ||||
| 1 | Novartis AG | 13 | 3.7 | 635,917 | 3.8 | % | $ | 31,993 | 7.3 | % | AA | Aa3 | AA- | – |
| 2 | Illumina, Inc. | 1 | 18.3 | 497,078 | 3.0 | 19,531 | 4.5 | - | – | – | – | |||
| 3 | Bristol-Myers Squibb Company | 6 | 4.6 | 419,624 | 2.5 | 15,840 | 3.6 | A- | A2 | A+ | – | |||
| 4 | Eli Lilly and Company | 6 | 9.7 | 290,132 | 1.7 | 15,563 | 3.6 | A | A2 | AA- | – | |||
| 5 | FibroGen, Inc. | 1 | 10.4 | 234,249 | 1.4 | 14,197 | 3.3 | – | – | – | – | |||
| 6 | Roche | 3 | 4.8 | 348,918 | 2.1 | 13,867 | 3.2 | AA | A1 | AA | – | |||
| 7 | United States Government | 9 | 4.8 | 332,578 | 2.0 | 13,119 | 3.0 | AAA | Aaa | AA+ | – | |||
| 8 | GlaxoSmithKline plc | 5 | 6.1 | 208,394 | 1.3 | 10,187 | 2.3 | A+ | A1 | A+ | – | |||
| 9 | Celgene Corporation | 3 | 8.1 | 250,586 | 1.5 | 9,340 | 2.1 | – | Baa2 | BBB+ | – | |||
| 10 | Onyx Pharmaceuticals, Inc. | 2 | 9.0 | 228,373 | 1.4 | 8,498 | 1.9 | – | – | – | – | |||
| 11 | Massachusetts Institute of Technology | 4 | 3.8 | 185,403 | 1.1 | 8,496 | 1.9 | – | Aaa | AAA | ü | |||
| 12 | NYU-Neuroscience Translational Research Institute | 2 | 10.5 | 86,756 | 0.5 | 8,012 | 1.8 | – | Aa3 | AA- | ü | |||
| 13 | The Regents of the University of California | 3 | 8.2 | 188,654 | 1.1 | 7,787 | 1.8 | AA | Aa1 | AA | ü | |||
| 14 | Alnylam Pharmaceuticals, Inc. | 1 | 3.3 | 129,424 | 0.8 | 6,081 | 1.4 | – | – | – | – | |||
| 15 | Gilead Sciences, Inc. | 1 | 7.0 | 109,969 | 0.7 | 5,824 | 1.3 | – | Baa1 | A- | – | |||
| 16 | Pfizer Inc. | 2 | 5.7 | 116,518 | 0.7 | 5,502 | 1.3 | A+ | A1 | AA | – | |||
| 17 | The Scripps Research Institute | 2 | 3.4 | 101,775 | 0.6 | 5,200 | 1.2 | AA- | Aa3 | – | ü | |||
| 18 | Theravance, Inc. (2) | 2 | 6.9 | 130,342 | 0.8 | 4,895 | 1.1 | – | – | – | – | |||
| 19 | Infinity Pharmaceuticals, Inc. | 2 | 1.6 | 68,020 | 0.4 | 4,423 | 1.0 | – | – | – | – | |||
| 20 | Quest Diagnostics Incorporated | 1 | 3.5 | 248,186 | 1.5 | 4,341 | 1.0 | BBB+ | Baa2 | BBB+ | – | |||
| **** | Total/weighted average top 20 | 69 | 7.3 | 4,810,896 | 28.9 | % | $ | 212,696 | 48.6 | % | **** | **** | **** | **** |
| (1) | Represents remaining lease term in years based on percentage of aggregate annualized base rent in effect as of June 30, 2013. | |||||||||||||
| --- | --- | |||||||||||||
| (2) | As of April 25, 2013, GlaxoSmithKline plc owned approximately 27% of the outstanding stock of Theravance, Inc. |

| Multinational Pharmaceutical | Institutional: University, <br> Non-Profit, and Government | Life Science Product and Service, <br> Medical Device, and Industrial Biotech | Biotechnology: Public & Private |
|---|---|---|---|
| · Astellas Pharma Inc.<br><br><br>· AstraZeneca PLC<br><br><br>· Bayer AG<br><br><br>· Bristol-Myers Squibb Company<br><br><br>· Eisai Co., Ltd.<br><br><br>· Eli Lilly and Company<br><br><br>· Genomics Institute of the Novartis Research Foundation<br><br><br>· GlaxoSmithKline plc<br><br><br>· Novartis AG<br><br><br>· Pfizer Inc.<br><br><br>· Roche<br><br><br>· Sanofi<br><br><br>· Shire plc<br><br><br>· UCB S.A. | · California Institute of Technology<br><br><br>· Dana-Farber Cancer Institute, Inc.<br><br><br>· Duke University<br><br><br>· Environmental Protection Agency<br><br><br>· Fred Hutchinson Cancer Research Center<br><br><br>· Massachusetts Institute of Technology<br><br><br>· National Institutes of Health<br><br><br>· NYU-Neuroscience Translational Research Institute<br><br><br>· Sanford-Burnham Medical Research Institute<br><br><br>· Stanford University<br><br><br>· The Regents of the University of California<br><br><br>· The Scripps Research Institute<br><br><br>· UMass Memorial Health Care, Inc.<br><br><br>· UNC Health Care System<br><br><br>· United States Government<br><br><br>· University of Washington | · Aramco Services Company, Inc.<br><br><br>· Canon U.S. Life Sciences, Inc.<br><br><br>· Covance Inc.<br><br><br>· DSM N.V.<br><br><br>· Fluidigm Corporation<br><br><br>· Illumina, Inc.<br><br><br>· Laboratory Corporation of America Holdings<br><br><br>· Life Technologies Corporation<br><br><br>· Monsanto Company<br><br><br>· Qiagen N.V.<br><br><br>· Quest Diagnostics Incorporated<br><br><br>· Sapphire Energy, Inc.<br><br><br>· Thermo Fisher Scientific, Inc. | · Alnylam Pharmaceuticals, Inc.<br><br><br>· Amgen Inc.<br><br><br>· ARIAD Pharmaceuticals, Inc.<br><br><br>· Biogen Idec Inc.<br><br><br>· Celgene Corporation<br><br><br>· Constellation Pharmaceuticals, Inc.<br><br><br>· Epizyme, Inc.<br><br><br>· Fate Therapeutics, Inc.<br><br><br>· FibroGen, Inc.<br><br><br>· FORMA Therapeutics, Inc.<br><br><br>· Gilead Sciences, Inc.<br><br><br>· Infinity Pharmaceuticals, Inc.<br><br><br>· Kadmon Corporation, LLC<br><br><br>· Medicago Inc.<br><br><br>· Nektar Therapeutics<br><br><br>· Onyx Pharmaceuticals, Inc.<br><br><br>· Proteostasis Therapeutics, Inc.<br><br><br>· Quanticel Pharmaceuticals, Inc.<br><br><br>· Theravance, Inc.<br><br><br>· Warp Drive Bio, LLC |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 19 | ||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Property Listing
(Dollars in thousands)
(Unaudited)
| Occupancy Percentage | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rentable Square Feet | Number of | Annualized | Operating and | |||||||
| Address | Submarket | Operating | Development | Redevelopment | Total | Properties | Base Rent | Operating | Redevelopment | |
| Greater Boston | **** | **** | **** | **** | **** | **** | **** | **** | **** | |
| 100 Technology Square | Cambridge/Inner Suburbs | 255,441 | – | – | 255,441 | 1 | $ | 17,369 | 100.0% | 100.0% |
| 200 Technology Square | Cambridge/Inner Suburbs | 177,101 | – | – | 177,101 | 1 | 10,569 | 100.0 | 100.0 | |
| 300 Technology Square | Cambridge/Inner Suburbs | 175,609 | – | – | 175,609 | 1 | 8,611 | 100.0 | 100.0 | |
| 400 Technology Square | Cambridge/Inner Suburbs | 212,124 | – | – | 212,124 | 1 | 9,928 | 85.7 | 85.7 | |
| 500 Technology Square | Cambridge/Inner Suburbs | 184,207 | – | – | 184,207 | 1 | 10,159 | 100.0 | 100.0 | |
| 600 Technology Square | Cambridge/Inner Suburbs | 128,224 | – | – | 128,224 | 1 | 4,474 | 99.6 | 99.6 | |
| 700 Technology Square | Cambridge/Inner Suburbs | 48,930 | – | – | 48,930 | 1 | 1,584 | 82.4 | 82.4 | |
| 161 First Street | Cambridge/Inner Suburbs | 46,356 | – | – | 46,356 | 1 | 2,083 | 100.0 | 100.0 | |
| 167 Sidney Street | Cambridge/Inner Suburbs | 26,589 | – | – | 26,589 | 1 | 1,392 | 100.0 | 100.0 | |
| 215 First Street | Cambridge/Inner Suburbs | 366,719 | – | – | 366,719 | 1 | 11,038 | 89.5 | 89.5 | |
| 225 Binney Street | Cambridge/Inner Suburbs | – | 305,212 | – | 305,212 | 1 | – | N/A | N/A | |
| 75/125 Binney Street | Cambridge/Inner Suburbs | – | 386,275 | – | 386,275 | 1 | – | N/A | N/A | |
| 300 Third Street | Cambridge/Inner Suburbs | 131,963 | – | – | 131,963 | 1 | 6,534 | 100.0 | 100.0 | |
| 480 Arsenal Street | Cambridge/Inner Suburbs | 140,744 | – | – | 140,744 | 1 | 4,644 | 100.0 | 100.0 | |
| 500 Arsenal Street | Cambridge/Inner Suburbs | 93,516 | – | – | 93,516 | 1 | 3,402 | 100.0 | 100.0 | |
| 780/790 Memorial Drive | Cambridge/Inner Suburbs | 99,350 | – | – | 99,350 | 2 | 6,674 | 100.0 | 100.0 | |
| 79/96 Charlestown Navy Yard | Cambridge/Inner Suburbs | 25,309 | – | – | 25,309 | 1 | 620 | 100.0 | 100.0 | |
| 99 Erie Street | Cambridge/Inner Suburbs | 27,960 | – | – | 27,960 | 1 | 1,143 | 100.0 | 100.0 | |
| 100 Beaver Street | Route 128 | 82,330 | – | – | 82,330 | 1 | 1,949 | 85.7 | 85.7 | |
| 285 Bear Hill Road | Route 128 | – | – | 26,270 | 26,270 | 1 | – | N/A | – | |
| 19 Presidential Way | Route 128 | 128,325 | – | – | 128,325 | 1 | 3,398 | 100.0 | 100.0 | |
| 29 Hartwell Avenue | Route 128 | 59,000 | – | – | 59,000 | 1 | 2,049 | 100.0 | 100.0 | |
| 3 Preston Court | Route 128 | 30,123 | – | – | 30,123 | 1 | 395 | 44.4 | 44.4 | |
| 35 Hartwell Avenue | Route 128 | 46,700 | – | – | 46,700 | 1 | 1,650 | 100.0 | 100.0 | |
| 35 Wiggins Avenue | Route 128 | 48,640 | – | – | 48,640 | 1 | 878 | 100.0 | 100.0 | |
| 44 Hartwell Avenue | Route 128 | 26,828 | – | – | 26,828 | 1 | – | – | – | |
| 45/47 Wiggins Avenue | Route 128 | 38,000 | – | – | 38,000 | 1 | 1,114 | 100.0 | 100.0 | |
| 60 Westview Street | Route 128 | 40,200 | – | – | 40,200 | 1 | 1,147 | 100.0 | 100.0 | |
| 6/8 Preston Court | Route 128 | 54,391 | – | – | 54,391 | 1 | 752 | 100.0 | 100.0 | |
| 111 Forbes Boulevard | Route 495/Worcester | 58,280 | – | – | 58,280 | 1 | 544 | 100.0 | 100.0 | |
| 130 Forbes Boulevard | Route 495/Worcester | 97,566 | – | – | 97,566 | 1 | 871 | 100.0 | 100.0 | |
| 20 Walkup Drive | Route 495/Worcester | 91,045 | – | – | 91,045 | 1 | 649 | 100.0 | 100.0 | |
| 30 Bearfoot Road | Route 495/Worcester | 60,759 | – | – | 60,759 | 1 | 2,765 | 100.0 | 100.0 | |
| 306 Belmont Street | Route 495/Worcester | 78,916 | – | – | 78,916 | 1 | 1,139 | 100.0 | 100.0 | |
| 350 Plantation Street | Route 495/Worcester | 11,774 | – | – | 11,774 | 1 | 92 | 42.5 | 42.5 | |
| Greater Boston | 3,093,019 | 691,487 | 26,270 | 3,810,776 | 36 | $ | 119,616 | 95.5% | 94.7% | |
| San Francisco Bay Area | **** | **** | **** | **** | **** | **** | **** | **** | **** | |
| 1500 Owens Street | Mission Bay | 158,267 | – | – | 158,267 | 1 | $ | 7,029 | 97.8% | 97.8% |
| 1700 Owens Street | Mission Bay | 157,340 | – | – | 157,340 | 1 | 9,102 | 99.9 | 99.9 | |
| 455 Mission Bay Boulevard South | Mission Bay | 210,398 | – | – | 210,398 | 1 | 8,241 | 97.8 | 97.8 | |
| 409/499 Illinois Street | Mission Bay | 234,249 | 222,780 | – | 457,029 | 2 | 14,197 | 100.0 | 100.0 | |
| 249/259 East Grand Avenue | South San Francisco | 300,119 | – | – | 300,119 | 2 | 11,473 | 100.0 | 100.0 | |
| 269 East Grand Avenue | South San Francisco | – | 107,250 | – | 107,250 | 1 | – | N/A | N/A | |
| 341/343 Oyster Point Boulevard | South San Francisco | 71,487 | – | 36,473 | 107,960 | 2 | 1,740 | 100.0 | 66.2 | |
| 400/450 East Jamie Court | South San Francisco | 163,035 | – | – | 163,035 | 2 | 5,249 | 100.0 | 100.0 | |
| 500 Forbes Boulevard | South San Francisco | 155,685 | – | – | 155,685 | 1 | 5,540 | 100.0 | 100.0 | |
| 600/630/650 Gateway Boulevard | South San Francisco | 150,960 | – | – | 150,960 | 3 | 3,762 | 91.0 | 91.0 | |
| 681 Gateway Boulevard | South San Francisco | 126,971 | – | – | 126,971 | 1 | 6,161 | 100.0 | 100.0 | |
| 7000 Shoreline Court | South San Francisco | 136,395 | – | – | 136,395 | 1 | 4,252 | 99.7 | 99.7 | |
| 901/951 Gateway Boulevard | South San Francisco | 170,244 | – | – | 170,244 | 2 | 5,276 | 88.3 | 88.3 | |
| 2425 Garcia Avenue & 2400/2450 Bayshore Parkway | Peninsula | 98,964 | – | – | 98,964 | 1 | 3,035 | 88.2 | 88.2 | |
| 2625/2627/2631 Hanover Street | Peninsula | 32,074 | – | – | 32,074 | 1 | 872 | 65.7 | 65.7 | |
| 3165 Porter Drive | Peninsula | 91,644 | – | – | 91,644 | 1 | 3,884 | 100.0 | 100.0 | |
| 3350 West Bayshore Road | Peninsula | 60,000 | – | – | 60,000 | 1 | 1,817 | 100.0 | 100.0 | |
| 75/125 Shoreway Road | Peninsula | 82,815 | – | – | 82,815 | 1 | 1,996 | 100.0 | 100.0 | |
| 849/863 Mitten Road & 866 Malcolm Road | Peninsula | 103,611 | – | – | 103,611 | 1 | 2,223 | 96.8 | 96.8 | |
| San Francisco Bay Area | 2,504,258 | 330,030 | 36,473 | 2,870,761 | 26 | $ | 95,849 | 97.3% | 95.9% |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 20 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Property Listing
(Dollars in thousands)
(Unaudited)
| Occupancy Percentage | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rentable Square Feet | Number of | Annualized | Operating and | |||||||
| Address | Submarket | Operating | Development | Redevelopment | Total | Properties | Base Rent | Operating | Redevelopment | |
| San Diego | **** | **** | **** | **** | **** | **** | **** | **** | **** | |
| 10931/10933 North Torrey Pines Rd | Torrey Pines | 96,641 | – | – | 96,641 | 1 | $ | 3,084 | 95.7% | 95.7% |
| 10975 North Torrey Pines Road | Torrey Pines | 44,733 | – | – | 44,733 | 1 | 1,595 | 100.0 | 100.0 | |
| 11119 North Torrey Pines Road | Torrey Pines | 72,506 | – | – | 72,506 | 1 | 1,577 | 63.5 | 63.5 | |
| 3010 Science Park Road | Torrey Pines | 74,557 | – | – | 74,557 | 1 | 3,215 | 100.0 | 100.0 | |
| 3115/3215 Merryfield Row | Torrey Pines | 158,645 | – | – | 158,645 | 2 | 7,125 | 100.0 | 100.0 | |
| 3530/3550 John Hopkins Court & 3535/3565 General Atomics Court | Torrey Pines | 241,191 | – | – | 241,191 | 4 | 7,815 | 96.3 | 96.3 | |
| 10300 Campus Point Drive | University Town Center | 449,759 | – | – | 449,759 | 1 | 15,783 | 96.1 | 96.1 | |
| 4755/4757/4767 Nexus Center Drive | University Town Center | 110,535 | – | 68,423 | 178,958 | 3 | 4,252 | 100.0 | 61.8 | |
| 5200 Illumina Way | University Town Center | 497,078 | – | – | 497,078 | 1 | 19,531 | 100.0 | 100.0 | |
| 9363/9373/9393 Towne Centre Drive | University Town Center | 138,578 | – | – | 138,578 | 3 | 3,559 | 95.3 | 95.3 | |
| 9880 Campus Point Drive | University Town Center | 71,510 | – | – | 71,510 | 1 | 2,774 | 100.0 | 100.0 | |
| 5810/5820 Nancy Ridge Drive | Sorrento Mesa | 87,298 | – | – | 87,298 | 1 | 1,204 | 55.2 | 55.2 | |
| 5871 Oberlin Drive | Sorrento Mesa | 33,817 | – | – | 33,817 | 1 | 973 | 100.0 | 100.0 | |
| 6138/6150 Nancy Ridge Drive | Sorrento Mesa | 56,698 | – | – | 56,698 | 1 | 1,586 | 100.0 | 100.0 | |
| 6175/6225/6275 Nancy Ridge Drive | Sorrento Mesa | 105,812 | – | – | 105,812 | 3 | 1,202 | 55.5 | 55.5 | |
| 7330 Carroll Road | Sorrento Mesa | 66,244 | – | – | 66,244 | 1 | 2,341 | 100.0 | 100.0 | |
| 10505 Roselle Street & 3770 Tansy Street | Sorrento Valley | 33,013 | – | – | 33,013 | 2 | 1,001 | 100.0 | 100.0 | |
| 11025/11035/11045 Roselle Street | Sorrento Valley | 66,442 | – | – | 66,442 | 3 | 1,621 | 100.0 | 100.0 | |
| 3985 Sorrento Valley Boulevard | Sorrento Valley | 60,545 | – | – | 60,545 | 1 | 1,534 | 100.0 | 100.0 | |
| 13112 Evening Creek Drive | I-15 Corridor | 109,780 | – | – | 109,780 | 1 | 2,495 | 100.0 | 100.0 | |
| San Diego | 2,575,382 | – | 68,423 | 2,643,805 | 33 | $ | 84,267 | 94.2% | 91.7% | |
| Greater NYC | **** | **** | **** | **** | **** | **** | **** | **** | **** | |
| 430/450 East 29th Street | Manhattan | 309,141 | 419,806 | – | 728,947 | 2 | $ | 25,481 | 99.8% | 99.8% |
| 100 Phillips Parkway | Bergen County | 78,501 | – | – | 78,501 | 1 | 2,213 | 90.8 | 90.8 | |
| 102 Witmer Road | Pennsylvania | 50,000 | – | – | 50,000 | 1 | 3,345 | 100.0 | 100.0 | |
| 5100 Campus Drive | Pennsylvania | 21,859 | – | – | 21,859 | 1 | 274 | 100.0 | 100.0 | |
| 701 Veterans Circle | Pennsylvania | 35,155 | – | – | 35,155 | 1 | 735 | 100.0 | 100.0 | |
| Greater NYC | 494,656 | 419,806 | – | 914,462 | 6 | $ | 32,048 | 98.4% | 98.4% | |
| Suburban Washington, D.C. | **** | **** | **** | **** | **** | **** | **** | **** | **** | |
| 12301 Parklawn Drive | Rockville | 49,185 | – | – | 49,185 | 1 | $ | 1,169 | 100.0% | 100.0% |
| 1330 Piccard Drive | Rockville | 131,511 | – | – | 131,511 | 1 | 2,877 | 94.0 | 94.0 | |
| 1405 Research Boulevard | Rockville | 71,669 | – | – | 71,669 | 1 | 2,119 | 100.0 | 100.0 | |
| 1500/1550 East Gude Drive (1) | Rockville | 90,489 | – | – | 90,489 | 2 | 1,511 | 90.5 | 90.5 | |
| 14920 Broschart Road | Rockville | 48,500 | – | – | 48,500 | 1 | 1,073 | 100.0 | 100.0 | |
| 15010 Broschart Road | Rockville | 38,203 | – | – | 38,203 | 1 | 741 | 85.8 | 85.8 | |
| 5 Research Court | Rockville | 54,906 | – | – | 54,906 | 1 | 1,425 | 100.0 | 100.0 | |
| 5 Research Place | Rockville | 63,852 | – | – | 63,852 | 1 | 2,364 | 100.0 | 100.0 | |
| 9800 Medical Center Drive | Rockville | 214,531 | – | 67,055 | 281,586 | 4 | 7,354 | 90.0 | 68.6 | |
| 9920 Medical Center Drive | Rockville | 58,733 | – | – | 58,733 | 1 | 455 | 100.0 | 100.0 | |
| 1300 Quince Orchard Road | Gaithersburg | 54,874 | – | – | 54,874 | 1 | 997 | 100.0 | 100.0 | |
| 16020 Industrial Drive | Gaithersburg | 71,000 | – | – | 71,000 | 1 | 1,048 | 100.0 | 100.0 | |
| 19/20/22 Firstfield Road | Gaithersburg | 132,639 | – | – | 132,639 | 3 | 3,103 | 93.6 | 93.6 | |
| 401 Professional Drive | Gaithersburg | 63,154 | – | – | 63,154 | 1 | 1,063 | 88.7 | 88.7 | |
| 620 Professional Drive | Gaithersburg | 27,950 | – | – | 27,950 | 1 | 495 | 100.0 | 100.0 | |
| 708 Quince Orchard Road | Gaithersburg | 49,624 | – | – | 49,624 | 1 | 1,145 | 99.3 | 99.3 | |
| 9 West Watkins Mill Road | Gaithersburg | 92,449 | – | – | 92,449 | 1 | 2,766 | 100.0 | 100.0 | |
| 910 Clopper Road | Gaithersburg | 180,650 | – | – | 180,650 | 1 | 3,343 | 91.3 | 91.3 | |
| 930/940 Clopper Road (2) | Gaithersburg | 104,302 | – | – | 104,302 | 2 | 1,654 | 93.4 | 93.4 | |
| 950 Wind River Lane | Gaithersburg | 50,000 | – | – | 50,000 | 1 | 1,082 | 100.0 | 100.0 | |
| 8000/9000/10000 Virginia Manor Rd | Beltsville | 191,884 | – | – | 191,884 | 1 | 1,502 | 58.8 | 58.8 | |
| 14225 Newbrook Drive | Northern Virginia | 248,186 | – | – | 248,186 | 1 | 4,341 | 100.0 | 100.0 | |
| Suburban Washington, D.C. | 2,088,291 | – | 67,055 | 2,155,346 | 29 | $ | 43,627 | 92.3% | 89.4% |
(1) Includes 25,000 RSF of non-laboratory space, which we intend to convert into laboratory space through redevelopment in 2014.
(2) Includes 60,000 RSF of non-laboratory space, which we intend to convert into laboratory space through redevelopment in 2014.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 21 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Property Listing
(Dollars in thousands)
(Unaudited)
| Occupancy Percentage | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Rentable Square Feet | Number of | Annualized | Operating and | ||||||
| Address | Submarket | Operating | Development | Redevelopment | Total | Properties | Base Rent | Operating | Redevelopment |
| Seattle | **** | **** | **** | **** | **** | **** | **** | **** | |
| 1201/1208 Eastlake Avenue | Lake Union | 203,369 | – | – | 203,369 | 2 | 100.0% | 100.0% | |
| 1551 Eastlake Avenue | Lake Union | 117,482 | – | – | 117,482 | 1 | 2,322 | 66.2 | 66.2 |
| 1600 Fairview Avenue | Lake Union | 27,991 | – | – | 27,991 | 1 | 1,569 | 100.0 | 100.0 |
| 1616 Eastlake Avenue | Lake Union | 142,688 | – | 26,020 | 168,708 | 1 | 6,083 | 96.8 | 81.9 |
| 199 East Blaine Street | Lake Union | 115,084 | – | – | 115,084 | 1 | 6,163 | 100.0 | 100.0 |
| 219 Terry Avenue North | Lake Union | 30,961 | – | – | 30,961 | 1 | 1,490 | 99.2 | 99.2 |
| 3000/3018 Western Avenue | Elliott Bay | 47,746 | – | – | 47,746 | 1 | 1,839 | 100.0 | 100.0 |
| 410 West Harrison Street & 410 Elliott Avenue West | Elliott Bay | 35,175 | – | – | 35,175 | 2 | 956 | 85.2 | 85.2 |
| Seattle | 720,496 | – | 26,020 | 746,516 | 10 | 93.1% | 89.9% | ||
| Research Triangle Park | |||||||||
| 100 Capitola Drive | Research Triangle Park | 65,965 | – | – | 65,965 | 1 | 100.0% | 100.0% | |
| 108/110/112/114 Alexander Drive | Research Triangle Park | 158,417 | – | – | 158,417 | 1 | 4,996 | 100.0 | 100.0 |
| 2525 East NC Highway 54 | Research Triangle Park | 81,580 | – | – | 81,580 | 1 | 1,673 | 100.0 | 100.0 |
| 5 Triangle Drive | Research Triangle Park | 32,120 | – | – | 32,120 | 1 | 824 | 100.0 | 100.0 |
| 601 Keystone Park Drive | Research Triangle Park | 77,395 | – | – | 77,395 | 1 | 1,309 | 100.0 | 100.0 |
| 6101 Quadrangle Drive | Research Triangle Park | 30,122 | – | – | 30,122 | 1 | 445 | 79.1 | 79.1 |
| 7 Triangle Drive | Research Triangle Park | 96,626 | – | – | 96,626 | 1 | 3,157 | 100.0 | 100.0 |
| 7010/7020/7030 Kit Creek Road | Research Triangle Park | 133,654 | – | – | 133,654 | 3 | 1,707 | 70.0 | 70.0 |
| 800/801 Capitola Drive | Research Triangle Park | 120,905 | – | – | 120,905 | 2 | 1,912 | 87.6 | 87.6 |
| 6 Davis Drive | Research Triangle Park | 100,000 | – | – | 100,000 | 1 | 1,062 | 100.0 | 100.0 |
| 555 Heritage Drive | Palm Beach | 45,023 | – | – | 45,023 | 1 | 614 | 55.9 | 55.9 |
| Research Triangle Park | 941,807 | – | – | 941,807 | 14 | 91.4% | 91.4% | ||
| Canada | **** | **** | **** | **** | **** | **** | **** | **** | |
| Canada | 46,032 | – | – | 46,032 | 1 | 100.0% | 100.0% | ||
| Canada | **** | 66,000 | – | – | 66,000 | 1 | 1,193 | 100.0 | 100.0 |
| Canada | **** | 142,935 | – | – | 142,935 | 1 | 3,259 | 92.8 | 92.8 |
| Canada | **** | 68,000 | – | – | 68,000 | 1 | 3,122 | 100.0 | 100.0 |
| Canada (1) | **** | 780,540 | – | – | 780,540 | 1 | – | N/A | N/A |
| Total Canada | 1,103,507 | – | – | 1,103,507 | 5 | 28.3% | 28.3% | ||
| Non-cluster markets | 61,002 | – | – | 61,002 | 2 | 54.0% | 54.0% | ||
| North America | **** | 13,582,418 | 1,441,323 | 224,241 | 15,247,982 | 161 | 433,347 | 94.6% | 92.9% |
| Asia | 617,602 | 618,976 | 85,728 | 1,322,306 | 9 | 68.1% | 59.8% | ||
| Continuing operations | 14,200,020 | 2,060,299 | 309,969 | 16,570,288 | 170 | 93.3% | 91.2% | ||
| Properties “held for sale” | 51,273 | – | – | 51,273 | 2 | ||||
| Total consolidated | **** | 14,251,293 | 2,060,299 | 309,969 | 16,621,561 | 172 | **** | **** | |
| Greater Boston | **** | **** | **** | **** | **** | **** | **** | **** | |
| Investment in unconsolidated JV — 360 Longwood Avenue | Longwood | – | 413,536 | – | 413,536 | 1 | **** | **** | |
| Total consolidated and unconsolidated | **** | 14,251,293 | 2,473,835 | 309,969 | 17,035,097 | 173 | **** | **** |
All values are in US Dollars.
(1) Represents land and improvements subject to a ground lease with a client tenant.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 22 |
|---|
VALUE-ADDED OPPORTUNITIES
AND EXTERNAL GROWTH
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Investments in Real Estate
(Dollars in thousands, except per square foot amounts)
(Unaudited)
Summary of investments in real estate
| June 30, 2013 | March 31, 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value | Square Feet | Cost per<br> Square<br> Foot | Book Value | Square Feet | Cost per<br> Square Foot | |||||||||
| Rental properties: | ||||||||||||||
| Land (related to rental properties) | $ | 512,915 | $ | 516,957 | ||||||||||
| Buildings and building improvements | 5,006,987 | 4,955,207 | ||||||||||||
| Other improvements | 166,894 | 163,864 | ||||||||||||
| Rental properties | 5,686,796 | 14,251,293 | $ | 399 | 5,636,028 | 14,168,626 | $ | 398 | ||||||
| Less: accumulated depreciation | (878,199 | ) | (849,891 | ) | ||||||||||
| Rental properties, net | 4,808,597 | 4,786,137 | ||||||||||||
| Construction in progress (“CIP”)/current value-added projects: | ||||||||||||||
| Active development in North America | 673,461 | 1,441,323 | 467 | 579,273 | 1,441,323 | 402 | ||||||||
| Investment in unconsolidated JV | 33,838 | (1) | 413,536 | (1) | 30,730 | 413,536 | (1) | |||||||
| Active redevelopment in North America | 104,994 | 224,241 | 468 | 141,470 | 331,380 | 427 | ||||||||
| Active development and redevelopment in Asia | 98,949 | 704,704 | 140 | 101,357 | 718,119 | 141 | ||||||||
| Generic infrastructure/building improvement projects in North America | 53,333 | (2) | 62,869 | |||||||||||
| 964,575 | 2,783,804 | 346 | 915,699 | 2,904,358 | 315 | |||||||||
| Subtotal | 5,773,172 | 17,035,097 | 339 | 5,701,836 | 17,072,984 | 334 | ||||||||
| Land/future value-added projects: | ||||||||||||||
| Land undergoing predevelopment activities (CIP) in North America (3) | 313,498 | 1,917,667 | 163 | 305,300 | 1,917,667 | 159 | ||||||||
| Land held for future development in North America | 211,292 | 3,531,843 | 60 | 238,933 | 3,792,181 | 63 | ||||||||
| Land held for future development /undergoing predevelopment activities (CIP) in Asia | 79,105 | 6,828,864 | 12 | 83,735 | 6,828,864 | 12 | ||||||||
| Land subject to sale negotiations | 76,312 | 458,724 | 166 | 45,378 | 399,888 | 113 | ||||||||
| 680,207 | 12,737,098 | 53 | 673,346 | 12,938,600 | 52 | |||||||||
| Investments in real estate, net | 6,453,379 | 29,772,195 | $ | 217 | 6,375,182 | 30,011,584 | $ | 212 | ||||||
| Add: accumulated depreciation | 878,199 | 849,891 | ||||||||||||
| Gross investments in real estate (3) | $ | 7,331,578 | 29,772,195 | $ | 7,225,073 | 30,011,584 |
(1) The book value for this unconsolidated joint venture represents our equity investment in the project. The gross investment in real estate at the joint venture level was approximately $408 and $359 per square foot as of June 30, 2013, and March 31, 2013, respectively.
(2) Represents the book value associated with approximately 96,372 square feet at four projects undergoing construction of generic laboratory improvements, of which approximately 81% was leased, but not delivered, as of June 30, 2013.
(3) In addition to assets included in our gross investment in real estate, we hold options/rights for parcels supporting the future ground-up development of approximately 420,000 RSF in Alexandria CenterTM for Life Science - New York City related to an option under our ground lease. Also, our asset base contains additional embedded development opportunities aggregating approximately 715,000 RSF which represents additional development and expansion rights related to existing rental properties.
Non-income-producing real estate assets as a percentage of gross investments in real estate

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 24 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Capital Expenditures
(Dollars in thousands, except per square foot amounts)
(Unaudited)
| Projected | ||||
|---|---|---|---|---|
| Projected construction spending | Six Months Ended December 31, 2013 | Thereafter | ||
| Development projects – North America | $ | 340,612 | ||
| Redevelopment projects – North America | 27,562 | 10,451 | ||
| Development and redevelopment projects – Asia | 14,185 | 37,798 | ||
| Future value-added construction projects | 41,237 | (1) | TBD | |
| Total development and redevelopment projects | 285,132 | 388,861 | ||
| Value-added predevelopment (2) | 43,024 | (3) | TBD | |
| Generic infrastructure/building improvement projects in North America (4) | 29,534 | TBD | ||
| Maintenance building improvements | 3,549 | TBD | ||
| Total construction spending | $ | 388,861 | ||
| Guidance range for development, redevelopment, and construction for the six months ended December 31, 2013 | 346,000 - 376,000 | (5) |
All values are in US Dollars.
(1) Includes future value-added projects, including among others, 3033 Science Park Road, and remaining construction costs related to certain value-added projects recently transferred into rental properties upon substantial completion. The recently completed projects include certain spaces, generally less than 10% of the project, that may require additional construction prior to occupancy. For example, this includes our recently delivered redevelopments at 400 Technology Square, 1551 Eastlake Avenue, and 10300 Campus Point Drive which generally have 15,000 to 30,000 RSF of value added activities to complete in connection with the lease-up of the space.
(2) Refer to the land undergoing predevelopment activities (additional CIP) section in the definition of future value-added projects.
(3) Includes traditional preconstruction costs plus predevelopment costs related to: i) approximately $16 million related to site and infrastructure costs for the 1.2 million RSF related to 50 Binney Street, 100 Binney Street and the 228,000 RSF of residential at the Alexandria Center™ at Kendall Square, including utility access and roads, installation of storm drain lines, infiltration systems, water lines, traffic lighting/signals, streets, and sidewalks, and ii) approximately $5 million related to the design, permitting, and construction of the building foundation for a new residential building adjacent to the 75/125 Binney Street development project at the Alexandria Center™ at Kendall Square. Site and infrastructure costs related to 75/125 Binney Street and 225 Binney Street are included in our estimate of cost at completion and initial stabilized yields for each project.
(4) Includes, among others, generic infrastructure building improvement projects in North America, including 2625/2627/2631 Hanover Street, 7030 Kit Creek Road, 1300 Quince Orchard Boulevard, 44 Hartwell Avenue, 215 First Street, and 300 Technology Square.
(5) The estimated development, redevelopment and construction amounts for the six months ended December 31, 2013 represent the mid-point of our guidance for total spending. Our guidance provides a range for the total construction spending for 2013 primarily to accommodate timing of construction activity.
| Historical construction spending | Six Months Ended<br> June 30, 2013 | |
|---|---|---|
| Development projects – North America | $ | 152,955 |
| Redevelopment projects – North America | 53,779 | |
| Development and redevelopment projects – Asia | 4,461 | |
| Total development and redevelopment projects | 211,195 | |
| Value-added predevelopment (1) | 28,194 | |
| Generic infrastructure/building improvement projects in North America (2) | 13,197 | |
| Total construction spending | $ | 252,586 |
(1) Includes traditional preconstruction costs plus predevelopment costs related to the 1.2 million RSF related to 50 Binney Street, 100 Binney Street and the 228,000 RSF of residential at the Alexandria Center™ at Kendall Square including: i) site and infrastructure costs for, including utility access and roads, installation of storm drain lines, infiltration systems, water lines, traffic lighting/signals, streets, and sidewalks, ii) building design, and iii) other related project costs including capitalized interest.
(2) Includes revenue-enhancing projects and amounts shown in the table below related to non-revenue-enhancing capital expenditures.
The table below shows the average per square foot of property-related non-revenue-enhancing capital expenditures, tenant improvements, and leasing costs (excluding capital expenditures and tenant improvements that are recoverable from client tenants, revenue-enhancing, or related to properties that have undergone redevelopment).
| **** | Six Months Ended | |
|---|---|---|
| June 30, 2013 | ||
| Non-revenue enhancing capital expenditures (1) | $ | 933 |
| Square feet in asset base | 14,010,754 | |
| Non-revenue enhancing capital expenditures per square foot | $ | 0.07 |
| Tenant improvements and leasing costs: | ||
| Re-tenanted space (2) | ||
| Tenant improvements and leasing costs | $ | 2,231 |
| Re-tenanted square feet | 132,585 | |
| Per square foot | $ | 16.83 |
| Renewal space | ||
| Tenant improvements and leasing costs | $ | 1,641 |
| Renewal square feet | 354,339 | |
| Per square foot | $ | 4.63 |
(1) Includes, among other costs, capital expenditures such as roof and HVAC system replacements.
(2) Excludes space that has undergone redevelopment before re-tenanting.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 25 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
All Active Development Projects in North America
(Dollars in thousands, except per square foot amounts)
(Unaudited)
| **** | **** | Leased Status | **** | Initial | **** | **** | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| **** | **** | Leased | Negotiating | Total Leased/Negotiating | Project | Occupancy | Stabilization | **** | |||||||||||||
| Property/Market – Submarket | CIP RSF | RSF | % | RSF | **** | % | RSF | % | Start Date | Date | Date | Client Tenants | |||||||||
| Consolidated development projects in North America | |||||||||||||||||||||
| 75/125 Binney Street/Greater Boston – Cambridge | 386,275 | 244,123 | 63% | 139,374 | (1) | 36% | 383,497 | 99% | 1Q13 | 1Q15 | 2015 | ARIAD Pharmaceuticals, Inc. | |||||||||
| 225 Binney Street/Greater Boston – Cambridge | 305,212 | 305,212 | 100% | – | –% | 305,212 | 100% | 4Q11 | Oct 2013 | Oct 2013 | Biogen Idec Inc. | ||||||||||
| 499 Illinois Street/San Francisco Bay Area – Mission Bay | 222,780 | 97,702 | 44% | 64,848 | (2) | 29% | 162,550 | 73% | 2Q11 | 2Q14 | 2014 | Illumina, Inc. | |||||||||
| 269 East Grand Avenue/San Francisco Bay Area – So. San Francisco | 107,250 | 107,250 | 100% | – | –% | 107,250 | 100% | 1Q13 | 4Q14 | 2014 | Onyx Pharmaceuticals, Inc. | ||||||||||
| 430 East 29th Street/Greater NYC – Manhattan | 419,806 | 182,448 | 44% | 52,257 | 12% | 234,705 | 56% | 4Q12 | Dec 2013 | 2015 | Roche/Investment-grade entity | ||||||||||
| Consolidated development projects in North America | 1,441,323 | 936,735 | 65% | 256,479 | 18% | 1,193,214 | 83% | ||||||||||||||
| Unconsolidated joint venture | |||||||||||||||||||||
| 360 Longwood Avenue/Greater Boston – Longwood | 413,536 | 154,100 | 37% | 70,000 | 17% | 224,100 | 54% | 2Q12 | 4Q14 | 2016 | Dana-Farber Cancer Institute, Inc. | ||||||||||
| Total/weighted average | 1,854,859 | 1,090,835 | 59% | 326,479 | 17% | 1,417,314 | 76% | ||||||||||||||
| Investment | **** | ||||||||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cost To Complete | **** | ||||||||||||||||||||
| 2013 | 2014 and Thereafter | Initial Stabilized | |||||||||||||||||||
| Construction | Internal | Construction | Internal | Total at | Cost | Yield (unlevered) | Average | ||||||||||||||
| Property/Market – Submarket | CIP | Loans | Funding | Loans | Funding | Completion | Per RSF | Cash | GAAP | Cash Yield | |||||||||||
| Consolidated development projects in North America | |||||||||||||||||||||
| 75/125 Binney Street/Greater Boston – Cambridge | $ | 123,218 | $ | 57,173 | $ | – | $ | 171,048 | $ | – | $ | 351,439 | (3) | $ | 910 | 8.0% | 8.2% | 9.1% | |||
| 225 Binney Street/Greater Boston – Cambridge | $ | 145,172 | $ | – | $ | 35,101 | $ | – | $ | – | $ | 180,273 | $ | 591 | 7.5% | 8.1% | 8.1% | ||||
| 499 Illinois Street/San Francisco Bay Area – Mission Bay | $ | 116,776 | $ | – | $ | 14,033 | $ | – | $ | 22,400 | $ | 153,209 | $ | 688 | 6.4% | 7.2% | 7.3% | ||||
| 269 East Grand Avenue/San Francisco Bay Area – So. San Francisco | $ | 9,626 | $ | 1,572 | $ | 5,674 | $ | 34,428 | $ | – | $ | 51,300 | $ | 478 | 8.1% | 9.3% | 9.3% | ||||
| 430 East 29th Street/Greater NYC – Manhattan | $ | 278,669 | $ | – | $ | 75,035 | $ | – | $ | 109,541 | $ | 463,245 | $ | 1,103 | 6.6% | 6.5% | 7.1% | ||||
| Consolidated development projects in North America | $ | 673,461 | $ | 58,745 | $ | 129,843 | $ | 205,476 | $ | 131,941 | $ | 1,199,466 | |||||||||
| Property/Market – Submarket | CIP | Construction Loans and JV Capital | Internal Funding | Construction Loans and JV Capital | Internal Funding | Total at Completion | |||||||||||||||
| Unconsolidated joint venture | |||||||||||||||||||||
| 100% of JV: 360 Longwood Avenue/Greater Boston – Longwood | $ | 168,776 | $ | 38,934 | $ | 13,560 | $ | 125,535 | $ | 3,195 | $ | 350,000 | $ | 846 | 8.3% | 8.9% | 9.3% | ||||
| Less: Funding from Secured Construction Loans and JV Partner Capital (4) | $ | (134,938 | ) | $ | (38,934 | ) | $ | – | $ | (125,535 | ) | $ | – | $ | (299,407 | ) | |||||
| ARE investment in 360 Longwood Avenue (27.5% interest) | $ | 33,838 | $ | – | $ | 13,560 | $ | – | $ | 3,195 | $ | 50,593 | |||||||||
| Total ARE investment | $ | 707,299 | $ | 58,745 | $ | 143,403 | $ | 205,476 | $ | 135,136 | $ | 1,250,059 | |||||||||
| Total 2013 and Thereafter | $ | 202,148 | $ | 340,612 |
(1) ARIAD Pharmaceuticals, Inc. executed an LOI at 75/125 Binney Street for 139,374 RSF of expansion space. An amendment to their lease is in process to increase their RSF to 383,497, or 99%, of the development.
(2) Includes 30,000 RSF subject to an executed LOI and lease negotiations. The remaining 34,848 RSF is under negotiation.
(3) We expect to close a construction loan financing in the third quarter of 2013 to provide funding for 65% of the total cost at completion.
(4) Includes non-recourse secured construction loan of approximately $213.2 million, at a rate of L+3.75% with a floor of 5.25%, of which approximately $75.0 million was drawn as of June 30, 2013.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 26 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
All Active Development Projects in North America
| Property | 75/125 Binney Street | 225 Binney Street | 499 Illinois Street |
|---|---|---|---|
| Submarket/Market | Cambridge/Greater Boston | Cambridge/Greater Boston | Mission Bay/San Francisco Bay Area |
| RSF | 386,275 | 305,212 | 222,780 |
| Photograph/ Rendering | ![]() |
![]() |
![]() |
| Property | 269 East Grand Avenue | 430 East 29 th Street | 360 Longwood Avenue |
| Submarket/Market | South San Francisco/San Francisco Bay Area | New York City/Greater New York | Cambridge/Greater Boston |
| RSF | 107,250 | 419,806 | 413,536 |
| Photograph/ Rendering | ![]() |
![]() |
![]() |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 27 | ||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
All Active Redevelopment Projects in North America
(Dollars in thousands, except per square foot amounts)
(Unaudited)
All project information, including rentable square feet; investment; Initial Stabilized Yields; Average Cash Yields; and project start, occupancy and stabilization dates, relates to the discrete portion of each property undergoing active redevelopment. A redevelopment project does not necessarily represent the entire property or the entire vacant portion of a property.
| **** | Project RSF | Leased Status | **** | **** | **** | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| **** | In | **** | **** | **** | Leased | Negotiating | Total Leased/Negotiating | Former | Use After | **** | |||||||||
| Property/Market - Submarket | Service | CIP | **** | Total | RSF | % | RSF | % | RSF | % | Use | Conversion | Client Tenants | ||||||
| 285 Bear Hill Road/Greater Boston – Route 128 | – | 26,270 | 26,270 | 26,270 | 100% | – | –% | 26,270 | 100% | Office/<br><br><br>Manufacturing | Laboratory | Intelligent Medical Devices, Inc. | |||||||
| 343 Oyster Point/San Francisco Bay Area – South San Francisco | 17,507 | 36,473 | 53,980 | 42,445 | 79% | – | –% | 42,445 | 79% | Office | Laboratory | Calithera BioSciences, Inc.;<br> CytomX Therapeutics, Inc. | |||||||
| 4757 Nexus Center Drive/San Diego – University Town Center | – | 68,423 | (1) | 68,423 | 68,423 | 100% | – | –% | 68,423 | 100% | Office/R&D/<br> Manufacturing/<br> Warehouse | Laboratory | Genomatica, Inc. | ||||||
| 9800 Medical Center Drive/Suburban Washington, D.C. – Rockville | 8,001 | 67,055 | 75,056 | 75,056 | 100% | – | –% | 75,056 | 100% | Office/<br> Laboratory | Laboratory | National Institutes of Health | |||||||
| 1616 Eastlake Avenue/Seattle – Lake Union | 40,756 | 26,020 | 66,776 | 40,756 | 61% | – | –% | 40,756 | 61% | Office | Laboratory | Infectious Disease Research Institute | |||||||
| Total/weighted average | 66,264 | 224,241 | 290,505 | 252,950 | 87% | – | –% | 252,950 | 87% | ||||||||||
| **** | Investment | **** | **** | **** | **** | **** | **** | **** | |||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **** | June 30 , 2013 | To Complete | **** | **** | **** | Initial Stabilized | **** | **** | Initial | **** | |||||||||
| **** | In | **** | **** | 2014 and | Total at | Cost | **** | Yield (unlevered) | Average | Project | Occupancy | Stabilization | |||||||
| Property/Market - Submarket | Service | CIP | 2013 | Thereafter | Completion | Per RSF | **** | Cash | GAAP | Cash Yield | Start Date | Date | Date | ||||||
| 285 Bear Hill Road/Greater Boston – Route 128 | $ | – | $ | 5,173 | $ | 4,023 | $ | – | $ | 9,196 | $ | 350 | 8.4% | 8.8% | 9.2% | 4Q11 | 3Q13 | 3Q13 | |
| 343 Oyster Point/San Francisco Bay Area – South San Francisco | $ | 5,222 | $ | 9,882 | $ | 1,317 | $ | 918 | $ | 17,339 | $ | 321 | 9.6% | 9.8% | 10.1% | 1Q12 | 3Q13 | 4Q13 | |
| 4757 Nexus Center Drive/San Diego – University Town Center | $ | – | $ | 10,619 | $ | 18,694 | $ | 5,516 | $ | 34,829 | $ | 509 | 7.6% | 7.8% | 8.5% | 4Q12 | 4Q13 | 4Q13 (1) | |
| 9800 Medical Center Drive/Suburban Washington, D.C. – Rockville | $ | 8,275 | $ | 69,279 | $ | 3,150 | $ | – | $ | 80,704 | $ | 1,075 | (2) | 5.4% | 5.4% | 5.4% | 3Q09 | 1Q13 | 3Q13 |
| 1616 Eastlake Avenue/Seattle – Lake Union | $ | 23,380 | $ | 10,041 | $ | 378 | $ | 4,017 | $ | 37,816 | $ | 566 | 8.4% | 8.6% | 9.4% | 4Q12 | 2Q13 | 2014 | |
| Total/weighted average | $ | 36,877 | $ | 104,994 | $ | 27,562 | $ | 10,451 | $ | 179,884 |
(1) We expect to deliver 54,102 RSF, or 79% of the total project, to Genomatica, Inc. in the fourth quarter of 2013. Genomatica, Inc. is contractually required to lease the remaining 14,411 RSF 18 to 24 months following the delivery of the initial 54,102 rentable square foot space.
(2) Our multi-tenant four building property at 9800 Medical Center Drive contains an aggregate of 281,586 RSF. Our total cash investment in the entire four building property upon completion of the redevelopment will approximate $580 per square foot. Our total expected cash investment for the four building property of approximately $580 per square foot includes our expected total investment at completion related to the 75,056 rentable square foot redevelopment of approximately $1,075 per square foot.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 28 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
All Active Redevelopment Projects in North America
| Property | 285 Bear Hill Road | 343 Oyster Point Boulevard | 4757 Nexus Center Drive |
|---|---|---|---|
| Submarket/Market | Route 128/Greater Boston | South San Francisco/San Francisco Bay Area | University Town Center/San Diego |
| RSF | 26,270 | 53,980 | 68,423 |
| Photograph/ Rendering | ![]() |
![]() |
![]() |
| Year Acquired/ Built | Acquired in 2011 | Built in 2000 | Acquired in 1998 |
| Redevelopment Opportunity Identified at Acquisition | Yes | N/A | Yes |
| <br><br><br>Former Use<br><br><br> | Office/Manufacturing | Office | Manufacturing/Warehouse/Office/R&D |
| <br><br><br>Use After Conversion<br><br><br> | Laboratory | Laboratory | Laboratory |
| Projected GAAP NOI per RSF | $31 | $31 | $40 |
| Projected Redevelopment Budget per RSF | $197 | $135 | $470 |
| <br><br><br>Key Tenants<br><br><br> | Intelligent Medical Devices, Inc. | Calithera Biosciences, Inc.; CytomX Therapeutics, Inc. | Genomatica, Inc. |
| Other Key Attributes | Conversion of office/manufacturing space through redevelopment. This portion of the building was originally developed by prior owner as office/manufacturing space in 1999. | Conversion of office space through redevelopment. This portion of the building was originally developed primarily as office in 2000. | Campus has approximately 50,000 of additional developable square feet to accommodate growth by Genomatica, Inc. and other client tenants. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 29 | ||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
All Active Redevelopment Projects in North America
| Property | 9800 Medical Center Drive | 1616 Eastlake Avenue |
|---|---|---|
| Submarket/Market | Rockville/Suburban Washington, D.C. | Lake Union/Seattle |
| RSF | 75,056 | 66,776 |
| Photograph/ Rendering | ![]() |
![]() |
| Year Acquired/ Built | Acquired in 2004 | Built in 2003 |
| Redevelopment Opportunity Identified at Acquisition | Yes | N/A |
| <br><br><br>Former Use<br><br><br> | Office/Laboratory | Office |
| <br><br><br>Use After Conversion<br><br><br> | Laboratory | Laboratory |
| <br><br><br>Projected GAAP NOI per RSF<br><br><br> | $58 | $49 |
| Projected Redevelopment Budget per RSF | $525 | $132 |
| <br><br><br>Key Tenants<br><br><br> | National Institutes of Health | Infectious Disease Research Institute |
| <br><br><br>Other Key Attributes<br><br><br> | NIH initially leased space at the campus in 2005. Expansion into the redevelopment space extends their tenancy at property to a total term of approximately 23 years. | Conversion of office space through redevelopment. This portion of the building was originally developed as office space in 2003. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 30 | |
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Future Redevelopment in North America
(Unaudited)
| **** | Land Undergoing Pre development Activities (Additional CIP) | Land Held for Future Development | Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market: Property - Submarket | Book Value (in thousands) | Rentable Square Feet | Cost per Square Foot | Book Value (in thousands) | Rentable Square Feet | Cost per Square Foot | Book Value (in thousands) | Rentable Square Feet | Cost per Square Foot | ||||||
| Greater Boston: | |||||||||||||||
| Alexandria Center™ at Kendall Square-Lab/Office - Cambridge/Inner Suburbs | $ | 258,442 | 974,264 | $ | 265 | $ | – | – | $ | – | $ | 258,442 | 974,264 | $ | 265 |
| Alexandria Center™ at Kendall Square-Residential - Cambridge/Inner Suburbs | 1,956 | 78,000 | 25 | 3,413 | 150,000 | 23 | 5,369 | 228,000 | 24 | ||||||
| Subtotal - Alexandria Center™ at Kendall Square | 260,398 | 1,052,264 | 247 | 3,413 | 150,000 | 23 | 263,811 | 1,202,264 | 219 | ||||||
| Technology Square - Cambridge/Inner Suburbs | – | – | – | 7,721 | 100,000 | 77 | 7,721 | 100,000 | 77 | ||||||
| Greater Boston | $ | 260,398 | 1,052,264 | $ | 247 | $ | 11,134 | 250,000 | $ | 45 | $ | 271,532 | 1,302,264 | $ | 209 |
| San Francisco Bay Area: | |||||||||||||||
| Grand Ave - South San Francisco | $ | – | – | $ | – | $ | 42,853 | 397,132 | $ | 108 | $ | 42,853 | 397,132 | $ | 108 |
| Rozzi/Eccles - South San Francisco | – | – | – | 72,864 | 514,307 | 142 | 72,864 | 514,307 | 142 | ||||||
| San Francisco Bay Area | $ | – | – | $ | – | $ | 115,717 | 911,439 | $ | 127 | $ | 115,717 | 911,439 | $ | 127 |
| San Diego: | |||||||||||||||
| Science Park Road - Torrey Pines | $ | 16,635 | 176,500 | $ | 94 | $ | – | – | $ | – | $ | 16,635 | 176,500 | $ | 94 |
| 5200 Illumina Way - University Town Center | 14,719 | 392,983 | 37 | – | – | – | 14,719 | 392,983 | 37 | ||||||
| 10300 Campus Point - University Town Center | 3,992 | 140,000 | 29 | – | – | – | 3,992 | 140,000 | 29 | ||||||
| Executive Drive - University Town Center | 3,995 | 49,920 | 80 | – | – | – | 3,995 | 49,920 | 80 | ||||||
| San Diego | $ | 39,341 | 759,403 | $ | 52 | $ | – | – | $ | – | $ | 39,341 | 759,403 | $ | 52 |
| Suburban Washington D.C.: | |||||||||||||||
| Medical Center Drive - Rockville | $ | – | – | $ | – | $ | 7,548 | 321,721 | $ | 23 | $ | 7,548 | 321,721 | $ | 23 |
| Research Boulevard - Rockville | – | – | – | 6,905 | 347,000 | 20 | 6,905 | 347,000 | 20 | ||||||
| Firstfield Road - Gaithersburg | – | – | – | 4,052 | 95,000 | 43 | 4,052 | 95,000 | 43 | ||||||
| Suburban Washington D.C. | $ | – | – | $ | – | $ | 18,505 | 763,721 | $ | 24 | $ | 18,505 | 763,721 | $ | 24 |
| Seattle: | |||||||||||||||
| Dexter/Terry Ave - Lake Union | $ | – | – | $ | – | $ | 18,747 | 232,300 | $ | 81 | $ | 18,747 | 232,300 | $ | 81 |
| Eastlake Ave - Lake Union | 13,759 | 106,000 | 130 | 15,248 | 160,266 | 95 | 29,007 | 266,266 | 109 | ||||||
| Seattle | $ | 13,759 | 106,000 | $ | 130 | $ | 33,995 | 392,566 | $ | 87 | $ | 47,754 | 498,566 | $ | 96 |
| Other Markets | $ | – | – | $ | – | $ | 31,941 | 1,214,117 | $ | 26 | $ | 31,941 | 1,214,117 | $ | 26 |
| Future value-added projects in North America | $ | 313,498 | 1,917,667 | $ | 163 | $ | 211,292 | 3,531,843 | $ | 60 | $ | 524,790 | 5,449,510 | $ | 96 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 31 | ||||||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities or Held for Future Development
Overview of Greater Boston Market

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 32 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities or Held for Future Development in Greater Boston Market

| Property | Alexandria Center ™ at Kendall Square |
|---|---|
| <br><br><br>Submarket/Market<br><br><br> | Cambridge/Greater Boston |
| Aerial | ![]() |
| Background | Alexandria received final approval from the City of Cambridge to develop the Alexandria Center™ at Kendall Square, a fully-integrated life science campus featuring four world-class laboratory/office facilities, high-quality amenities, and green space. Alexandria’s entitlement efforts resulted in an increase of 1.1 million developable square feet over the original entitlements in place at acquisition. |
| Update | · 4Q11: Commenced development of a build-to-suit for Biogen Idec Inc. at 225 Binney Street<br><br><br>· 1Q13: Commenced development of build-to-suit for ARIAD Pharmaceuticals, Inc. at 75/125 Binney Street |
| Near-Term Opportunity | Laboratory ground-up development projects at 50 and 100 Binney Street aggregating approximately 1.0 million RSF plus 228,000 RSF of residential; subject to market conditions, we expect to commence development of these opportunities over the next one to three years and we may consider financing these projects with joint venture capital. We believe the estimated investment, excluding land, to develop laboratory buildings, with an underground parking garage, on these parcels ranges from $660 to $825 per square foot. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 33 |
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities
Overview of San Diego Market

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 34 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities in San Diego Market

| Property | 10300 Campus Point Drive | 5200 Illumina Way |
|---|---|---|
| Submarket/Market | University Town Center/San Diego | University Town Center/San Diego |
| Aerial | <br><br><br> <br><br><br> |
![]() |
| Background | 10300 Campus Point Drive is Alexandria’s flagship 449,759 rentable square foot, multi-tenant campus in University Town Center. | Alexandria owns and operates the headquarters campus of Illumina, Inc., the leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function with a YE12 market capitalization<br><br><br>of $6.9 billion. |
| Update | · 4Q10: Acquired as a manufacturing facility and began redeveloping it into a state-of-the-art laboratory property<br><br><br>· 3Q12: Completed redevelopment of 10300 Campus Point Drive, a 96% leased project with leading tenants including Eli Lilly and Company, Celgene Corporation, Covance Inc., and the Regents of the University of California | · 4Q10: Acquired world-class campus from Biogen Idec Inc.<br><br><br>· 4Q10: Leased entire 3 building campus to Illumina, Inc.<br><br><br>· 4Q12: Completed development of fourth building with 127,373 RSF for Illumina, Inc.<br><br><br>· 1Q13: Completed development of fifth building with 23,124 RSF for Illumina, Inc. |
| Near-Term Opportunity | Ground-up development projects aggregating approximately 140,000 RSF; subject to market conditions, we expect to commence development of these opportunities over the next one to three years. We believe the estimated investment, excluding land, to develop laboratory buildings on these parcels ranges from $450 to $500 per square foot. | Future ground-up development projects for two buildings (building 6 and 7) aggregating 392,983 RSF; subject to market conditions, we expect to commence development of these opportunities over the next one to three years. We believe the estimated investment, excluding land, to develop laboratory buildings on these parcels ranges from $450 to $500 per square foot. Additionally, the site supports an above ground parking garage which Illumina, Inc. may elect to lease at a similar return to the Company as a new building. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 35 | |
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities in San Diego Market

| Property | 3013/3033 Science Park Road |
|---|---|
| Submarket/Market | Torrey Pines/San Diego |
| Aerial | <br><br><br>**** |
| Background | ARE Spectrum is Alexandria’s 335,145 rentable square foot, multi-tenant campus located in Torrey Pines. The existing operating laboratory properties are fully leased to the Scripps Research Institute and Sapphire Energy, Inc. |
| Update | · 2Q12 - Acquired the 3013/3033 Science Park Road sites with a short-term lease in-place.<br><br><br>· 2013 - Commenced predevelopment activities to design future laboratory product in a highly desirable and dense lab market. |
| Near-Term Opportunity | Ground-up development and possible redevelopment opportunities aggregating 176,500 RSF for either multi-tenant use or a large campus user. Subject to market conditions, we expect to commence construction of these opportunities over the next one to three years. We believe the estimated investment, excluding land, to construct laboratory buildings on these parcels ranges from $350 to $500 per square foot. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 36 |
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities or Held for Future Development
Overview of Seattle Market

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 37 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities or Held for Future Development in Seattle Market

| Property | Dexter/Terry Avenue and Eastlake Avenue |
|---|---|
| Submarket/Market | Lake Union/Seattle |
| Aerial | ![]() |
| Background | Alexandria’s Dexter/Terry Avenue and Eastlake Avenue assets are located at Lake Union, home to numerous highly renowned medical research institutions, including the Fred Hutchinson Cancer Research Center and the University of Washington. |
| Update | · 2010: Completed 115,084 rentable square foot build-to-suit for Gilead Sciences, Inc.<br><br><br>· 2011: Commenced redevelopment of 117,482 square foot project at 1551 Eastlake Avenue<br><br><br>· 2012: Commenced redevelopment of 66,776 square foot project at 1616 Eastlake Avenue<br><br><br>· 2012: Sold two assets to residential developers for an average sales price per square foot of approximately $72<br><br><br>· 2014: Sale of 810 Dexter Avenue North is expected to close in the next two to three quarters |
| Near-Term Opportunity | Build-to suit opportunities, as well as expansion opportunities related to existing client tenants. Subject to market conditions, we expect to monetize these land sites through dispositions or commencement of development over the next one to three years. We believe the estimated investment, excluding land, to develop laboratory buildings on these parcels ranges from $375 to $550 per square foot. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 38 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Held for Future Development
Overview of San Francisco Bay Area Market

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 39 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Held for Future Development in San Francisco Market

| Property | East Grand Avenue |
|---|---|
| Submarket/Market | South San Francisco/San Francisco Bay Area |
| Aerial | ![]() |
| Background | Alexandria owns and operates the headquarters campus of Onyx Pharmaceuticals, Inc., the cutting-edge global commercial-stage oncology company. |
| Update | · 2010: Completed development of 249 East Grand Avenue, 100% leased to Onyx Pharmaceuticals, Inc.<br><br><br>· 4Q12: Completed development of 259 East Grand Avenue, 100% leased to Onyx Pharmaceuticals, Inc.<br><br><br>· 1Q13: Commenced construction on 269 East Grand Avenue, 100% pre-leased to Onyx Pharmaceuticals, Inc. |
| Near-Term Opportunity | Ground-up development projects aggregating 121,632 RSF on the Onyx campus; subject to market conditions. We believe the estimated investment, excluding land, to develop a laboratory building on this parcel ranges from $375 to $430 per square foot. This site supports an above ground parking garage which Onyx may elect to lease at a similar return to the Company as a new building. Additionally, we also have approximately 790,000 RSF of future opportunities at other sites in South San Francisco. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 40 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities or Held for Future Development
Overview of Suburban Washington, D.C. Market

| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 41 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Future Value-Added Projects in North America
Land Undergoing Predevelopment Activities or Held for Future Development in Washington, D.C. Market

| Property | 9800 Medical Center Drive |
|---|---|
| Submarket/<br><br><br>Market | Rockville/Suburban Washington, D.C. |
| Aerial | ![]() |
| Background | Alexandria’s 9800 Medical Center Drive campus is located in the heart of the Shady Grove Life Sciences Center. |
| Update | · 2013: Alexandria expects to complete redevelopment of 75,056 RSF; 100% pre-leased to National Institutes of Health for 15 years<br><br><br>· 2013: Upon completion of the redevelopment, the National Institutes of Health will occupy approximately 135,000 RSF, or 48% of the campus |
| Near-Term Opportunity | Future development projects for expansion opportunities of 260,721 RSF at 9800 Medical Center Drive plus 408,000 RSF at other well-located sites in Rockville. We are not likely to commence ground-up development in the near-term given current market conditions. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 42 |
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Real Estate Investment in Asia
(Unaudited)
Property listing
| **** | **** | **** | Annualized | Occupancy Percentage | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| **** | Rentable Square Feet | Number of | Base Rent | Operating and | |||||||
| Country | Operating | Development | Redevelopment | Total | Properties | (in thousands) | Operating | Redevelopment | |||
| China | **** | **** | **** | **** | |||||||
| China | 299,484 | – | – | 299,484 | 1 | $ | 452 | 46.7 | % | 46.7 | % |
| China | – | 309,476 | – | 309,476 | 1 | – | N/A | N/A | |||
| Total China | 299,484 | 309,476 | – | 608,960 | 2 | 452 | 46.7 | 46.7 | |||
| India | **** | **** | **** | **** | **** | **** | **** | **** | |||
| India | 33,698 | – | – | 33,698 | 1 | 220 | 40.4 | 40.4 | |||
| India | 143,260 | – | – | 143,260 | 1 | 2,498 | 87.7 | 87.7 | |||
| India | – | 134,500 | – | 134,500 | 1 | – | N/A | N/A | |||
| India | – | 175,000 | – | 175,000 | 1 | – | N/A | N/A | |||
| India | 54,960 | – | 41,068 | 96,028 | 1 | 668 | 100.0 | 57.2 | |||
| India | – | – | 44,660 | 44,660 | 1 | – | N/A | – | |||
| India | 86,200 | – | – | 86,200 | 1 | 898 | 100.0 | 100.0 | |||
| Total India | 318,118 | 309,500 | 85,728 | 713,346 | 7 | 4,284 | 88.1 | 69.4 | |||
| Total Asia | 617,602 | 618,976 | 85,728 | 1,322,306 | 9 | $ | 4,736 | 68.1 | % | 59.8 | % |
(1) Represents annualized base rent for non-laboratory use.
Summary of investments in real estate
| June 30, 2013 | March 31, 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value<br> (in thousands) | Rentable<br> Square Feet | Cost per<br> Square Foot | Book Value<br> (in thousands) | Rentable<br> Square Feet | Cost per<br> Square Foot | |||||
| Rental properties, net, in China | $ | 21,233 | 299,484 | $ | 71 | $ | 21,352 | 299,484 | $ | 71 |
| Rental properties, net, in India | 34,077 | 318,118 | 107 | 35,337 | 304,503 | 116 | ||||
| CIP/current value-added projects: | ||||||||||
| Active development projects in China | 59,584 | 309,476 | 193 | 58,500 | 309,476 | 189 | ||||
| Active development projects in India | 28,875 | 309,500 | 93 | 29,713 | 309,500 | 96 | ||||
| Active redevelopment projects in India | 10,490 | 85,728 | 122 | 13,144 | 99,143 | 133 | ||||
| 98,949 | 704,704 | 140 | 101,357 | 718,119 | 141 | |||||
| Land held for future development/land undergoing predevelopment activities (additional CIP) - India | 79,105 | 6,828,864 | 12 | 83,735 | 6,828,864 | 12 | ||||
| Total investments in real estate, net, in Asia | $ | 233,364 | 8,151,170 | $ | 29 | $ | 241,781 | 8,150,970 | $ | 30 |
Active development and redevelopment
| Investment (in thousands) | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Project RSF | Leased Status RSF | To Complete | |||||||||||||||||
| In | Leased | Negotiating | Total Leased/Negotiating | June 30, 2013 | 2014 and | Total at | |||||||||||||
| Description | Service | CIP | Total | RSF | % | RSF | % | RSF | % | In Service | CIP | 2013 | Thereafter | Completion | |||||
| China development project | – | 309,476 | 309,476 | – | –% | – | –% | – | –% | $ | – | $ | 59,584 | $ | 1,776 | $ | 20,940 | $ | 82,300 |
| India development projects | – | 309,500 | 309,500 | 203,000 | 66% | – | –% | 203,000 | 66% | – | 28,875 | 10,186 | 12,724 | 51,785 | |||||
| India redevelopment projects | 54,960 | 85,728 | 140,688 | 55,160 | 39% | 6,400 | 5% | 61,560 | 44% | 5,862 | 10,490 | 2,223 | 4,134 | 22,709 | |||||
| Total active development and redevelopment in Asia | 54,960 | 704,704 | 759,664 | $ | 5,862 | $ | 98,949 | $ | 14,185 | $ | 37,798 | $ | 156,794 | ||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 43 | ||||||||||||||||||
| --- | --- |
BALANCE SHEET
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Credit Metrics
(Unaudited)
| Net Debt/Adjusted EBITDA | Net Debt to Gross Assets (Excluding Cash and Restricted Cash) |
|---|---|
| Fixed Charge Coverage Ratio | Interest Coverage Ratio |
| Unencumbered NOI as a % of Total NOI | Unencumbered Assets Gross Book Value as a % of Gross Assets |
| Liquidity | Unhedged Variable Rate Debt as a % of Total Debt |
| (1) | Periods represent quarter annualized metrics. We believe key credit metrics for the three months ended June 30, 2013, annualized, reflect the completion of many development and redevelopment projects and are indicative of the Company’s current operating trends. |
| --- | --- |
| (2) | Certain encumbered properties under redevelopment were completed just prior to or during the three months ended June 30, 2013, including 400 Technology Square, 9800 Medical Center Drive, and 259 East Grand Avenue. The additional lease commencements generated incremental encumbered NOI relative to the existing base of unencumbered NOI and resulted in a decrease in our ratio of unencumbered NOI as a percentage of total NOI. We expect the ratio of unencumbered NOI to increase by 12%-to-14% in the first quarter of 2014 when the $211 million secured loan related to our properties at Alexandria Technology Square matures and is refinanced with the issuance of unsecured notes payable. |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 45 |
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Debt
(Dollars in thousands)
(Unaudited)
Fixed rate/hedged and unhedged variable rate debt
| Fixed Rate/Hedged<br> Variable Rate | Unhedged<br> Variable Rate | Total<br> Consolidated | Percentage of<br> Total | Weighted Average<br> Interest Rate at<br> End of Period (1) | Weighted Average<br> Remaining Term<br> (including extension<br> options, in years) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Secured notes payable, net | $ | 591,623 | $ | 119,406 | $ | 711,029 | 24.0% | 5.48% | 2.7 |
| Unsecured senior notes payable, net | 1,048,395 | – | 1,048,395 | 35.4 | 4.29 | 9.3 | |||
| $1.5 billion unsecured senior line of credit | – | – | – | – | 1.39 | 3.8 | |||
| 2016 Unsecured Senior Bank Term Loan | 400,000 | 200,000 | 600,000 | 20.3 | 2.24 | 3.0 | |||
| 2017 Unsecured Senior Bank Term Loan | 600,000 | – | 600,000 | 20.3 | 3.93 | 3.6 | |||
| Total debt / weighted average | $ | 2,640,018 | $ | 319,406 | $ | 2,959,424 | 100.0% | 4.09% | 5.3 |
| Percentage of total debt | 89% | 11% | 100% | ||||||
| (1) | Represents the weighted average contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate swap agreements. The effective interest rate excludes bank fees and amortization of loan fees. | ||||||||
| --- | --- |
Debt maturities
| Weighted<br> Average<br> Interest | Maturity | Remaining for the Period Ending December 31, | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt | Stated Rate | Rate (1) | Date (2) | 2013 | 2014 | 2015 | 2016 | 2017 | Thereafter | Total | ||||||||||||||||
| Secured notes payable | ||||||||||||||||||||||||||
| Greater Boston | 5.26 | % | 5.59% | 4/1/14 | $ | 1,945 | $ | 208,683 | $ | – | $ | – | $ | – | $ | – | $ | 210,628 | ||||||||
| Suburban Washington, D.C. | 2.18 | 2.18 | 4/20/14 | (3) | – | 76,000 | – | – | – | – | 76,000 | |||||||||||||||
| San Diego | 6.05 | 4.88 | 7/1/14 | 59 | 6,458 | – | – | – | – | 6,517 | ||||||||||||||||
| San Diego | 5.39 | 4.00 | 11/1/14 | 74 | 7,495 | – | – | – | – | 7,569 | ||||||||||||||||
| Seattle | 6.00 | 6.00 | 11/18/14 | 120 | 240 | – | – | – | – | 360 | ||||||||||||||||
| Suburban Washington, D.C. | 5.64 | 4.50 | 6/1/15 | 54 | 138 | 5,788 | – | – | – | 5,980 | ||||||||||||||||
| Greater Boston, San Francisco Bay Area, and San Diego | 5.73 | 5.73 | 1/1/16 | 814 | 1,713 | 1,816 | 75,501 | – | – | 79,844 | ||||||||||||||||
| Greater Boston, San Diego, and Greater NYC | 5.82 | 5.82 | 4/1/16 | 438 | 931 | 988 | 29,389 | – | – | 31,746 | ||||||||||||||||
| San Francisco Bay Area | 6.35 | 6.35 | 8/1/16 | 1,149 | 2,487 | 2,652 | 126,715 | – | – | 133,003 | ||||||||||||||||
| San Francisco Bay Area | LIBOR+1.50 | 1.70 | 7/1/17 | (4) | – | – | 43,046 | – | – | – | 43,046 | |||||||||||||||
| San Diego, Suburban Washington, D.C., and Seattle | 7.75 | 7.75 | 4/1/20 | 685 | 1,453 | 1,570 | 1,696 | 1,832 | 108,469 | 115,705 | ||||||||||||||||
| San Francisco Bay Area | 6.50 | 6.50 | 6/1/37 | – | 17 | 18 | 19 | 20 | 773 | 847 | ||||||||||||||||
| Average/Total | 5.42 | % | 5.48 | 5,338 | 305,615 | 55,878 | 233,320 | 1,852 | 109,242 | 711,245 | ||||||||||||||||
| $1.5 billion unsecured senior line of credit (6) | LIBOR+1.20%(5) | 1.39 | 4/30/17 | – | – | – | – | – | – | – | ||||||||||||||||
| 2016 Unsecured Senior Bank Term Loan (6) | LIBOR+1.75% | 2.24 | 6/30/16 | (3) | – | – | – | 600,000 | – | – | 600,000 | |||||||||||||||
| 2017 Unsecured Senior Bank Term Loan (6) | LIBOR+1.50% | 3.93 | 1/31/17 | (3) | – | – | – | – | 600,000 | – | 600,000 | |||||||||||||||
| Unsecured senior notes payable | 4.60 | % | 4.61 | 4/1/22 | – | 250 | – | – | – | 550,000 | 550,250 | |||||||||||||||
| Unsecured senior notes payable | 3.90 | % | 3.94 | 6/15/23 | – | – | – | – | – | 500,000 | 500,000 | |||||||||||||||
| Average/Subtotal | 4.09 | 5,338 | 305,865 | 55,878 | 833,320 | 601,852 | 1,159,242 | 2,961,495 | ||||||||||||||||||
| Unamortized discounts | – | (294 | ) | (200 | ) | (139 | ) | (177 | ) | (184 | ) | (1,077 | ) | (2,071 | ) | |||||||||||
| Average/Total | 4.09% | $ | 5,044 | $ | 305,665 | $ | 55,739 | $ | 833,143 | $ | 601,668 | $ | 1,158,165 | $ | 2,959,424 | |||||||||||
| Balloon payments | $ | – | $ | 297,330 | $ | 48,774 | $ | 830,029 | $ | 600,000 | $ | 654,352 | $ | 2,430,485 | ||||||||||||
| Principal amortization | 5,044 | 8,335 | 6,965 | 3,114 | 1,668 | 503,813 | 528,939 | |||||||||||||||||||
| Total consolidated debt | $ | 5,044 | $ | 305,665 | $ | 55,739 | $ | 833,143 | $ | 601,668 | $ | 1,158,165 | $ | 2,959,424 | ||||||||||||
| Fixed rate/hedged variable rate debt | $ | 4,924 | $ | 229,425 | $ | 12,693 | $ | 633,143 | $ | 601,668 | $ | 1,158,165 | $ | 2,640,018 | ||||||||||||
| Unhedged variable rate debt | 120 | 76,240 | 43,046 | 200,000 | – | – | 319,406 | |||||||||||||||||||
| Total consolidated debt | $ | 5,044 | $ | 305,665 | $ | 55,739 | $ | 833,143 | $ | 601,668 | $ | 1,158,165 | $ | 2,959,424 | ||||||||||||
| (1) | Represents the weighted average contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate swap agreements. The weighted average interest rate excludes bank fees and amortization of loan fees. | |||||||||||||||||||||||||
| --- | --- | |||||||||||||||||||||||||
| (2) | Includes any extension options that we control. | |||||||||||||||||||||||||
| (3) | This loan may be prepaid without any prepayment penalty. | |||||||||||||||||||||||||
| (4) | We have two, one year options to extend the stated maturity date of July 1, 2015 | |||||||||||||||||||||||||
| (5) | In addition to the stated rate, we are subject to an annual facility fee of 0.25%. | |||||||||||||||||||||||||
| (6) | Does not reflect amendments completed or in progress subsequent to June 30, 2013, that will reduce our borrowing costs and/or extend our maturity as noted on page 2 of our accompanying earnings press release. | |||||||||||||||||||||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 46 | |||||||||||||||||||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Summary of Debt
(Dollars in thousands)
(Unaudited)
Debt covenants
| Unsecured Senior Notes Payable | Unsecured Senior Line of Credit and<br> Unsecured Senior Bank Term Loans | |||
|---|---|---|---|---|
| Debt Covenant Ratios | Requirement | Actual (1) | Current Requirement | Actual (1) |
| Total Debt to Total Assets | < 60% | 36% | < 60% | 33% |
| Secured Debt to Total Assets | < 40% | 9% | < 40% | 8% |
| Consolidated EBITDA to Interest Expense | > 1.50x | 5.28x | > 1.50x | 2.5x |
| Unencumbered Total Asset Value to Unsecured Debt | >150% | 284% | N/A | N/A |
| Unsecured Leverage Ratio | N/A | N/A | < 60% | 37% |
| Unsecured Interest Coverage Ratio | N/A | N/A | > 1.75x | 7.2x |
(1) Actual covenants are calculated pursuant to the specific terms as detailed in each agreement.
Summary of interest rate swap agreements
| Interest Pay | Fair Value as of | Notional Amount in Effect as of | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Transaction Date | Effective Date | Termination Date | Rate (1) | June 30, 2013 | June 30, 2013 | December 31, 2013 | ||||
| December 2006 | December 29, 2006 | March 31, 2014 | 4.990% | $ | (1,804 | ) | $ | 50,000 | $ | 50,000 |
| October 2007 | October 31, 2007 | September 30, 2013 | 4.642% | (563 | ) | 50,000 | – | |||
| December 2006 | November 30, 2009 | March 31, 2014 | 5.015% | (2,721 | ) | 75,000 | 75,000 | |||
| December 2006 | November 30, 2009 | March 31, 2014 | 5.023% | (2,725 | ) | 75,000 | 75,000 | |||
| December 2011 | December 31, 2012 | December 31, 2013 | 0.640% | (553 | ) | 250,000 | – | |||
| December 2011 | December 31, 2012 | December 31, 2013 | 0.640% | (553 | ) | 250,000 | – | |||
| December 2011 | December 31, 2012 | December 31, 2013 | 0.644% | (279 | ) | 125,000 | – | |||
| December 2011 | December 31, 2012 | December 31, 2013 | 0.644% | (279 | ) | 125,000 | – | |||
| December 2011 | December 31, 2013 | December 31, 2014 | 0.977% | (1,536 | ) | – | 250,000 | |||
| December 2011 | December 31, 2013 | December 31, 2014 | 0.976% | (1,534 | ) | – | 250,000 | |||
| Total | $ | (12,547 | ) | $ | 1,000,000 | $ | 700,000 | |||
| (1) | In addition to the interest pay rate, borrowings outstanding under our unsecured senior bank term loans include an applicable margin ranging from 1.50% to 1.75% as of June 30, 2013. | |||||||||
| --- | --- | |||||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 47 | |||||||||
| --- | --- |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Assets Held for Sale and Summary of Real Estate Sales
(Dollars in thousands)
(Unaudited)
Non-income-producing land sales
| Description | Sales Price | |
|---|---|---|
| Completed | ||
| Land sold during the second quarter of 2013 | $ | 18,050 |
| Projected | ||
| Land subject to purchase and sale agreement | $ | 55,000 |
| Land subject to sale negotiations | 30,000 | |
| Additional land sales | 46,000 - 86,000 | |
| Total projected non-income producing land sales for the six months ended December 31, 2013 | $ | 131,000 - 171,000 |
Net assets of discontinued operations
| Description | June 30, 2013 | ||
|---|---|---|---|
| Properties “held for sale,” net | $ | 4,180 | |
| Other assets | 7 | ||
| Total assets | 4,187 | ||
| Total liabilities | (8 | ) | |
| Net assets of discontinued operations | $ | 4,179 |
Income from discontinued operations, net
| **** | Three Months Ended June 30, | Six Months Ended June 30, | **** | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| **** | 2013 | 2012 | 2013 | 2012 | **** | ||||||
| Total revenues | $ | 241 | $ | 8,831 | $ | 3,737 | $ | 18,138 | |||
| Operating expenses | 217 | 2,506 | 1,629 | 5,549 | |||||||
| NOI from discontinued operations | 24 | 6,325 | 2,108 | 12,589 | |||||||
| Interest expense | – | – | – | – | |||||||
| Depreciation expense | – | 1,614 | 930 | 3,233 | |||||||
| (Gain) loss on sale of real estate | (219 | ) | (2 | ) | 121 | (2 | ) | ||||
| Income from discontinued operations, net | $ | 243 | $ | 4,713 | $ | 1,057 | $ | 9,358 |
Income-producing assets sold in second quarter
| Property | Location | Date of<br> Purchase | Date of Sale | RSF | Annualized<br> GAAP<br> NOI (1) | Sales Price | Sales Price<br> per RSF | Gain<br> on Sale (2) | Unlevered<br> IRR | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 702 Electronic Drive | Horsham, PA | June 1998 | April 2013 | 40,171 | $ | 438 | $ | 4,362 | $ | 109 | $ | 219 | 10.0% |
| (1) | Annualized using actual year-to-date results as of the quarter ended prior to date of sale or June 30, 2013, whichever is earlier. | ||||||||||||
| --- | --- | ||||||||||||
| (2) | Excludes impairment charges aggregating $2.1 million recognized during the year ended December 31, 2012. | ||||||||||||
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br><br><br>ALL RIGHTS RESERVED © 2013 | 48 | ||||||||||||
| --- | --- |
DEFINITIONS AND
OTHER INFORMATION
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Definitions and Other Information
(Unaudited)
This section contains additional information for sections throughout this supplemental information package as well as explanations of certain non-GAAP financial measures and the reasons why we use these supplemental measures of performance. Additional detail can be found in our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, as well as other documents filed with or furnished to the SEC from time to time.
Adjusted EBITDA and Adjusted EBITDA margins
EBITDA represents earnings before interest, taxes, depreciation, and amortization (“EBITDA”), a non-GAAP financial measure, and is used by us and others as a supplemental measure of performance. We use adjusted EBITDA (“Adjusted EBITDA”) and Adjusted EBITDA margins to assess the performance of our core operations, for financial and operational decision making, and as a supplemental or additional means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA also serves as a proxy for a component of a financial covenant under certain of our debt obligations. Adjusted EBITDA is calculated as EBITDA excluding net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels. We believe Adjusted EBITDA and Adjusted EBITDA margins provide investors relevant and useful information because they permit investors to view income from our operations on an unleveraged basis before the effects of taxes, non-cash depreciation and amortization, net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels. By excluding interest expense and gains or losses on early extinguishment of debt, EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins allow investors to measure our performance independent of our capital structure and indebtedness and, therefore, allow for a more meaningful comparison of our performance to that of other companies, both in the real estate industry and in other industries. We believe that excluding non-cash charges related to share -based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use. We believe that adjusting for the effects of gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels provides useful information by excluding certain items that are not representative of our core operating results. These items are dependent upon historical costs, and are subject to judgmental inputs and the timing of our decisions. EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins have limitations as measures of our performance. EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins do not reflect our historical cash expenditures or future cash requirements for capital expenditures or contractual commitments. While EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins are relevant and widely used measures of performance, they do not represent net income or cash flows from operations as defined by GAAP, and they should not be considered as alternatives to those indicators in evaluating performance or liquidity. Further, our computation of EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins may not be comparable to similar measures reported by other companies.
The following table reconciles net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, to EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins:
| Three Months Ended | Six Months Ended | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (dollars in thousands) | 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | ||||||||||||
| Net income | $ | 33,337 | $ | 30,237 | $ | 28,807 | $ | 18,305 | $ | 25,641 | $ | 63,574 | $ | 58,416 | |||||
| Interest expense – continuing operations | 15,978 | 18,020 | 17,941 | 17,092 | 17,922 | 33,998 | 34,148 | ||||||||||||
| Depreciation and amortization – continuing operations | 46,580 | 46,065 | 47,515 | 46,584 | 50,741 | 92,645 | 92,527 | ||||||||||||
| Depreciation and amortization – discontinued operations | – | 930 | 557 | 1,589 | 1,614 | 930 | 3,233 | ||||||||||||
| EBITDA | 95,895 | 95,252 | 94,820 | 83,570 | 95,918 | 191,147 | 188,324 | ||||||||||||
| Stock compensation expense | 4,463 | 3,349 | 3,748 | 3,845 | 3,274 | 7,812 | 6,567 | ||||||||||||
| Loss on early extinguishment of debt | 560 | – | – | – | 1,602 | 560 | 2,225 | ||||||||||||
| (Gain) loss on sale of real estate | (219 | ) | 340 | – | (1,562 | ) | (2 | ) | 121 | (2 | ) | ||||||||
| Gain on sale of land parcel | (772 | ) | – | – | – | – | (772 | ) | (1,864 | ) | |||||||||
| Impairment of real estate | – | – | 1,601 | 9,799 | – | – | – | ||||||||||||
| Impairment of land parcel | – | – | 2,050 | – | – | – | – | ||||||||||||
| Adjusted EBITDA | $ | 99,927 | $ | 98,941 | $ | 102,219 | $ | 95,652 | $ | 100,792 | $ | 198,868 | $ | 195,250 | |||||
| Total revenues | $ | 154,235 | $ | 150,380 | $ | 151,554 | $ | 142,850 | $ | 145,593 | $ | 304,615 | $ | 281,304 | |||||
| Adjusted EBITDA margins | 65% | 66% | 67% | 67% | 69% | 65% | 69% |
Adjusted funds from operations
AFFO is a non-GAAP financial measure that we use as a supplemental measure of our performance. We compute AFFO by adding to or deducting from FFO, as adjusted: (1) maintenance building improvements, and non-revenue-enhancing tenant improvements and leasing commissions (excludes development and redevelopment expenditures); (2) effects of straight-line rent and straight-line rent on ground leases; (3) capitalized income from development projects; (4) amortization of acquired above and below market leases, loan fees, and debt premiums/discounts; (5) non-cash compensation expense; and (6) allocation of AFFO attributable to unvested restricted stock awards.
We believe that AFFO is a useful supplemental performance measure because it further adjusts to: (1) deduct certain expenditures that, although capitalized and classified in depreciation expense, do not enhance the revenue or cash flows of our properties; (2) eliminate the effect of straight-lining our rental income and capitalizing income from development projects in order to reflect the actual amount of contractual rents due in the period presented; and (3) eliminate the effect of non-cash items that are not indicative of our core operations and do not actually reduce the amount of cash generated by our operations. We believe that eliminating the effect of non-cash charges related to share-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use. We believe that AFFO provides useful information by excluding certain items that are not representative of our core operating results because such items are dependent upon historical costs or subject to judgmental valuation inputs and the timing of our decisions.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 50 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Definitions and Other Information
(Unaudited)
AFFO is not intended to represent cash flow for the period, and is intended only to provide an additional measure of performance. We believe that net income attributable to Alexandria’s common stockholders is the most directly comparable GAAP financial measure to AFFO. We believe that AFFO is a widely recognized measure of the operations of equity REITs, and presenting AFFO will enable investors to assess our performance in comparison to other equity REITs. However, other equity REITs may use different methodologies for calculating AFFO and, accordingly, our AFFO may not be comparable to AFFO calculated by other equity REITs. AFFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.
Annualized base rent
Annualized base rent means the annualized fixed base rental amount in effect as of the end of the period, related to our operating rentable square feet (using rental revenue computed on a straight-line basis in accordance with GAAP).
Average cash yield
See definition of Initial Stabilized Yield (unlevered).
Capitalized interest
A key component of our business model is our value-added development and redevelopment projects. These programs are focused on providing high-quality generic life science laboratory space to meet the real estate requirements of and are reusable by various life science industry client tenants. Upon completion, each value-added project is expected to generate significant revenues and cash flows. Our development and redevelopment projects are generally in locations that are highly desirable to life science entities which we believe results in higher occupancy levels, longer lease terms, and higher rental income and returns. Development projects consist of the ground-up development of generic life science laboratory facilities. Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into generic life science laboratory space. We also have certain significant value-added projects undergoing important and substantial predevelopment activities to bring these assets to their intended use. These critical activities add significant value and are required for the construction of buildings. The projects will provide high-quality facilities for the life science industry and are expected to generate significant revenue and cash flows for the Company. In accordance with GAAP, we capitalize project costs clearly related to the construction, development, and redevelopment as a cost of the project. Indirect project costs such as construction administration, legal fees, and office costs that clearly relate to projects under construction, development, and redevelopment are also capitalized as a cost of the project. We capitalize project costs only during periods in which activities necessary to prepare an asset for its intended use are in progress. We also capitalize interest cost as a cost of the project only during the period for which activities necessary to prepare an asset for its intended use are ongoing, provided that expenditures for the asset have been made and interest cost is incurred. Additionally, should activities necessary to prepare an asset for its intended use cease, interest, taxes, insurance, and certain other direct project costs related to these assets would be expensed as incurred.
Cash interest
Cash interest is equal to interest expense calculated in accordance with GAAP, plus capitalized interest, less amortization of loan fees, and amortization of debt premiums/discounts.
Construction in progress/current value-added projects
Active development/active redevelopment projects
A key component of our business model is our value-added development and redevelopment projects. These programs are focused on providing high-quality, generic, and reusable life science laboratory space to meet the real estate requirements of a wide range of clients in the life science industry. Upon completion, each value-added project is expected to generate significant revenues and cash flows. Our development and redevelopment projects are generally in locations that are highly desirable to life science entities, which we believe results in higher occupancy levels, longer lease terms, and higher rental income and returns. Development projects consist of the ground-up development of generic and reusable life science laboratory facilities. We generally will not commence new development projects for aboveground vertical construction of new life science laboratory space without first securing pre-leasing for such space except when there is significant market demand for high-quality laboratory facilities. Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into generic life science laboratory space.
Dividend payout ratio
Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends on our common stock (shares of common stock outstanding on the respective record date multiplied by the related dividend per share) to FFO attributable to Alexandria’s common stockholders on a diluted basis, as adjusted.
Dividend yield
Dividend yield for the quarter represents the annualized quarter dividend divided by the closing common stock price at the end of the quarter.
EBITDA
See Adjusted EBITDA and Adjusted EBITDA margins
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 51 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Definitions and Other Information
(Unaudited)
Fixed charge coverage ratio
The fixed charge coverage ratio is useful to investors as a supplemental measure of our ability to satisfy fixed financing obligations and preferred stock dividends. The following table presents a reconciliation of interest expense, the most directly comparable GAAP financial measure to cash interest and fixed charges:
| Three Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (dollars in thousands) | 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | ||||||||||
| Adjusted EBITDA | $ | 99,927 | $ | 98,941 | $ | 102,219 | $ | 95,652 | $ | 100,792 | |||||
| Interest expense – continuing operations | $ | 15,978 | $ | 18,020 | $ | 17,941 | $ | 17,092 | $ | 17,922 | |||||
| Add: capitalized interest | 15,690 | 14,021 | 14,897 | 16,763 | 15,825 | ||||||||||
| Less: amortization of loan fees | (2,427 | ) | (2,386 | ) | (2,505 | ) | (2,470 | ) | (2,214 | ) | |||||
| Less: amortization of debt premium/discounts | (123 | ) | (115 | ) | (110 | ) | (112 | ) | (110 | ) | |||||
| Cash interest | 29,118 | 29,540 | 30,223 | 31,273 | 31,423 | ||||||||||
| Dividends on preferred stock | 6,471 | 6,471 | 6,471 | 6,471 | 6,903 | ||||||||||
| Fixed charges | $ | 35,589 | $ | 36,011 | $ | 36,694 | $ | 37,744 | $ | 38,326 | |||||
| Fixed charge coverage ratio – quarter annualized | 2.8x | 2.7x | 2.8x | 2.5x | 2.6x | ||||||||||
| Fixed charge coverage ratio – trailing 12 months | 2.7x | 2.7x | 2.6x | 2.6x | 2.7x |
Funds from operations and funds from operations, as adjusted
GAAP basis accounting for real estate assets utilizes historical cost accounting and assumes that real estate values diminish over time. In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Board of Governors of the National Association of Real Estate Investment Trusts (“NAREIT”) established the measurement tool of FFO. Since its introduction, FFO has become a widely used non-GAAP financial measure among equity REITs. We believe that FFO is helpful to investors as an additional measure of the performance of an equity REIT. Moreover, we believe that FFO, as adjusted, is also helpful because it allows investors to compare our performance to the performance of other real estate companies between periods, and on a consistent basis, without having to account for differences caused by investment and disposition decisions, financing decisions, terms of securities, capital structures, and capital market transactions. We compute FFO in accordance with standards established by the Board of Governors of NAREIT in its April 2002 White Paper and related implementation guidance (“NAREIT White Paper”). The NAREIT White Paper defines FFO as net income (computed in accordance with GAAP), excluding gains (losses) from sales of depreciable real estate and land parcels and impairments of depreciable real estate (excluding land parcels), plus real estate related depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Impairments of real estate relate to decreases in the estimated fair value of real estate due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period. Impairments of real estate represent the non-cash write-down of assets when fair value over the recoverability period is less than the carrying value. We compute FFO, as adjusted, as FFO calculated in accordance with the NAREIT White Paper, plus losses on early extinguishment of debt, preferred stock redemption charges, and impairments of land parcels, less realized gain on equity investment primarily related to one non-tenant life science entity, and the amount of such items that is allocable to our unvested restricted stock awards. Our calculations of both FFO and FFO, as adjusted, may differ from those methodologies utilized by other equity REITs for similar performance measurements, and, accordingly, may not be comparable to those of other equity REITs. Neither FFO nor FFO, as adjusted, should be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of liquidity, nor are they indicative of the availability of funds for our cash needs, including funds available to make distributions.
Future value-added projects
Land held for future development
All predevelopment efforts have been advanced to appropriate stages and no further predevelopment activities are ongoing and therefore, interest, property taxes, and other costs related to these assets are expensed as incurred. We generally will not commence new development projects for aboveground vertical construction of new life science laboratory space without first securing pre-leasing for such space.
Land undergoing predevelopment activities (additional CIP)
Land undergoing predevelopment activities includes activities prior to commencement of vertical construction of aboveground building improvements and is classified as construction in progress. We generally will not commence ground-up development of any parcels undergoing predevelopment activities without first securing pre-leasing for such space. If vertical aboveground construction is not initiated at completion predevelopment activities, the land parcel will be classified as land held for future development. Our objective with predevelopment is to reduce the time it takes to deliver projects to prospective client tenants. The largest project included in land undergoing predevelopment consists of substantially all of our 1.2 million developable square feet at the Alexandria Center™ at Kendall Square in East Cambridge, Massachusetts.
We are required to capitalize project costs, including interest, property taxes, insurance, and other costs directly related and essential to the development or construction of a project during periods when activities necessary to prepare an asset for its intended use are in progress. Predevelopment costs generally include the following activities prior to commencement of vertical construction:
· Traditional preconstruction costs including entitlement, design, construction drawings, Building Information Modeling (3-D virtual modeling), budgeting, sustainability and energy optimization reviews, permitting, and planning for all aspects of the project prior to vertical construction of aboveground building improvements including infrastructure, belowground site work, utility connections, land grading and egress and regress access points. Traditional preconstruction costs also include interest, property taxes, and insurance.
· Site and infrastructure construction costs including belowground site work, utility connections, land grading, drainage, egress and regress access points, foundation, and other costs to prepare the site for vertical construction of aboveground building improvements. For example, site and infrastructure costs for the 1.2 million RSF related to 50 Binney Street, 100 Binney Street, and 228,000 RSF of residential of the Alexandria Center™ at Kendall Square are classified as preconstruction prior to commencement of vertical construction. Site and infrastructure costs related to 75/125 Binney Street and 225 Binney Street are included in our estimate of cost of completion and initial stabilized yields for each project.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 52 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Definitions and Other Information
(Unaudited)
Gross assets
Gross assets are equal to total assets plus accumulated depreciation, less cash, cash equivalents, and restricted cash.
Initial stabilized yield (unlevered)
Initial Stabilized Yield is calculated as the quotient of the estimated amounts of NOI and our investment in the property at stabilization. Our Initial Stabilized Yield excludes the impact of leverage. Our cash rents related to our value-added projects are expected to increase over time and our Average Cash Yields are expected, in general, to be greater than our Initial Stabilized Yields on a cash basis. Our estimates for initial cash and GAAP yields, and total costs at completion, represent our initial estimates at the commencement of the project. We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected project yields or costs.
· Initial Stabilized Yield - cash basis: reflects cash rents at the date of stabilization and does not reflect contractual rent escalations beyond the stabilization date.
· Initial Stabilized Yield - GAAP basis: reflects cash rents, including contractual rent escalations and any rent concessions over the term of the lease, calculated on a straight-line basis.
Average Cash Yield reflects cash rents, including contractual rent escalations, over the term of the initial leases at stabilization, calculated on a straight-line basis, but excludes any rent concessions.
Interest coverage ratio
Interest coverage ratio is the ratio of Adjusted EBITDA to cash interest. This ratio is useful to investors as an indicator of our ability to service our cash interest obligations. See fixed charge coverage ratio for calculation of cash interest. The following table summarizes the calculation of the interest coverage ratio:
| Three Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (dollars in thousands) | 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | |||||
| Adjusted EBITDA | $ | 99,927 | $ | 98,941 | $ | 102,219 | $ | 95,652 | $ | 100,792 |
| Cash interest | $ | 29,118 | $ | 29,540 | $ | 30,223 | $ | 31,273 | $ | 31,423 |
| Interest coverage ratio – quarter annualized | 3.4x | 3.3x | 3.4x | 3.1x | 3.2x | |||||
| Interest coverage ratio – trailing 12 months | 3.3x | 3.2x | 3.2x | 3.2x | 3.3x |
Net debt
Net debt is equal to the sum of total debt less cash, cash equivalents, and restricted cash.
NOI
NOI is a non-GAAP financial measure equal to income from continuing operations, the most directly comparable GAAP financial measure, plus loss (gain) on early extinguishment of debt, impairment of land parcel, depreciation and amortization, interest expense, and general and administrative expense. We believe NOI provides useful information to investors regarding our financial condition and results of operations because it reflects primarily those income and expense items that are incurred at the property level. Therefore, we believe NOI is a useful measure for evaluating the operating performance of our real estate assets. NOI on a cash basis is NOI on a GAAP basis, adjusted to exclude the effect of straight-line rent adjustments required by GAAP. We believe that NOI on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent adjustments to rental revenue.
Further, we believe NOI is useful to investors as a performance measure, because when compared across periods, NOI reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations. NOI excludes certain components from income from continuing operations in order to provide results that are more closely related to the results of operations of our properties. For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level. In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level. Real estate impairments have been excluded in deriving NOI because we do not consider impairment losses to be property level operating expenses. Real estate impairment losses relate to changes in the values of our assets and do not reflect the current operating performance with respect to related revenues or expenses. Our real estate impairments represent the write down in the value of the assets to the estimated fair value less cost to sell. These impairments result from investing decisions and the deterioration in market conditions that adversely impact underlying real estate values. Our calculation of NOI also excludes charges incurred from changes in certain financing decisions, such as losses on early extinguishment of debt, as these charges often relate to the timing of corporate strategy. Property operating expenses that are included in determining NOI consist of costs that are related to our operating properties, such as utilities, repairs and maintenance, rental expense related to ground leases, contracted services, such as janitorial, engineering, and landscaping, property taxes and insurance, and property level salaries. General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies that are incurred as part of corporate office management. NOI presented by us may not be comparable to NOI reported by other equity REITs that define NOI differently. We believe that in order to facilitate a clear understanding of our operating results, NOI should be examined in conjunction with income from continuing operations as presented in our condensed consolidated statements of income. NOI should not be considered as an alternative to income from continuing operations as an indication of our performance, or as an alternative to cash flows as a measure of liquidity, or our ability to make distributions.
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 53 |
|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC.
June 30, 2013
Definitions and Other Information
(Unaudited)
Same property comparisons
As a result of changes within our total property portfolio, the financial data presented in the Summary of Same Property Comparisons shows significant changes in revenue and expenses from period to period. In order to supplement an evaluation of our results of operations over a given period, we analyze the operating performance for all properties that were fully operating for the entire periods presented for the quarter periods (herein referred to as “Same Properties”) separate from properties acquired subsequent to the first day in the first period presented, properties undergoing active development and active redevelopment, and corporate entities (legal entities performing general and administrative functions), which are excluded from same property results (herein referred to as “Non-Same Properties”). Additionally, rental revenues from lease termination fees, if any, are excluded from the results of the Same Properties.
Total market capitalization
Total market capitalization is equal to the sum of outstanding shares of Series E Preferred Stock and common stock multiplied by the related closing price of each class at the end of each period presented, the liquidation value of the series D cumulative convertible preferred stock and total debt.
Unencumbered NOI as a percentage of total NOI
Unencumbered NOI as a percentage of total NOI is a non-GAAP financial measure that we believe is useful to investors as a performance measure of our results of operations of our unencumbered real estate assets, as it reflects primarily those income and expense items that are incurred at the unencumbered property level. We use unencumbered NOI as a percentage of total NOI in order to assess our compliance with our financial covenants under our debt obligations because the measure serves as a proxy for a financial measure under such debt obligations. Unencumbered NOI is derived from assets classified in continuing operations which are not subject to any mortgage, deed of trust, lien, or other security interest as of the period for which income is presented. Unencumbered NOI for periods prior to the three months ended June 30, 2013, has been reclassified to conform to current period presentation related to discontinued operations.
| Three Months Ended | Six Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (dollars in thousands) | 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 | |||||||
| Unencumbered NOI | $ | 75,225 | $ | 71,402 | $ | 74,680 | $ | 71,349 | $ | 74,823 | $ | 146,627 | $ | 141,022 |
| Encumbered NOI | 32,687 | 33,754 | 30,698 | 27,298 | 28,668 | 66,441 | 57,727 | |||||||
| Total NOI from continuing operations | $ | 107,912 | $ | 105,156 | $ | 105,378 | $ | 98,647 | $ | 103,491 | $ | 213,068 | $ | 198,749 |
| Unencumbered NOI as a percentage of total NOI | 70% | 68% | 71% | 72% | 72% | 69% | 71% |
Unlevered IRR
We believe Unlevered IRR is a useful supplemental performance measure used by investors to evaluate the performance of a specific real estate investment. Unlevered IRR is the annualized implied discount rate calculated from the cash flows of a real estate asset over the holding period for such asset. Unlevered IRR represents the return that equates the present value of all capital invested in a real estate asset to the present value of all cash flows generated by that real estate asset, or the discount rate that provides a net present value of all cash flows related to a real estate asset to zero. Unlevered IRR is calculated based upon the actual timing of cash flows, including among others i) the initial cash purchase price; ii) cash NOI (GAAP NOI excluding the impact of straight-line rents); iii) capital expenditures; iv) leasing costs, and v) the net sales proceeds of each respective real estate asset. Losses incurred upon sale or non-cash impairment charges recognized during our ownership period are reflected in the unlevered IRR through the net sales proceeds of each real estate asset. The calculation of Unlevered IRR does not include general and administrative costs of the Company or interest expense related to the Company’s financing costs, because they are not directly related or attributable to the operations of the real estate asset.
Weighted average interest rate for capitalization
The weighted average interest rate for calculating capitalization of interest required pursuant to GAAP represents a weighted average rate based on the rates applicable to borrowings outstanding during the period and includes the impact of our interest rate swap agreements, amortization of debt discounts/premiums, amortization of loan fees, and other bank fees. A separate calculation is performed each month to determine our weighted average interest rate for capitalization for the month. The rate will vary each month due to changes in variable interest rates, outstanding debt balances, the proportion of variable rate debt to fixed rate debt, the amount and terms of effective interest rate swap agreements, and the amount of loan fee amortization.
Weighted average shares for calculating FFO, FFO, as adjusted, and AFFO per share
Weighted average shares represent the weighted average of common shares outstanding during the period. The following calculation of weighted average shares was applied to arrive at FFO per share attributable to Alexandria’s common stockholders, FFO per share attributable to Alexandria’s common stockholders, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders:
| Three Months Ended | Six Months Ended | ||||||
|---|---|---|---|---|---|---|---|
| **** | 6/30/13 | 3/31/13 | 12/31/12 | 9/30/12 | 6/30/12 | 6/30/13 | 6/30/12 |
| Weighted average shares of common stock outstanding for calculating FFO, FFO, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – basic | 66,972,892 | 63,161,319 | 63,091,781 | 62,364,210 | 61,663,367 | 65,077,635 | 61,585,587 |
| Effect of assumed conversion and dilutive securities: | |||||||
| Assumed conversion of 8.00% Unsecured Senior Convertible Notes | 6,146 | 6,146 | 6,146 | 6,087 | 6,087 | 6,146 | 6,087 |
| Dilutive effect of stock options | – | – | – | – | 173 | – | 667 |
| Weighted average shares of common stock outstanding for calculating FFO, FFO, as adjusted, and AFFO per share attributable to Alexandria’s common stockholders – diluted | 66,979,038 | 63,167,465 | 63,097,927 | 62,370,297 | 61,669,627 | 65,083,781 | 61,592,341 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC.<br> ALL RIGHTS RESERVED © 2013 | 54 | ||||||
| --- | --- |












<br><br><br>
<br><br><br>****

